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Abstract
Convulsive status epilepticus (CSE) is the most common medical neurological 
emergency in childhood. To ultimately improve the management of CSE, an 
understanding of its incidence, aetiology, seizure types, treatment and outcome in 
the general childhood population is required.
Using emerging techniques for systematic reviews in observational studies, a 
systematic review of the epidemiology of status epilepticus was conducted. All 
eligible studies were based on predominantly or exclusively adult populations. The 
data from these studies suggest that the epidemiology of CSE in childhood differs 
from that in adults. Thus, an epidemiological study on CSE in a paediatric 
population was required. The North London convulsive STatus EPilepticus in 
childhood Surveillance Study (NLSTEPSS), a prospective study, is the first such 
study.
In NLSTEPSS, children with CSE were identified through a multi-tiered 
notification system. Data were collected using a standard questionnaire and 
capture-recapture was used to assess ascertainment. The incidence of CSE in 
childhood is 18-20/100,000/year (95% Cl 17- 23/100,000/yr), with a higher 
incidence amongst non-white children, children of lower socioeconomic status and 
younger children. Lack of prehospital treatment, and treatment with more than 2 
doses of benzodiazepines independently increase the likelihood of CSE lasting 
longer than 60 minutes.
A third of children with CSE are not given prehospital treatment and only 21% of 
those treated are given adequate initial doses. Treatment with more than 2 doses of 
benzodiazepines is associated with respiratory depression. Intravenous lorazepam 
may be better first line therapy than rectal diazepam and intravenous phenytoin may 
be better second line therapy than rectal paraldehyde.
CSE lasting longer than 60 minutes and CSE associated with respiratory depression 
independently increase the likelihood of admission to paediatric intensive care 
(PICU). Thus, strategies to reduce those factors may reduce admissions to PICU.
On the basis of the data from NLSTEPSS, treatment guidelines for CSE in 
childhood may need to be revised and a new treatment guideline is proposed.
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PART ONE 
INTRODUCTION/ BACKGROUND
- 2 0 -
CHAPTER ONE: INTRODUCTION
1.1 Aims of the study
Status epilepticus is the most common medical neurological emergency in 
childhood (Delorenzo et al. 1995, Hesdorffer et al. 1998) and may be convulsive or 
non-convulsive in nature. Most available data on status epilepticus were obtained 
from either hospital-based or tertiary clinic series resulting in biased information 
that may not be applicable to the general childhood population. In order to 
ultimately improve the management of convulsive status epilepticus (CSE) in 
childhood, an understanding of the epidemiology of CSE in the general childhood 
population is required. This thesis will attempt to advance the understanding of 
status epilepticus in the general childhood population by providing population based 
estimates of the incidence, aetiology, seizure characteristics, treatment and short 
term outcome of convulsive status epilepticus in a paediatric population.
1.2 Historical perspective
The probable first documented clinical description of CSE is found on the Sakkiku 
cuneiform which dates from 718-612 BC. That description concludes with a 
statement suggesting that CSE may be fatal but there was no suggestion that CSE 
originated from the brain. From then until the Renaissance in the 16th century, there 
is little mention of CSE in any medical literature. In 1586, Gavassetti observed that 
the brain of cardinal Commendoni was swollen and its ventricular system dilated 
following fatal SE that had lasted 24 hours. The brain was identified as the origin 
of CSE in the description by Thomas Willis in the Pathologicae Cerebrae in 1667. 
Until the work of Louis Calmeil and Desire-Magloire Bourneville at the Salpetriere,
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ththe biggest asylum in Europe and its sister institution the Bicetre in the mid 19 
century, SE was largely considered as a single condition characterised by 
generalised tonic clonic seizures. The term “etat de mal” was coined by the 
patients of these institutions themselves and is first found in CalmeiTs thesis. The 
latinised English version of this expression, status epilepticus, was first used in 
Bazires translation of Trousseau’s lectures on clinical medicine (Shorvon 1994a). 
Since the early restrictive conception of SE, it has become clear that SE is not a 
single condition and there are now many clinical descriptions of different types of 
SE.
1.3 Definition of SE
It is widely acknowledged that generalised tonic-clonic CSE is a common medical 
neurological emergency requiring prompt, adequate and appropriate treatment. Its 
diagnosis is usually not difficult except in patients in whom the seizures are 
prolonged and whose clinical features become increasingly attenuated (Lowenstein 
and Aminoff 1992; Treiman 1995). There remains some debate on the most 
appropriate emergency treatment of CSE, particularly on the role of prehospital 
treatment, the route of administration and choice of drugs. Although there are 
consensus views on the emergency management of CSE worldwide, these differ 
from one another (Epilepsy Foundation of America’s Working Group on Status 
Epilepticus 1993; Emergency Paediatrics Section 1996; O’Regan et al. 1996; 
Treiman et al., 1998; Scott et al. 1999; Appleton et al. 2000). There remains some 
debate on the definition of status epilepticus.
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In the first International Classification of Epileptic Seizures that was developed by 
the International League Against Epilepsy (ILAE) in 1964, status epilepticus was 
defined as “ a seizure that persists for a sufficient length of time or is repeated 
frequently enough to produce a fixed and enduring epileptic condition” 
(Commission on the Terminology of the International League Against Epilepsy 
1964). This definition was retained unchanged in the revised classification 
published in 1970 (Gastaut 1970) and remains the official definition of SE by the 
World Health Organisation. The definition was modified slightly in 1981 to refer 
to that situation in which “ a seizure persists for a sufficient length of time or is 
repeated frequently enough that recovery between attacks does not occur” 
(Commission on the Terminology of the International League Against Epilepsy 
1981). Status epilepticus has been described as “the maximum expression of 
epilepsy” (Shorvon 1994b). In pathophysiological terms, SE can be defined as a 
condition in which there is failure of the usual mechanisms that terminate seizures 
but currently there is limited understanding of those mechanisms and this definition 
is not clinically useful. These definitions can be considered inadequate as they all 
lack a specific duration of seizure activity and thus do not clarify when a short 
seizure becomes SE.
1.3.1 Definition fo r  epidemiological, pathophysiological and outcome purposes 
The most common duration of seizure activity qualifying as SE has been 30 
minutes, leading to the commonly used definition “ a seizure or series of seizures 
which last for 30 minutes or more without full recovery of consciousness between 
the seizures” (Celesia 1976; Brodie 1990; Shepherd 1994). The basis of this 
duration has been rooted in the seminal work of Meldrum and colleagues in the 
1970’s where 30 minutes reflects a time during which ongoing seizures can cause
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neuronal injury in animal models (Meldrum et al. 1973). In addition to the work of 
Meldrum and colleagues, other animal data suggest that seizures need to last at least 
thirty minutes for neuronal damage to occur (Lemos et al., 1995; Fujikawa 1996). 
For epidemiological, pathophysiological and outcome purposes, a definition that 
includes a duration of seizures lasting at least thirty minutes is therefore appropriate 
in order to identify those patients at risk of brain injury.
1.3.2 Definition fo r treatment purposes
It is not ethical to wait for at least 30 minutes of seizure activity before initiating 
treatment and in order to prevent permanent neurological sequelae that may arise 
from seizure activity lasting at least thirty minutes, for treatment purposes, a much 
shorter duration of seizure activity qualifying as status epilepticus may be 
appropriate. In a review on the treatment of SE published in 1991, Bleck defined 
SE using a duration of at least 20 minutes (Bleck 1991). In the Veterans Affairs 
Cooperative Trial on Treatment of Generalised Convulsive Status Epilepticus, SE 
was defined using a duration of at least 10 minutes (Treiman et al., 1998). The 
results of two more recent studies suggest that the most appropriate treatment 
definition time may be even shorter than those previously used. Although most 
seizures spontaneously terminate within five minutes of their onset, the majority of 
seizures that last longer than five minutes, are unlikely to stop spontaneously within 
the next few minutes and will continue for at least 30 minutes (DeLorenzo et al., 
1999; Lowenstein et al., 1999; Shinnar et al., 2001a). It may therefore be argued 
that patients who have a seizure lasting 5 minutes are already likely to have failure 
of the usual mechanisms of seizure termination and are in the early stages of SE. 
Thus, for treatment purposes, a definition of SE stating a time of at least 5 minutes 
may be appropriate. As increasing seizure duration is associated with increasing
- 2 4 -
difficulty in seizure termination (Knudsen 1979; Shinnar et al., 2001a), the period 
immediately following the five minute duration threshold provides a window of 
opportunity in which rescue therapy may be given and work but within which 
rescue failure may also be anticipated and planned for. The results of a study of 44 
children with 58 episodes of generalised seizures by Knudsen, suggest that in 
children, the optimum period for initiation of rescue therapy may be within 15 
minutes of the onset of the seizure, as children treated within 15 minutes of the 
onset of the seizure were more likely to have seizure termination than those treated 
after 15 minutes (Knudsen 1979). Figure 1.1 summarises duration of seizure 
activity against key time periods in the natural history of a seizure.
• E
Tim e definition for SE 
for treatment purposes
Interval within 
which most seizures 
spontaneously stop
? Optimum interval 
for initiation o f  
rescue therapy
Tim e definition for SE for 
epidem iological, pathophysiological 
and outcom e purposes
i
15 30
Tim e after onset o f  seizure (m ins)
Figure 1.1: Duration of seizure activity against key time periods in the natural 
history of a seizure.
Thus, all the above definitions of SE are suitable in different situations, but there is 
none that is ideal for every situation. In an attempt to overcome the problems with 
previous definitions, Shorvon has proposed that SE be defined as “a condition in 
which epileptic activity persists for 30 minutes or more, causing a wide spectrum of 
clinical symptoms and with a highly variable pathophysiological anatomical and 
aetiological basis (Shorvon 1994b).” Although it addresses some of the problems
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with prior definitions, it is still not suitable for all situations. It is likely that 
different definitions of SE will be required for different settings. This thesis aims to 
characterise the epidemiology of CSE in childhood and thus, a definition that 
includes seizures lasting at least thirty minutes will be used.
1.4 Aetiology of SE
There is good evidence from epidemiological studies and clinical series that 
aetiology of SE is an important determinant of the outcome of patients with SE and 
it is therefore important to identify the causes of SE. A classification of status 
epilepticus according to aetiology recommended by the ILAE is listed in Table 1.1
The classification of aetiologies recommended by the ILAE is more applicable to 
adults but the aetiology of status epilepticus in children has a different profile from 
that in adults (DeLorenzo et al., 1996; Hesdorffer et al., 1998). In children, a 
significant proportion of SE is associated with fever. Some children with SE with 
fever would have had pre-existing neurological abnormalities, including epilepsy, 
whilst others would have been previously neurologically normal. The latter group 
includes: (1) those children in whom their SE were prolonged febrile seizures, 
defined as SE in a previously neurologically normal child aged between 6 months 
and five years during a febrile (temperature above 38 °C) illness in the absence of 
defined central nervous system (CNS) infection (Scott et al., 2002; Scott et al., 
2003) and (2) children with acute symptomatic SE due to CNS infections. Results 
from epidemiological studies and thus less likely to be subject to referral bias, 
suggest that prolonged febrile seizures are associated with low morbidity and 
mortality (Nelson and Ellenberg, 1978; Maytal et al., 1990; Hesdorffer et al., 1998).
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1. Acute symptomatic - SE in a previously neurologically normal child, within a 
week of an underlying aetiology including CNS infection, prolonged febrile 
seizures, encephalopathy, head trauma, cerebrovascular disease and metabolic or 
toxic derangements.
2. Remote symptomatic - SE in the absence of an identified acute insult but with a 
history of a pre-existing CNS abnormality more than 1 week before.
3. Idiopathic Epilepsy related - SE that is not symptomatic and occurred in children 
with a prior diagnosis of idiopathic epilepsy or when the episode of SE is the 
second unprovoked seizure that has led to a diagnosis of idiopathic epilepsy.
4. Cryptogenic Epilepsy related - SE that is not symptomatic and occurred in 
children with a prior diagnosis of cryptogenic epilepsy or when the episode of SE 
is the second unprovoked seizure that has led to a diagnosis of cryptogenic 
epilepsy.
5. Unclassified - SE that cannot be classified into any other group.
Table 1.1: International League Against Epilepsy’s recommended classification of 
SE according to aetiologies (Gastaut 1983; International League Against Epilepsy 
1993).
A classification system, such as that recommended by the ILAE, that includes 
prolonged febrile seizures in the same category as SE due to an identified acute 
neurological insult, such as acute bacterial meningitis, may be inappropriate for 
paediatric epidemiological or outcome studies. The results of studies that use such a
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classification system may erroneously amplify the severity of outcome of prolonged 
febrile seizures and conversely, dilute the severity of acute neurological insults. In 
addition, the precise pathophysiological mechanisms for prolonged febrile seizures 
are unknown but there is evidence of age and genetic influences (Annegers et al., 
1987; Offringa et al. 1991; Hauser 1994; Berg et al. 1996; Corey et al. 2004). In 
order to identify factors associated with prolonged febrile seizures that may lead to 
pathophysiological hypotheses on the mechanisms for prolonged febrile seizures, 
including the genetic mechanisms, perhaps an attempt to identify prolonged febrile 
seizures as a distinct category of status epilepticus should be made. A revised 
classification system of the aetiologies of SE, with prolonged febrile seizures as a 
distinct category, may be more applicable to paediatric studies whilst retaining the 
flexibility to present data in keeping with the current ILAE guidelines and thereby 
facilitate comparison with other studies. Nonetheless, such a revised classification 
would still have its limitations as accurate categorisation of individual cases may 
depend on the degree of investigation, the availability of ancillary tests and clinical 
data. Accurate diagnosis may require state of the art technology and procedures.
For example, in the absence of a diagnostic lumbar puncture, it may be difficult to 
establish whether a ten month old previously neurologically normal child presenting 
with SE associated with fever and categorised as having a prolonged febrile 
seizures, should have been categorised as acute symptomatic SE. It is also possible 
that an eight month old child presenting with afebrile SE may have a focal area of 
cortical dysplasia and not have any further seizures or may have had the initial 
presentation of epilepsy with severe myoclonic epilepsy of infancy with frequent 
episodes of SE.
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1.5 Other classifications of status epilepticus
Status epilepticus may be classified as convulsive or non-convulsive in nature.
1.5.1 Definition o f  Convulsive Status Epilepticus (CSE)
Convulsive status epilepticus is defined as a seizure with focal or generalised motor 
manifestations, or series of such seizures between which consciousness is not 
regained, which last for at least 30 minutes (Commission on the Terminology of the 
International League Against Epilepsy 1981; International League Against Epilepsy 
1993).
Episodes of convulsive status epilepticus may be further subcategorised according 
to seizure types and whether the episodes were intermittent or continuous in 
character.
1.5.1.1 Convulsive Status Epilepticus (CSE) and Seizure Types
Based on the criteria of the International League Against Epilepsy, convulsive status 
epilepticus may be defined as: primary generalised, focal with secondary 
generalisation and focal (International League Against Epilepsy 1993; Engel 2001). 
CSE seizure types that may be subtyped into tonic, clonic and tonic-clonic seizures.
1.5.1.2 Intermittent or Continuous Convulsive Status Epilepticus (CSE)
Episodes of CSE that are a single continuous seizure may be characterised as 
continuous CSE, and episodes that are serial seizures without recovery of 
consciousness between seizures may be characterised as intermittent CSE.
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1.5.2 Definition ofNon-Convulsive Status Epilepticus (NCSE)
Whilst a clear and widely recognised clinical/EEG definition for non-convulsive 
status epilepticus has not been established, a working definition has been multiple 
seizures or continuous seizure activity on EEG with cognitive or behavioural change 
unaccompanied by frank convulsive movements (Kaplan 2003).
1.6 Outcome of Status Epilepticus from Hospital based studies
1.6.1 Definition o f  hospital based studies
Hospital based studies may be defined as studies conducted in single hospitals or 
networks of hospitals over a wide geographic region without well defined study 
populations (Kilgore and Nyambat 2004).
1.6.2 Outcome o fSE  from Paediatric Intensive Care Unit (P1CU) based studies 
Most of what is known about SE is derived from hospital-based studies. Despite 
this, studies on the admission to paediatric intensive care for status epilepticus i.e. 
the most severe end of the spectrum are very limited. In the only published study, a 
Canadian study, 147 children (1.6% of all admissions) were admitted to PICU for or 
with SE, over a ten year period (Lacroix et al., 1994). Most cases (79%) occurred in 
children who had been previously neurologically normal but had an acute 
neurological insult resulting in SE. Case fatality during hospitalisation was 6%, but 
9% within one year of onset of SE. However, of the 114 children who were 
previously neurologically normal, neurological sequelae ranging from minor 
neurological and/or neurodevelopmental impairment to persistent vegetative states 
were identified in about a third (32%) of patients at discharge. At one year 23% still 
showed some deficit (Lacroix et al., 1994).
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1.6.3 Outcome o fSE  from Non-PIC U, hospital based studies 
There have also been estimates of morbidity and mortality from hospital based 
studies that were not PICU based. In their retrospective review of 239 episodes of 
status epilepticus admitted to a tertiary institution, Aicardi and Chevrie identified 
physical and cognitive problems in 53% of children following SE (Aicardi et al., 
1970). Other studies estimate the risk of partial or generalised epilepsy following 
SE to be between 19% and 82% (Yager et al., 1988; Maytal et al., 1989; Shorvon 
1994b). Mortality in the Aicardi series was 11% (Aicardi et al., 1970) but 
subsequent studies have reported a lower mortality of between 2.3 and 6% (Celesia 
1983; Maytal et al., 1989; Phillips and Shanahan 1989). Some of this apparent 
reduction in mortality may have been due to a change in the definition of SE. Data 
from animal studies (Meldrum et al. 1973; Lemos et al., 1995; Fujikawa 1996) and 
hospital based studies (Aminoff et al. 1980; Towne et al., 1994; Sagduyu et al.,
1998) suggest that mortality increases in proportion to seizure duration. In the 
Aicardi study SE was defined as seizure activity lasting at least 60 minutes 
compared to more recent studies that used 30 minutes within their operational 
definition. It is also possible that the apparent reduction in mortality may be 
partially attributed to improved treatment of status epilepticus (International League 
Against Epilepsy 1993) as well as inexplicable changes in disease mortality with 
time.
Hospital based studies have suggested that age, duration of SE and aetiology are the 
major determinants of morbidity and mortality from SE (Aicardi et al., 1970;
Rowan and Scott 1970; Dunn 1988; Maytal et al., 1989; Phillips and Shanahan 
1989; Gross-Tsur and Shinnar 1993; Shorvon 1994b; Towne et al. 1994). Several
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such studies have reported that death and neurological sequelae are more common 
in the two extremes of age, those less than three years of age and those older than 60 
years (Dunn 1988; Maytal et al., 1989; Gross-Tsur and Shinnar 1993). Two of 
these studies reported that this observation may have been primarily due to an 
increased proportion of acute symptomatic SE in the extremes of age since there 
was no difference within age groups of the outcome amongst other aetiologies 
(Maytal et al., 1989; Gross-Tsur and Shinnar 1993). Two hospital-based studies 
identified duration of seizures as important determinants of outcome (Rowan and 
Scott 1970; Dunn 1988). In their case series of 42 patients, Rowan and Scott 
reported that status epilepticus that lasted a mean of 1.5 hours were not associated 
with any residual neurological deficit, episodes lasting 10 hours were associated 
with neurological sequelae and episodes lasting 13 hours were associated with 
death. Dunn reported that duration of seizures were twice as long in those patients 
who died or who were left with residual neurological deficit (mean duration 3.9 
hours) compared to patients with no new neurological deficits. There is also 
evidence that children whose status epilepticus is caused by acute neurological 
insults and those with progressive neurological abnormalities have the worst 
prognosis (Phillips and Shanahan 1989; DeLorenzo et al., 1992; Gross-Tsur and 
Shinnar 1993; Shorvon 1994b; Towne et al. 1994).
Thus, hospital based studies suggest that SE is potentially harmful. However, in 
order for institutions, and even governments, to make decisions on allocation of 
resources that may be used to develop primary and secondary preventative strategies 
for SE, data on the frequency, aetiology and morbidity and mortality associated with 
status epilepticus in the general population are required.
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CHAPTER 2: A SYSTEMATIC REVIEW OF THE INCIDENCE, 
AETIOLOGY AND OUTCOME OF STATUS EPILEPTICUS
Through a systematic review, the candidate aimed to assess the methodological 
quality as well as similarities and differences between available population based 
studies in order to assimilate available data to clarify the epidemiology of SE.
2.1 Systematic reviews and observational studies
A systematic review was conducted in order to minimise bias and random errors, 
while at the same time producing an accurate summary of all available data. In 
general, there is a vast amount of original research on any one subject published 
each year and studies vary in their methodology, sample size, quality and results. It 
is therefore difficult to keep abreast of and to synthesize all available information on 
a body of research. A systematic review entails a structured approach to 
identifying, assessing, synthesizing and combining the results of all relevant studies 
to make conclusions about a body of research. Without such a systematic approach, 
a review, while potentially useful, may be incomplete and may comprise only data 
previously known to the reviewer (Mulrow 1987; Elboume et al. 1989; Chalmers et 
al. 2002). Some reviewers may be experts in a particular subject, but not be well 
informed about other related subjects. This will result in a final review that may be 
biased towards personal knowledge but not necessarily an accurate summary of all 
available data on the subject.
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On the whole, systematic reviews have been conducted for randomised controlled 
trials (RCTs) as RCTs have long been viewed as the "gold standard" of evidence for 
intervention studies; observational studies have been largely overlooked. This has 
resulted in the development of methodology for systematic reviews mainly for 
RCTs. However, in some situations, only data from observational studies, such as 
non-intervention epidemiological studies, are available, possible or appropriate 
(Berlin 1995). To illustrate this, observational studies have been used to evaluate 
educational programmes (Sipe and Curlette 1997) and assess risk factors for disease 
(Ioannidis and Lau 1999). Studies on the latter may not be randomised because the 
risk factors may be related to intrinsic human practices and it is unethical to expose 
subjects to harmful risk factors (Lipsett and Campleman 1999). Thus, there is 
increasing recognition that observational studies provide useful evidence, resulting 
in more recent, active development of methodologies for systematic reviews of 
observational studies (Mulrow et al., 1997; Sutton et al., 1998; Stroup et al., 2000) 
and recently, there have been several systematic reviews of qualitative studies 
(Bahtsevani et al., 2004; Gruenewald et al., 2004; Milton et al., 2004; Walter et al., 
2004; Donald et al., 2005).
2.2 Aim of the systematic review
The specific aim of this systematic review is to identify and synthesize all available 
population based data on SE to arrive at conclusions on the epidemiology of SE 
including:
• The incidence of SE and the effect of gender, ethnicity and age on incidence.
• The range of aetiologies of SE, including the association of SE with epilepsy
• The recurrence of SE
• The mortality associated with SE
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In addition, the systematic review will highlight deficiencies in knowledge on status 
epilepticus that may be addressed in subsequent studies.
2.3 Methods
2.3.1 Search Strategy
A systematic search for ascertainment of appropriate articles was conducted using 
the recommendations of the NHS Centre for Reviews and Dissemination (NHS 
Centre for Reviews and Dissemination 2001). For details of the search strategy, see 
Table 2.1.
Step 1: Computer assisted literature searches of the bibliographic databases: Medline, Cochrane 
Collaboration database, Embase, Web of Science and CINALH for papers published between 
1966 and November 2002 using the following search terms:
• Status epilepticus and population*
• Status epilepticus and epidemiology
• Status epilepticus and incidence
• Status epilepticus and aetiolog*
• Status epilepticus and etiolog*
• Status epilepticus and cause*
• Status epilepticus and seizure type
• Status epilepticus and mortality
• Status epilepticus and fatality
All of the above searches were repeated with prolonged febrile convulsion* or prolonged febrile 
seizure* instead of status epilepticus.
All the searches were combined with (or stepwise limits conducted in Medline):
(i) review (ii) meta-analysis
Step 2: The reference list of articles identified in step 1 was examined to identify additional 
relevant studies.
Step 3: An internet search up to December 31, 2003 using Google as the search engine using the 
search strategy in Step 1 was conducted.
Step 4: The conference proceedings and abstracts of the British Paediatric Neurology 
Association (BPNA), the American Epilepsy Society (AES) and European Paediatric Neurology 
Society (EPNS) Year 1995 to Year 2003 were handsearched.
Table 2.1: Search strategy for population based studies on status epilepticus.
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2.3.2 Selection criteria
All population-based studies on status epilepticus where the primary outcome was 
incidence, aetiology, seizure types or mortality of SE were included. Studies of all 
age groups were included. Studies that were based in a single institution or did not 
involve a network of hospitals serving a well-defined general population and non­
primary studies were excluded.
2.3.3 Data extraction and assessment o f  Study Quality
Data to be extracted were agreed by the candidate and one of the candidate’s 
supervisors, and included study period, details of the study population, selection 
criteria, definitions, classification of seizure types, validation of the databases and 
outcome measures. The candidate extracted the data using a data extraction form 
and a second reviewer confirmed them. To assess methodological quality, the 
candidate developed a scoring system based on a published proposal for reporting 
meta-analysis of observational studies (Stroup et al., 2000) and the guidelines for 
epidemiologic studies on epilepsy of the International League Against Epilepsy 
(International League Against Epilepsy 1993) (see Table 2.2). Each study was 
scored on the following items: type of study design, description of study population, 
adequacy of case definitions, selection criteria of study population, definition of 
seizure types and aetiologies according to the ILAE guidelines, adequacy of 
definition of outcome measures, type of rate/effect/impact and whether there were 
adjustments for degree of ascertainment. In accordance with the ILAE guidelines 
for epidemiologic studies on epilepsy, the more important determinants of quality 
were considered to be type of study design, definitions of cases and outcomes, 
classification of seizure type and adjustment of rates. Thus, these items were given 
greater scores. Using the scoring system, each study was assessed independently by
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the two reviewers. Inter-rater agreement (kappa scores) for assessment of quality of 
study methodology was determined for each study.
Study Design 12 = Prospective 
5= Retrospective
Sample Size 2= Clearly defined 
1= Unclearly defined 
0= Not defined
Methodological definitions in 4= All clear
Individual studies 2= Most clear 
1= Most not clear
Inclusion criteria for selection of 4= Clear
cases of SE from study population 2= Unclear 
1= Not defined
Seizure type defined according to 4= Clear
the ILAE guidelines? 2= Unclear 
1= No
Risk factors/ aetiology defined 4= Clear
according to ILAE guidelines? 2= Unclear 
1= No
Definitions of outcome parameters 2= All clear 
1= Unclear 
0= Most not clear
Standardization of rates/ratios 4= Either age-specific/ age-adjusted/ 
sex- specific
2= Age-specific /age- adjusted/ sex-specific 
1= Crude only
Ascertainment adjustment 4= Clear 
1= Unclear/None
Table 2.2: Scoring system for assessment of methodological quality of population 
based studies on SE. Maximum score = 40, minimum score =11.
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2.4 Results
There were neither systematic reviews nor meta-analyses. Six population-based 
projects on status epilepticus (Richmond Group, Virginia, USA; Rochester Group, 
Minnesota, USA; French speaking Cantons Group, Switzerland; Hessen Group, 
Germany; California Group, USA; St. Louis Group, USA) yielding nine published 
reports (DeLorenzo et al., 1995; DeLorenzo et al., 1996; Logroscino et al., 1997; 
Hesdorffer et al., 1998; Coeytaux et al., 2000; Knake et al., 2001; Logroscino et al., 
2002; Wu et al., 2002) and three abstracts (Morton et al., 2001; Towne et al. 2002; 
Trevathan et al., 2002;) fulfilled the inclusion criteria for entry into the review. Four 
projects were conducted in the USA, three of which were retrospective (Rochester, 
California, St. Louis Groups) and one was prospective (Richmond Group). The 
remaining two population-based projects were European based and prospective 
(Hessen Group and the French speaking Cantons Group). All studies were 
conducted after the ILAE's guidelines for epidemiologic studies were published.
The results are presented for data collection up to December 31, 2003. Studies were 
pooled only when their definitions of relevant variables were similar or the results 
could be processed and analysed as such. For a glossary of definitions used in the 
studies, see Appendix 1.
2.4.1 Description o f  the Studies
The description of the studies, methodological quality scores and inter-rater 
agreement are shown in Table 2.3. The quality scores ranged from 19-34 out of a 
possible maximum of 40. Inter-rater agreement was good to very good with kappa 
scores between 0.67 - 1.0.
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P U B L I S H E D  P A P E R S
D e L o r e n z o  1 9 9 5 U S A P r o s p e c t iv e 1 3 7  a d u l t s ,  2 9  c h i l d r e n M o s t  C l e a r U n c l e a r C l e a r U n c l e a r C l e a r A g e - s p e c i f i c C l e a r 3 2 0 .6 7
D e L o r e n z o  1 9 9 6 U S A P r o s p e c t iv e 1 3 7  a d u l t s ,  2 9  c h i l d r e n M o s t  C l e a r U n c l e a r C l e a r U n c l e a r C l e a r A g e - s p e c i f i c C l e a r 3 2 0 .6 7
L o g r o s c i n o  1 9 9 7 U S A R e t r o s p e c t i v e 1 3 2  a d u l t s  ,5 2  c h i l d r e n M o s t  C l e a r C l e a r C l e a r C l e a r C l e a r A g e -  a n d  s e x - s p e c i f i c N o 2 8 1.0
H e s d o r f f e r  1 9 9 8 U S A R e t r o s p e c t i v e 1 3 0  a d u l t s ,  6 9  c h i l d r e n M o s t  C l e a r C l e a r C l e a r C l e a r C l e a r A g e -  a n d  s e x - s p e c i f i c N o 2 8 1 .0
W a te r h o u s e  1 9 9 9 U S A P r o s p e c t iv e 4 3 3  a d u l t s ,  2 1 2  c h i l d r e n M o s t  C l e a r C l e a r C l e a r U n c l e a r C l e a r C r u d e U n c l e a r 3 1 0 .8 9
C o e y t a u x  2 0 0 0 S w i t z e r l a n d P r o s p e c t iv e 1 0 8  a d u l t s ,  6 4  c h i l d r e n M o s t  C l e a r U n c l e a r C l e a r U n c l e a r C l e a r A g e -  a n d  s e x - s p e c i f i c N o 31 1 .0
K n a k e  2 0 0 1 G e r m a n y P r o s p e c t iv e 1 5 0  a d u l t s M o s t  C l e a r U n c l e a r C l e a r U n c l e a r C l e a r A g e - a d ju s t e d  a n d  s e x  - s p e c i f i c C l e a r 3 4 0 .6 7
L o g r o s c i n o  2 0 0 2 U S A R e t r o s p e c t i v e 1 1 0  a d u l t s  ,3 5  c h i l d r e n M o s t  C l e a r C l e a r C l e a r C l e a r C l e a r A g e -  a n d  s e x - s p e c i f i c N o 2 8 1 .0
W u  2 0 0 2 U S A R e t r o s p e c t i v e 1 2 7 1 6  a d u l t s ,  
2 8 8 5  c h i l d r e n
M o s t  C l e a r C l e a r N o N o C l e a r C r u d e N o 1 9 0 .7 8
A B S T R A C T S
M o r t o n  2 0 0 1 U S A P r o s p e c t iv e 5 9 8  c h i l d r e n M o s t  C l e a r C l e a r C l e a r U n c l e a r C l e a r C r u d e U n c l e a r 31 0 .7 8
T o w n e  2 0 0 2 U S A P r o s p e c t iv e 3 1 8  a d u l t s M o s t  C l e a r C l e a r C l e a r U n c l e a r C l e a r C r u d e U n c l e a r 31 0 .7 8
T r e v a t h a n  2 0 0 2 U S A R e t r o s p e c t i v e 3 9 ,6 4 9  s u b je c t s M o s t  C l e a r C l e a r N o N o C l e a r A g e - s p e c i f i c N o 2 2 0 .7 8
Table 2.3: Description, methodology scores and interrater agreement of methodology scores of population-based studies on the epidemiology of status 
epilepticus.
Methodology scores are based on the scoring system detailed in Table 2.1. Methods definitions refers to definitions outlined in the methodology of 
individual studies. Inclusion criteria refers to the criteria for selection of cases of SE from study population. ILAE SE type and ILAE Aetiology refers to 
whether the types of SE and aetiology of SE were classified according to ILAE guidelines. Outcome refers to whether the outcome parameters were clearly 
defined or not. Standardization o f Rates/Ratios refers to whether rates/ratios were standardized and the type. Ascertainment Adjustment refers to whether an 
adjustment was made for degree of ascertainment. Maximum methodology score = 40, minimum score =11.  Displayed scores are that of the candidate.
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2.4.2 Characteristics o f  SE
2.4.2.1 Incidence
The incidence of SE showed a bimodal distribution with peaks in children less than a 
year of age and the elderly (DeLorenzo et al., 1996; Hesdorffer et al., 1998; Wu et al., 
2002). Children less than a year of age had the highest incidence (135- 
156/100,000/yr) (DeLorenzo et al., 1996; Hesdorffer et al., 1998). In general, males 
were more likely to have SE than females, and non-white patients were more likely to 
have SE than white patients. For further details, see Table 2.4.
2.4.2.2 Aetiology
The cause of SE varied according to age groups. In children, prolonged febrile 
seizures (35%) (Hesdorffer et al., 1998) and low anti-epileptic drug levels (21%) 
(DeLorenzo et al., 1996) were most common. In contrast, in adults, cerebrovascular 
disease/accidents, withdrawal or low levels (34%) of maintenance anti-epileptic drugs 
were most likely. Acute symptomatic SE accounted for most aetiologies across all 
age groups. Few episodes of SE were idiopathic (see Table 2.5 for further details on 
aetiology).
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Incidence Rate
(per/100,000 persons/year)
Richmond 
(Virginia, USA)
Rochester 
(Minnesota, USA)
Hessen
(Germany)
French speaking 
Cantons (Switzerland)
California
(USA)
Crude 41 - 15.8 9.9
¥
6.8
Ascertainment adjusted 61 - 17.1 - -
Age-adjusted - 18.3 17.1 10.3 -
In Children 38 24 - 21 3.86
In Adults 27 6 4 5 4.58
In the Elderly 86 62 54 15 14.6
Male : Female - 2:1 2:1 2:1 1:1
Non-white : White 3:1 - - - 2:1
Peak age (years of age) <1 , >60 <1 , >65 >60 <5, >60
Table 2.4: Incidence of SE according to research groups.
As the main aim of the St. Louis Group was to identify determinants of mortality associated with status
epilepticus, the incidence of status epilepticus was not estimated in their study and consequently, the St. Louis Group is not listed in this table. 
* Restricted to generalised convulsive status epilepticus.
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Aetiology Richmond
C(%) A(%) T(%)
Rochester 
C(%) A(%) T(%)
Germany 
C(%) A(%) T(%)
Switzerland 
C(%) A(%) T(%)
Prolonged febrile seizures - - - 23 0 8 - -
Acute Symptomatic 57 72 70 46 52 50 87 66 61 63
Remote Symptomatic 38 25 27 18 20 20 63 25 31 28
Progressive Symptomatic - - - 0 13 8 -
Idiopathic/Unknown 5 3 3 13 15 14 9 9 8 9
Table 2.5: Aetiology of SE according to research groups. Californian Group excluded because proportional contributions of 
aetiologies from their study could not be determined.
C = Children A = Adults T = Total
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2.4.2.3 SE and epilepsy
SE occurred within the context of epilepsy in less than 50% of cases overall. In 
children, 16-38% had a history of epilepsy, whilst in adults, 42-50% had a history of 
epilepsy (DeLorenzo et al., 1996; Knake et al., 2001). The percentage of SE patients 
with a history of epilepsy was higher in those who resided in rural areas (49-56%) 
compared to those who resided in urban areas (33%) (Coeytaux et al., 2001; Knake et 
al., 2001).
2.4.2.4 Duration
Most SE lasted less than 24 hours (DeLorenzo et al., 1996; Hesdorffer et al., 1998; 
Knake et al., 2001). All prolonged febrile seizures were shorter than 2 hours 
(Hesdorffer et al., 1998). In the paediatric population, the duration of continuous SE 
(median 60.5 minutes) was shorter than that of intermittent SE (median 87 minutes, 
p<0.02). In contrast, adults had no difference in duration of continuous SE (median
97.5 minutes) compared to intermittent SE (median 85 minutes) (Waterhouse et al.
1999).
2.4.2.5 Recurrence
Recurrence of SE occurred in 13.3- 18.5 % (DeLorenzo et al., 1996; Hesdorffer et al., 
1998; Knake et al., 2001). A distinction between recurrence in adults and children 
was made in one study and in that study, recurrence was highest in the paediatric 
population (DeLorenzo et al., 1996). In adults, almost all (93.8%) patients with 
recurrences had a history of epilepsy (Knake et al., 2001).
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2.4.2.6 Mortality
Mortality associated with SE across all age groups ranged from 1.6-22% during 
hospitalisation for SE or within 30 days of SE (short-term mortality) and 43% within 
10 years following initial survival 30 days after SE (long term mortality). Age and 
aetiology of SE were the major determinants of short-term and long term mortality. 
Mortality is lowest in children (short term mortality from 3-9% and long term 
mortality around 7%) and highest in the elderly (short term mortality from 22-38% 
and long term mortality 82%). Amongst children, those aged under one year had the 
highest short term mortality (17-18%) (Morton et al., 2001). The Standardised 
Mortality Ratio (SMR), the relative risk of mortality compared to the general 
population, for subjects with long term mortality associated with SE was 2.8 (95% Cl 
2.1-3.5). The SMR in those older than 65 years was 2.2 (95% Cl 1.6-2.9) and in those 
aged less 65 years, the SMR was 5.1 (95% Cl 2.8-8.0).
Most deaths during hospitalisation for SE or within 30 days of SE occurred in those 
with an acute symptomatic aetiology (DeLorenzo et al., 1996; Logroscino et al.,
1997). No deaths occurred in those with prolonged febrile seizures. In subjects with 
long term mortality, the SMR was significantly elevated in the acute and remote 
symptomatic SE groups. Acute symptomatic SE was associated with a higher 
mortality rate than idiopathic/cryptogenic SE. When mortality associated with 
different seizure types was reviewed, myoclonic SE in particular was associated with 
high short-term and long term mortality. Subjects with myoclonic SE had a 
significant relative risk (RR) of long term mortality in comparison to those with 
generalised SE (RR 4.0, 95% Cl 1.3-13). There was no difference in short-term case
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fatality between continuous and intermittent SE in children, but in adults, short-term 
case fatality was 31.4% in continuous compared to 19.6% in intermittent SE (p<0.01).
The effect of duration of SE and gender on short-term mortality is uncertain 
(Logroscino et al., 1997; Waterhouse et al. 1999; Wu et al., 2002) but there was 
increased long term mortality in subjects with SE lasting more than 24hrs when 
compared to those with SE lasting less than 2 hrs (RR 2.3, 95% Cl 1.1-5.1) 
(Logroscino et al., 2002). Ethnicity had no effect on short-term mortality.
2.5 Discussion
The methodology for systematic reviews of non-interventional research is still in its 
infancy. In this systematic review of observational studies, the methodology has been 
based on recently published proposals for reporting meta-analyses of observational 
studies and guidelines for systematic reviews of qualitative studies (Abou-Khalil et 
al., 1993; Stroup et al., 2000). A similar methodology has been used in a published 
systematic review of incidence studies of epilepsy (Kotsopoulos et al., 2002).
Differences in definitions, classification of seizures and aetiologic criteria in 
epidemiological studies on epilepsy have often resulted in discordant results between 
studies and have made comparison of results difficult (International League Against 
Epilepsy 1993). In an attempt to address this issue, in 1993 the ILAE published 
guidelines for epidemiologic studies on epilepsy (International League Against 
Epilepsy 1993). Although the studies identified for the current systematic review 
were conducted after the ILAE's published guidelines for epidemiologic studies on 
epilepsy, there is still heterogeneity in the basic epidemiological parameters listed
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above. Thus, a meta-analysis of the data from these studies was not possible but 
through the development of a unique scoring system based on a published proposal 
for reporting meta-analysis of observational studies (Stroup et al., 2000) and the 
ILAE's guidelines (International League Against Epilepsy 1993), the candidate was 
able to assess the methodological quality of studies and to compare studies. Most 
population-based studies on SE have high methodology scores. It is interesting that 
studies that had the largest study sample size (Trevathan et al., 2002; Wu et al., 2002) 
had the lowest methodology scores, suggesting that sample size alone is not an 
adequate guide to the quality of any individual study.
The range of reported crude incidence rates is wide (6.8-41/100,000/yr). The lowest 
incidence rate is from a study with a low methodology score (Wu et al., 2002). This 
suggests that the true incidence rate of SE is higher than the 6.8/100,000/yr in 
California. The remaining five studies that reported incidence rates had similar 
quality scores which were high ( DeLorenzo et al., 1996; Hesdorffer et al., 1998; 
Knake et al., 2001) but despite this there was still a wide range of incidence rates (9.9- 
41/100,000/yr). It may be hypothesised that differences in case ascertainment between 
studies may partly explain the wide range of reported incidence rates. Quantification 
of ascertainment was not determined in the Swiss study (Coeytaux et al., 2001) and it 
is possible that their reported crude incidence of 9.9/100,000/yr may have been an 
underestimate due to incomplete ascertainment. The retrospective nature of the 
Rochester study suggests that their reported incidence of 18/100,000 persons/year 
may also be an underestimation. However, the Hessen and Rochester studies had 
similar ascertainment methodologies, similar degrees of ascertainment, similar quality 
scores, took underascertainment into account and reported ascertainment corrected
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rates. Despite this, the reported ascertainment corrected incidence in the Richmond 
study is still treble that of the Hessen study (see Table 2.3 for further details). These 
results suggest that case ascertainment may not be the only explanation for the wide 
range in reported incidence.
Though the definition of SE was similar in all studies, inclusion criteria differed 
between studies. The Richmond, Rochester, Hessen and Swiss studies included 
convulsive (CSE) and non-convulsive SE (NCSE) while the Californian study 
excluded episodes of NCSE. NCSE only accounted for up to 6% of SE cases in 
studies that included both types of SE. The Swiss study, which has one of the lower 
reported rates, excluded patients with postanoxic encephalopathies which accounted 
for 10% of cases in the Rochester study. Therefore, difference in inclusion criteria 
may partially explain the diversity in incidence rates.
The Richmond group has partly attributed its much higher incidence to its greater 
non-white racial composition compared to other study areas and a higher incidence 
being reported in non-white subjects relative to white subjects. From the published 
literature and on discussion with two of the authors of the Richmond study, it remains 
unclear from the Richmond Group whether "initial" cases used to calculate incidence 
refer to cases with a lifetime first episode of SE, or first SE during the study period. If 
it is the latter, the reported incidence may be an over estimate and a more accurate 
incidence may be closer to that reported by the Rochester and Hessen Groups. It is 
also possible that the difference is partly explainable by a different age and or sex 
composition of Richmond compared to other study areas. Males are twice as likely as 
females to have an episode of SE. This gender difference may be partly due to a
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higher incidence of certain aetiologies including cerebrovascular disease and brain 
trauma in males, but it may reflect a possible role of hormonal influences in the 
termination of seizures (Moshe et al., 1995; Standley et al., 1995).
In order to take into account differences in the composition of populations and to 
facilitate analysis of trends over time, standardized rates and ratios are important.
This is reflected in the ILAE’s guidelines for epidemiologic studies, which 
recommends that age- and sex-specific rates should be provided wherever possible 
and if summary frequency indices are reported, adjustment to a well-defined and 
accessible specified population should be made. Some studies in this systematic 
review do not report these standardized rates and is reflected in their quality scores 
(see Table 2.2).
Overall, the age adjusted incidence of SE in the white population in Europe and the 
USA is approximately 20/100,000/yr with higher incidence in early childhood and in 
the elderly. Epidemiological studies in countries with limited resources have found a 
higher incidence of epilepsy than developed countries but there are no such studies on 
status epilepticus. The effects of socioeconomic, cultural and environmental 
conditions on the incidence of SE are not known and studies examining these effects 
are needed in order to improve our understanding of SE worldwide.
Up to 50% of all incident episodes of SE occur within the context of epilepsy and less 
than half of these would have a history of epilepsy. Therefore, approximately 25% of 
patients with a life time first episode of status epilepticus have a history of epilepsy.
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The Rochester Group reported a recurrence nearly one and a half times as great as in 
the Richmond and Hessen studies, but this difference is likely to be due to the follow- 
up period. In the former it was up to thirty years after incident SE compared to follow 
up of up to two years in the latter.
The onset of SE may not be observed and in the absence of continuous EEG 
monitoring there may be uncertainty about the cessation of seizure activity 
particularly when seizure control requires ventilatory support. Thus, determination of 
duration of seizures in observational studies is difficult and conclusions on the effect 
on seizure length on morbidity and mortality associated with SE should be interpreted 
with caution. It is important to note though, that there are experimental data in 
animals that suggest that longer duration of SE is associated with worse outcome 
(Meldrum et al. 1973). If longer duration of SE in man is associated with worse 
outcome, there is a potential danger of the continuation of SE without seizures 
detectable only by EEG as described by Treiman and colleagues (Treiman et al.,
1987). In the Veterans Affairs study comparing four treatments for generalized CSE, 
65% of patients with subtle SE died within 30 days of SE, compared to 27 % of 
patients with overt SE (Treiman et al., 1998). Therefore continuous EEG monitoring 
may be very important in guiding treatment of SE and reduce its associated morbidity 
and mortality.
Therapeutic regime may affect outcome by reducing seizure length. However, data 
on the treatment regime for SE in large population based studies were sparse. Two 
studies reported that a significant proportion of patients were not treated prior to 
arrival in hospital (Cascino et al., 2001; Coeytaux et al., 2001). This is important as
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delayed treatment may increase the frequency of seizures lasting at least thirty 
minutes (Knudsen 1979). In their retrospective study, Cascino and colleagues also 
reported two other main observations on the treatment of SE. Patients who received 
an adequate initial dose of emergency anti-epileptic drugs (AEDs) were more likely to 
have seizure termination but patients were frequently given inadequate doses of 
emergency AEDs (Cascino et al., 2001; Coeytaux et al., 2001). The efficacy and 
safety of benzodiazepines in the treatment of SE in adults in the out of hospital setting 
has been demonstrated in a large randomized controlled study in adults (Alldredge et 
al., 2001). Other studies examining the treatment of SE, including the treatment in 
children, are needed for comparison, but the above data would suggest that early 
treatment with adequate doses of benzodiazepines in the out of hospital setting may be 
important.
It is possible that data from population-based studies on SE can provide information 
on the morbidity attributable to SE providing the research methodology is able to 
detect such downstream consequences. However, the problems of measuring 
attributable cognitive and behavioural problems are many and may be better 
addressed by studies of specific subgroups with specific syndromes within SE where 
the confounding factors can be minimised. Thus, morbidity attributable to SE was 
excluded from this review.
The data from this systematic review on the epidemiology of status epilepticus concur 
with those from hospital based studies in that age and aetiology are the most 
important determinants of short term case fatality in SE. Children have a low case 
fatality and acute symptomatic causes (excluding prolonged febrile seizures) are
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associated with the worst prognosis (Aicardi et al., 1970; Aminoff et al. 1980; Dunn 
1988; Yager et al., 1988; Maytal et al., 1989; Sung et al., 1989; Shorvon 1994b). The 
influence of duration of status epilepticus on short term case fatality is less clear. Two 
studies of similar methodological quality reported opposing findings (Logroscino et 
al., 1997; Waterhouse et al. 1999). The Richmond Group found that duration of status 
epilepticus was associated with increased mortality but the Rochester Group did not. 
However, the Richmond Groups' study (Waterhouse et al. 1999) was prospective and 
had a larger sample size and their findings are consistent with animal studies and 
clinical series that suggest that longer duration causes brain damage (Aicardi et al., 
1970; Meldrum and Horton 1973; Dunn 1988; Yager et al., 1988; Sung et al., 1989; 
Hui et al., 2003).
Only one study has reported on long term mortality (Logroscino et al., 2002). The 
study was small and was conducted in a homogenous white middle class population 
thus limiting the generalisation of its findings. Like short term fatality, children fared 
better than adults and most deaths occurred in the elderly. However, the mortality in 
the elderly with SE is only increased two fold over that of general elderly population 
(SMR = 2). In those aged under 65 years, there is a five fold increase (SMR = 5). 
Together, these data suggest that SE is associated with increased mortality after initial 
survival but the increased risk of death associated with SE in the elderly is partly 
attributable to the higher death rate from any cause in the elderly. The long term 
standardised mortality ratio for symptomatic SE was significantly elevated, but not 
elevated in idiopathic or cryptogenic SE. This suggests that SE in isolation, without 
any identifiable underlying cause, does not alter long term mortality. Although this 
study group, the Rochester group, found that duration of SE had no effect on short
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term mortality, they found that longer duration of SE was associated with increased 
long term mortality.
2.6 Conclusions
Although there are few population-based studies on status epilepticus, most are of 
good quality. The available data is consistent with the view that there are differences 
in incidence, aetiology and outcome between children and adults. SE is more 
common in children than adults (see Table 2.3), prolonged febrile seizures may 
account for up to a third of cases of SE in childhood (see Table 2.4) and mortality is 
lower in children. However, most studies eligible for this review were in primarily or 
exclusively adult populations and therefore paediatric results may not be an accurate 
reflection of the epidemiology of SE in the paediatric population. Of note, there are 
limited data within these studies on prolonged febrile seizures. Furthermore, data 
from adults may not be directly applicable to children as the physical and 
neurochemical characteristics of the developed brain differ to that of the developing 
brain (Holmes 1997). The results of the systematic review would also indicate that 
there is limited information on the association of ethnicity on SE and virtually none 
on the associations between socioeconomic, cultural and environmental differences 
and SE. The data from the systematic review also suggest that longer duration of SE 
is associated with increased short term and long term mortality. There are sparse data 
on the treatment of SE in the general population but the available data indicate that a 
significant proportion of patients are not treated or inadequately treated in the 
prehospital setting. Therefore, in order to ultimately improve the management of 
children with CSE, there is an urgent need for population-based studies on CSE in a
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purely paediatric population to more accurately assess the frequency, morbidity and 
mortality of CSE and to identify factors, including the role of prehospital treatment of 
CSE, that may influence these variables.
Therefore the aims of the studies to be reported in this thesis are:
1. To estimate the incidence, occurrence, aetiology, seizure characteristics, 
recurrence and the short term mortality associated with childhood CSE
2. To investigate the relationships between ethnicity, socioeconomic status, age 
and incidence of childhood CSE
3. To identify factors associated with CSE lasting longer than 60 minutes 
compared to CSE lasting 30-60 minutes
4. To characterise the emergency treatment of childhood CSE in the study 
population
5. To characterise the clinical features of children admitted to PICU for CSE and 
identify factors associated with admission to PICU for CSE
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CHAPTER 3: CENSUS 2001 AND NORTH LONDON
3.1 Introduction
To address the aims of this study, accurate population data and a suitable well-defined 
childhood population are required. As the most comprehensive, accurate source of 
available information about the general population in the United Kingdom (UK) is 
obtained from the Census and this study was conducted over the period 2002-2004, 
accurate population based data for this study were obtained from Census 2001.
In order to identify all possible cases of CSE within a specified geographical area, a 
network of hospitals, ideally with a well established referral system serving that area, 
needs to be identified. To assess the effect of socioeconomic status and ethnicity on 
the incidence of CSE, a geographically defined population of varied ethnic and 
socioeconomic composition is required. The current study was carried out in North 
London where there are more than half a million children and there is a wide cross- 
section of ethnic and socioeconomic groups. North London has a well established 
referral network between hospitals with paediatric services and has a designated 
children’s acute transport service (CATS) to assist in the management of critically ill 
children before and during transfer to a paediatric intensive care unit.
In this chapter, Census 2001 (including a scoring system for assessing socioeconomic 
profile of local areas) and North London (including the referral network between 
hospitals as well as the age, ethnic and socioeconomic profile of North London) are 
described.
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3.2 Census 2001
3.2.1 Background
Each decade in the United Kingdom, a day is set aside for a Census - a count of all 
people and households. In England and Wales, the Census is planned and carried out 
by the Office for National Statistics and elsewhere in the UK, responsibility lies with 
the General Register Office for Scotland and the Northern Ireland Statistics and 
Research Agency. The latest Census was held on April 29, 2001.
Every effort was made to include everyone in the Census. It was designed to cover 
the entire population at the same time and to ask the same core questions everywhere, 
thus facilitating comparisons between different parts of the country. Data provided by 
the Census include an accurate count of the population in each area as well as accurate 
data on the age, ethnic and socioeconomic make up of the population. Such 
information assists Government in determining the size of grants allocated to each 
local authority and health authority. In turn, these authorities use the census data to 
allocate resources and plan programmes and services.
3.2.2 Census 2001 Methods
For the Census 2001, a major publicity campaign was undertaken to heighten 
awareness that a Census was being taken. A special programme was established to 
help groups who might have had difficulty with completing the Census forms e.g. the 
visually impaired and those who were unable to read or write English. Using a field 
force set up throughout the country, Census forms were delivered to every household. 
Completed forms were either posted back to temporary local offices or collected by
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the field force. There was a legal obligation on every household to complete a Census 
form.
Questions from the form provided information on accommodation, family 
relationships, demographic characteristics, migration, cultural characteristics, health 
and provision of care, qualifications, employment, workplace and journey to work. 
The 2001 Census forms were scanned and the answers coded into categories by either 
automatic systems that recognised terms given in response to questions or by manual 
coding. It has been previously shown that the database is well validated (Office of 
National Statistics 2001). In order to safeguard confidentiality, the Census forms 
were collected and processed in secure conditions. Statistical results of the Census 
are presented in a manner to protect against the inadvertent disclosure of information 
about identifiable individuals.
Data from UK Censuses are collated to provide statistics such as age-specific 
population and ethnic, socioeconomic and gender composition of small local areas 
within the UK. Such statistics, Small Area Statistics (SAS), were aggregated and 
presented for Enumeration Districts (EDs) as the smallest output geographical area for 
all UK Censuses from 1961 to 1991. SAS for larger areas such as local authorities, 
wards and districts could be compiled by combining the results from EDs. However 
the size and character of each ED were variable, making the resultant SAS less than 
ideal for statistical analysis and comparison of geographical area. An alternative to 
EDs as the smallest geographical output area for SAS was needed.
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For Census 2001, SAS are determined from Super Output Areas (SOA) rather than 
EDs as the smallest output geographical area. SOAs are areas grouped together using 
zone design software creating statistical areas that are similar in size (average of 1,500 
residents and 400 households) and social homogeneity. Each area is usually 
comprised of whole unit postcodes and is regularly shaped with ‘natural’ boundaries 
where possible. Therefore, SAS indicators from Census 2001 reflect an up to date 
profile of the local area. One such indicator is the Indices of Multiple Deprivation 
2004 (IMD 2004), which were primarily determined from data from Census 2001 
supplemented by local data.
3.2.3 Indices o f  Multiple Deprivation 2004 (IMD 2004)
The aim of creating indices to measure deprivation at the local level, in order to 
identify priority areas and to target programmes, has been a consistent feature of 
government policy since at least the mid 1960s. These indices have traditionally been 
concerned with a single specific area of policy such as health but deprivation is multi­
dimensional rather than uni-dimensional. Thus, since the 1980s, the creation of a 
national index of "multiple deprivation" at the local level has become a central 
government issue. Such indices of multiple deprivation that have been developed 
have included the Carstairs Index, Townsend Material Deprivation Index, Jarman 
Underprivileged Area Index, Indices of Multiple Deprivation 2000 and the more 
recent Index of Multiple Deprivation 2004 (Carstairs and Morris 1989; Morris and 
Carstairs 1991; Department of the Environment 2000; Office of the Deputy Prime 
Minister 2004).
- 5 7 -
IMD 2004 is a unified, multiple deprivation, SOA based index, that estimates social 
as well as economic deprivation. It is an improvement on its predecessors as it 
incorporates more recent data and more aspects of deprivation. IMD 2004 was 
constructed by the Social Disadvantage Research Centre (SDRC) at the Department of 
Social Policy and Social Research at the University of Oxford. It is based on the 
concept that there are distinct dimensions of deprivation that can be identified and 
estimated separately. It is comprised of seven separate dimensions of deprivation, 
each with its own measured indicators of deprivation, whose scores have been 
standardised and combined in a weighted manner to make a single score (see 
Appendix 2 for further details). IMD 2004 is based on 37 indicators in total. Thus, 
each local area, SOA, has seven separate scores for seven different areas of possible 
deprivation: Income, Employment, Health and disability, Education, skills and 
training, Housing and Services, Crime and Living Environment. Each local area can 
be ranked in relation to all other local areas in the United Kingdom according to any 
of the dimensions of deprivation or the combined IMD 2004 (Office of the Deputy 
Prime Minister 2004).
There are 32,482 SOAs throughout the United Kingdom with associated IMD 2004 
scores. IMD 2004 scores range from 0.55 to 85.69, with higher scores correlating with 
a higher degree of socioeconomic deprivation.
In North London, there are 2,007 SOAs with IMD 2004 scores ranging from 2.36 to 
76.36. By determining the full postal code of the home address of an individual, the 
corresponding SOA and IMD 2004 score may be determined. As individuals within 
an area all experience the various aspects of deprivation within the area, IMD 2004
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scores may be used as a proxy measure of an individual’s extent of socioeconomic 
deprivation.
3.3 North London
3.3.1 Geography
For the purposes of this study, North London is defined as a 494.29 square kilometres 
region of London north of the River Thames constituted by the fifteen boroughs of 
Barnet, Brent, Camden, City of London, Enfield, Hackney, Hammersmith and 
Fulham, Haringey, Harrow, Islington, Kensington and Chelsea, Newham, Tower 
Hamlets, City of Westminster and Waltham Forest (see Figure 3.1).
I I -  London B oroughs
Brent
KENT
Figure 3.1: Area bounded by represents North London.
•  Accident and Emergency (A&E) departments
•  PICUs
3.3.2 Acute emergency services for children in North London
3.3.2.1 Hospitals with 24 hr A&E services
In North London, accident and emergency services are provided through the National 
Health Service (NHS). Patients that are taken to the accident and emergency
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department (A&E) by ambulance are taken to their nearest A&E by road. Most 
patients will be transported to a hospital within their borough, but occasionally, their 
nearest hospital will be in an adjacent borough. Mapping the network of hospitals in 
London that provide 24-hour A&E services for children against the geographical 
boundaries of North London, shows that there are seventeen hospitals that may 
provide 24-hour A&E services for children normally resident in North London (see 
Figure 3.1). These hospitals are: Barnet General Hospital, Central Middlesex 
Hospital, Chase Farm Hospital, Chelsea & Westminster Hospital, Homerton Hospital, 
King George Hospital, Newham General Hospital, North Middlesex Hospital, 
Northwick Park Hospital, Royal Free Hospital, Royal London Hospital, St. Mary’s 
Hospital, St. Thomas’ Hospital, University College London Hospital, Watford 
General Hospital, Whipp’s Cross Hospital and the Whittington Hospital. Any study 
on a North London population that involves a condition in which emergency 
treatment is urgently needed, such as CSE, requires that all these hospitals are 
included.
3.3.3.2 Paediatric Intensive Care Units and Children’s Acute Transport Service
To facilitate the fast, effective and efficient transfer of critically ill children to a 
Paediatric Intensive Care Unit (PICU), a designated Children’s Acute Transport 
Service (CATS) has been established in North London. Children requiring intensive 
care are referred directly to CATS, where telephone consultation with paediatric 
intensivists and liaison with other sub-specialists are also provided. Most critically ill 
children within North London are treated in two PICUs based in North London:
Great Ormond Street Hospital PICU and St. Mary’s Hospital PICU, but occasionally, 
children are treated at one of the three PICUs based in South London: Guy’s Hospital
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PICU, King's College Hospital PICU and St. George’s Hospital PICU (see Figure 
3.1). Therefore, any study in North London involving a condition that results in 
critically ill children, such as CSE, requires the inclusion of all these PICUs as well as 
CATS.
3.3.3 Population data on North London
From Census 2001, the total population of North London is 3,022,519. Of these, 
605,320 (20%) are children (aged less than 16 years of age). Within North London, 
England and Wales approximately 20% of the population are children. There are 
similar proportions of men and women in North London, England and Wales but there 
is a difference in the ethnic composition. Within North London, people of white 
ethnicity account for 67% of the population compared to 92% throughout England 
and Wales. For further details of the ethnic, sex and age composition of England and 
Wales and North London, see Appendix 3. In the childhood population, the borough 
of Hackney is the most densely populated borough within North London (2489
• 9  9children/km ) and the City of London is the least dense (232/ km ). For further details 
on population density of boroughs in North London see Table 3.1.
3.3.3.1 Ethnicity composition o f  North London
North London is cosmopolitan. Half of children are of white ethnicity. There are 
similar proportions of children of Asian and black ethnicity and almost ten percent of 
children are of mixed ethnicity. Children of any other ethnic group account for three 
percent of the childhood population. For further details on the ethnic profile of North 
London see Appendix 3.
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3.3.3.2 Socioeconomic composition o f  North London
There are varying levels of socioeconomic deprivation in North London. Within 
boroughs there are very deprived areas intermixed with those with little deprivation. 
IMD scores range from 2.36 to 76.36 with higher scores associated with increasing 
socioeconomic deprivation. The mean IMD 2004 score of the fifteen boroughs of 
North London range from 13.57 in Harrow to 45.75 in Tower Hamlets. For further 
details on mean IMD scores of boroughs of North London, see Table 3.1.
Boroughs Childhood
Population
Childhood Population Density 
(number per sq km)
Mean 
IMD 2004
Barnet 63756 735 16.09
Brent 52169 1207 25.93
Camden 32867 1508 34.65
City of London 673 232 15.32
Enfield 57793 715 23.11
Hackney 47430 2489 45.05
Hammersmith & Fulham 27226 1660 27.79
Haringey 44605 1507 37.69
Harrow 41691 826 13.57
Islington 32242 2170 42.66
Kensington and Chelsea 24795 2044 21.65
Newham 63841 1763 40.53
Tower Hamlets 44890 2271 45.75
Waltham Forest 46868 1208 30.25
Westminster 24474 1139 31.66
Table 3.1: Childhood population density and mean IMD 2004 for boroughs of North 
London (Office of National Statistics 2004; Office of National Statistics 2004).
The contents of this chapter illustrate that North London has a large paediatric 
population with varied ethnic and socioeconomic composition within a well defined 
geographical area and a well established referral network for paediatric clinical 
services. Thus, it is feasible to conduct a prospective paediatric population based 
study on CSE in North London but the success of such a study is reliant on the degree 
of ascertainment of cases.
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In the next chapter, the methods used to identify all possible cases of childhood CSE 
in North London during the study period and the statistical method used to estimate 
degree of ascertainment will be described.
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CHAPTER 4: METHODS FOR ASCERTAINMENT AND 
CAPTURE-RECAPTURE
4.1 Introduction
One of the main strengths of population based studies is that in principle, they are free 
from the referral bias which may occur in hospital based studies. The higher the 
degree of case ascertainment the greater the likelihood that results may be more 
applicable to the general population. Therefore, for a population based study on CSE 
in childhood, as many cases of childhood CSE as possible need to be identified; 
ideally, all should be identified. Identification of cases using a single source is likely 
to result in an underestimation of the total number of cases. Therefore in this study, 
the candidate used a multi-source identification system involving paediatricians from 
the network of hospitals described in the previous chapter. Cases were identified 
primarily through a passive telephone notification system directed at trainee 
paediatricians, nurses and administrative staff, an active regional surveillance scheme, 
based on the British Paediatric Surveillance Unit’s methodology and directed at 
consultant paediatricians and audits of paediatric admissions to hospitals in the North 
London network and referrals to the Children’s Acute Transport Service. Notifications 
of cases by the regional surveillance scheme and telephone notifications system were 
administrated by a centrally based coordinating centre.
To facilitate the identification of cases of CSE and subsequent data collection on such 
cases, the candidate co-founded a research collaborative group constituted by the 
principal researchers and a paediatrician from each hospital within the network 
previously described. The main initial remits of the research collaborative group were
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to publicise the study in their local hospital, assist in the design of the data collection 
methodology and to aid data collection. A steering group of experts in paediatric 
epidemiology and biostatistics and paediatric neurosciences was established by the 
candidate to oversee the study. Members of the Steering Group were Dr. Rod Scott 
and Professor Brian Neville from Paediatric Neurosciences, Dr. Helen Bedford, Dr. 
Angie Wade and Dr. Pat Tookey from the Centre for Paediatric Epidemiology and 
Biostatistics, Institute of Child Health, London and Mr. Richard Lynn from the British 
Paediatric Surveillance Unit (BPSU).
It is recognised that the lists of patients identified from either of these sources could 
be incomplete and consequently a method of estimating the degree of ascertainment 
of cases was required. Capture-recapture is such a method. The systems of 
identification of cases of CSE for this study and the application of capture-recapture 
to the data obtained through those systems are reported in this chapter.
4.2 A telephone notification system
As convulsive status epilepticus is an acute neurological emergency, the candidate 
wanted to identify all patients with convulsive status epilepticus as soon as possible 
after presentation to hospital to maximise the accuracy and completeness of data 
collection. Therefore, the primary source of identification of children with CSE used 
in the current study was a telephone notification system. Children with CSE 
identified through telephone notifications were defined as being identified by 
“PHONE”.
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4.2.1 Design o f  the telephone notification system
The candidate established a designated 24 hour telephone notification hotline at the 
research coordinating centre. The hotline was manned by a research administrator 
from 9:00 am to 5:00pm weekdays and outside of those hours, an answering service 
was in place. A telephone number that could be readily remembered in an 
alphanumeric form and associated with the study was specifically chosen i.e. 
02072783777, alphanumeric form 020-72STEPSS. Through an intensive schedule of 
regular promotional talks by the candidate at hospitals within the research network 
and to CATS, plus the distribution of promotional "post- its", posters and wallet sized 
laminated cards to medical and nursing staff at hospitals within the network and from 
CATS, trainee paediatricians, nursing and administrative staff were asked to report 
cases of CSE immediately after presentation to the research coordinating centre. To 
further maximise trainee paediatricians’ awareness about the study, local collaborators 
included information on the study as part of the induction process for each doctor that 
joined the paediatric staff.
4.2.2 Potential weaknesses o f  the telephone notification system
The main potential weakness of this telephone reporting system is that it was passive. 
Hence the need for the publicity and motivational efforts described above. An 
additional alternative, active source of notification of cases of notification, such as 
that conducted by the British Paediatric Surveillance Unit (BPSU), was required.
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4.3 BPSU-like regional surveillance scheme
The next source of identification of cases considered was modelled on the system of 
the British Paediatric Surveillance Unit (BPSU) of the Royal College of Paediatrics 
and Child Health (RCPCH) as it’s effectiveness in assembling sufficient cases of 
particular conditions to study epidemiological characteristics has been researched and 
recognised (Verity and Preece 2002). Cases identified through the BPSU-like scheme 
were defined as being identified by “FORMS”.
4.3.1 BPSU methodology
The BPSU conducts a national active surveillance system based on a postal 
questionnaire scheme. At the end of each month the BPSU mails out a report card 
containing a list of conditions being surveyed to every senior doctor who is likely to 
have clinical responsibility for children with rare conditions. Reporting clinicians are 
asked to check boxes against any of the reportable conditions they have seen in the 
preceding month, or to check a "nil return" box if none have been seen and return the 
card to the BPSU. "Positive" returns are notified to the appropriate investigator, who 
contacts the reporting clinician directly for data collection. Supplemental data are 
provided through other data sources such as laboratory reports via the Health 
Protection Agency (HPA), Hospital Episode Statistics. The BPSU does not receive 
any patient identifiable data and is not involved with direct patient contact. 
Investigators that need to contact families directly do so through doctors caring for 
those families.
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4.3.2 Main weakness o f  BPSU
The main concern about the BPSU scheme is its completeness of the ascertainment of 
cases. At the end of each month, responders are asked to report cases in the preceding 
month. Thus, there may be an element of recall bias with subsequent missed cases. 
Though the BPSU has a 92% response rate, its ascertainment of eligible cases has 
been estimated at 45% (Rahi and Dezateux 1999).
4.3.3. A regional BPSU-like scheme rather than the national BPSU scheme 
Generally, only rare childhood illness or diseases that require ascertainment of cases 
on a national scale in order to generate sufficient numbers for study are included in 
the BPSU scheme. CSE is not uncommon and the current study was regional rather 
than national. In addition, the BPSU does not receive any patient identifiable 
information and such information was required in the current study to confirm 
residence within North London, to prevent multiple counts of single cases and to 
identify recurrences of episodes of CSE. Therefore, after discussion with the BPSU, 
the candidate’s population based study on childhood CSE in North London was not 
considered suitable for the BPSU. Nonetheless, the BPSU, along with the Centre for 
Paediatric Epidemiology and Biostatistics of the Institute of Child Health, assisted in 
the design and implementation of a regional active surveillance scheme for the study.
4.3.4 Design o f  regional BPSU-like scheme
Any such surveillance scheme should aim to also have a high response rate and 
ideally, a better ascertainment than the BPSU. In a systematic review of strategies for 
increasing response rates to postal questionnaires, Edwards and colleagues (Edwards 
et al., 2002) examined 292 eligible trials including a total of 258, 315 participants that
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evaluated 75 different strategies for increasing response to postal questionnaires.
They identified a range of strategies that seem to increase response to postal 
questionnaires including shorter questionnaires, the use of brown envelopes versus 
white envelopes, first class outward mailing versus other classes and postal follow up 
including a questionnaire versus postal follow up excluding a questionnaire. For 
further details on the effect of strategies on improving response rates, see Appendix 4.
Bearing the results of Edwards systematic review in mind, monthly surveillance forms 
used in the regional BPSU-like scheme were short (single side of A4 paper), coloured, 
personalised, forms that were sent first class in brown envelopes with enclosed self 
addressed return envelopes. Paediatricians were asked to indicate how many cases of 
CSE they had seen in the preceding month and to provide details on patient initials, 
date of birth and date of the CSE event (Appendix 5). If there was no response, 
paediatricians were sent a follow-up note with another copy of the surveillance forms 
(see Appendix 6).
A comprehensive mailing list of paediatricians was compiled by contacting all 
paediatric departments within the research network and requesting the names of all 
consultant paediatricians, regardless of subspecialty. In order to maximise 
completeness, the list, which was updated yearly, was cross-referenced by the BPSU 
against its list of paediatricians in London. Prior to commencement of the 
surveillance scheme, each month for 2 months, information sheets and letters were 
sent to each paediatrician in the network informing them of the study and the 
surveillance scheme and requesting their assistance in the study (Appendix 7 and
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Appendix 8). Within the first 3 months of commencement, the BPSU included 
information on the study in its quarterly newsletter to all paediatricians.
4.3.5 Potential weaknesses o f  the regional BPSU-like scheme
Like the BPSU, the main potential weaknesses of this regional surveillance scheme
are underascertainment and delayed identification of cases.
4.4 Audits of admissions to hospitals and referrals to PICU
This third source of identification of cases was based on a search for specific 
International Classification of Diseases (ICD) codes amongst hospital admissions 
and/or referral diagnoses to CATS. Cases identified through the audits were defined 
as being identified by “AUDIT”. The ability to exchange comparable data from one 
geographical location to another, nationally and internationally, to allow comparison 
from one population to another and to permit longitudinal study of diseases, is one of 
the major strengths of the ICD.
4.4.1 International Classification o f Diseases
The International Classification of Diseases (ICD) has been customarily revised every 
10 years in order to keep up with the advances of medicine and is currently in its tenth 
revision (ICD-10). The ICD functions as a classification system of causes of 
morbidity and mortality as well as basis for medical record indexing and retrieval. 
Through an alphanumeric coding scheme, diagnoses are coded using a core 
classification from which a series of subcategories can be derived, each reaching a 
different degree of specificity and adapted to a particular specialty or type of user.
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The coding scheme is complex and for accurate coding, people who code diagnoses 
should be trained appropriately in its usage.
4.4.2 Potential weaknesses o f  identifying cases o f  CSE using ICD codes
The accuracy of data obtained through ICD codes is limited by the precision of the 
coding process which is prone to errors (MacIntyre et al., 1997; Fabry et al., 2003; 
Rinaldi et al., 2003). Clinicians should accept personal responsibility for coding 
patients' diagnoses at the time of consultation or discharge from hospital (Wood et al., 
1989) but the workload of clinicians frequently limits the time available to learn how 
to code and to code diagnoses. Uncertainty of diagnosis can be common, particularly 
in patients with complex problems (MacIntyre et al., 1997). Coding is usually 
performed manually and attempts to develop computerized tools to increase the 
efficiency and accuracy of coding using ICD 10 have proven difficult (Fabry et al., 
2003). Therefore, coding remains primarily a manual task conducted retrospectively 
by non-clinicians not directly involved in patient management and with varying 
degrees of training in coding. On this basis, epidemiological data and forecasts for 
allocation of health resources based only on the ICD system must be considered with 
caution.
4.4.3 Conduct o f  audits o f  hospital admissions and referrals to CATS
Each year, a complete review of all cases of SE and febrile seizures was performed. 
The review evaluated all hospital ICD-10 codes for SE (G41) and febrile seizures 
(R56.0) and referrals to CATS for seizures/convulsions/status epilepticus. The labour 
intensive nature of these yearly reviews made it impossible for the candidate to 
conduct them in the twenty one hospitals within the research network. Over the two
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year study period, reviews were conducted at Great Ormond Street Hospital, a tertiary 
hospital with a PICU but without an A&E department, at the CATS centre and six 
randomly selected North London hospitals with 24 hour accident and emergency 
services. Random selection of the six North London hospitals was conducted using 
SPSS version 10 (Chicago, Illinois). All North London hospitals were listed by the 
candidate on an SPSS version 10 (Chicago, Illinois) datasheet and a fellow PhD 
student used the software to randomly select six hospitals from the datasheet. As 
there was a delay in the identification of cases of CSE through the audits, in order to 
minimise bias, the clinical details of episodes of CSE identified only through these 
audits were not included in this study. The number of cases identified by audits 
whether in isolation or also by the other two systems described above were recorded 
in order to assess the degree of ascertainment through capture-recapture (see section 
4.6 below for details on capture-recapture).
4.5 Identification of cases of CSE through other sources
As the candidate was based at Great Ormond Street Hospital for Children NHS Trust 
(GOSH), some cases of CSE were reported directly to the candidate by intensive care 
and neurology staff. Occasionally, cases were also reported by electronic mail. As 
these were all passive notifications immediately after admission, such cases were 
considered “telephone notifications” and were defined as being identified by 
“PHONE”.
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4.6 Capture-recapture
4.6.1 Introduction
As the name suggests, capture -  recapture methods were originally developed for use 
in animal ecology, from which they draw their name (Shepherd 1994) and were later 
adapted for use in connection with human populations. Capture-recapture methods in 
epidemiology are attempts to estimate or adjust for the extent of incomplete 
ascertainment using information from overlapping lists of cases from distinct sources. 
The number of cases identified by each source and the overlap between sources are 
used to estimate the total number of cases in a population and by extrapolation, the 
number of unascertained cases. Different capture-recapture models are used 
according to the number of sources of identification and the different models are 
described in Sections 4.6.3 and 4.6.5. The value of capture-recapture has been 
demonstrated even for apparently exhaustive studies. In a study of the prevalence of 
Huntington’s disease in Maryland on April 1, 1980, the authors used 14 different 
ascertainment sources, including genealogical records from pedigrees, in an attempt to 
identify all possible cases and reported a total of 217 cases on the prevalence day 
(Folstein et al., 1987). By applying capture-recapture methodology, Hook and Regal 
demonstrated that the ascertainment from that apparently exhaustive study was 
between 59 to 76%, suggesting that the true estimate was higher than that reported 
(Hook and Regal 1992).
4.6.2 History o f  adaptation for human population studies
According to Seber, the first use of the capture-recapture method can be traced to 
Laplace who applied it to estimate the population of France in 1786 (Seber 1982).
The first application of the method to human health may be regarded as Sekar and
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Deming's use of the method to estimate birth and death rates and the extent of 
registration in the United States of America in 1949 (Sekar and Deming 1949). Since 
then a number of epidemiological studies have successfully used the method (Tracey 
1941; Shapiro 1949; Wittes and Sidel 1968; Wittes et al., 1974; Hogan 1993; Rahi 
and Dezateux 1999; Whitfield and Kelly 2002; Acin et al., 2003; Gill et al., 2003; 
Pezzotti et al., 2003). The earliest epidemiological studies using the method were 
conducted in 1968 by Wittes and Seidel who estimated the frequency of birth defects 
(Wittes and Sidel 1968) and by Lewis and Hassanein who investigated hospital 
infections in 1969 (Lewis and Hassanein 1969). However, the method was not taken 
up and it was not until the late 1980s that the method began to be used to any great 
extent. The early papers almost exclusively used the two sample approach but 
recently, new methodologies using multiple samples have been developed (Brodie 
1990; Derroch et al., 1993; Chao et al., 2001;).
4.6.3 Two-sample capture-recapture model
4.6.3.1 Application to ecology studies
The simplest capture-recapture model is the so-called two sample model, also called 
the Petersen method because of Petersen's work with tagged fish ini 894 (Hook and 
Regal 1995) and is used solely to estimate the unknown size of a population. An 
animal experiment will be used illustrate the method. Assume that a first sample of 
animals {nj) is captured, marked and returned to the total population of animals (N). 
Then the marked proportion in the population is m/N.  A second sample of animals 
(iri2) is captured and this includes a number (mj) that were previously marked. Given 
that the two samples are independently drawn, one would expect the proportion of 
marked to unmarked animals in the second sample to be the same as the proportion of
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the number of animals captured in the first sample to the number in the whole 
population i.e. 7H2/W2 = nj/N, and therefore N =  niri2/m2 (Wittes and Sidel 1968; 
Hook and Regal 1995).
Confidence intervals for the ascertainment-adjusted estimate of N  may be calculated 
using the formula: 95% confidence intervals = N ±  1.96[V[(a+b+l)(a+c+l)(b)(c)] / 
[(a+1) (a+2)], where a is the number of animals identified in both samples, b is the 
number of animals identified only from the first sample and c is the number of 
animals identified only from the second sample (Regal and Hook 1984).
4.6.3.2 Application to human population studies
The capture-recapture method can, in principle, be applied to any human population 
studies in which there are two incomplete lists i.e. one replaces "being caught in 
sample x" with "being on list x" and referring to the method as “two source capture- 
recapture” instead of two sample capture-recapture” . This is the case in 
epidemiological studies where lists may be collated from various sources such as 
hospital records, laboratory records, clinic records and others. However, not all cases 
may be admitted to hospital, or have laboratory investigations or be seen in clinic. 
Thus, lists collated from such sources may be incomplete and the challenge is to 
estimate those cases that are missing from both lists. Intuitively, the two source 
method may appear simple and straightforward but in order for capture-recapture 
estimates to be valid, four key assumptions should be fulfilled.
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4.6.3.3 Assumptions for capture-recapture methods
1. There is no change to the population during the investigation (the population is 
closed).
2. There is no loss of the tag/identifier (individuals can be matched from capture to 
recapture).
3. For each source, each individual has the same chance of being included in the 
sample (equal catchability)
4. The sources are independent.
In the current study, assumptions 1 to 3 were fulfilled i.e. the North London 
population size was approximately constant during the study period; unique patient 
identifiers collected on each patient in this study including patient initials, gender, 
date of birth, home postal code, hospital registration number and admitting and or 
referring hospital ensured that individuals could be matched across all sources of 
identification of cases of CSE; a strict definition of CSE was used to prevent different 
interpretations amongst clinicians. It is, however, unlikely that assumption 4 was 
fulfilled in this study. Generally, independence between sources is untenable in 
practice in epidemiological studies and this is the main weakness of a two-source 
capture-recapture model (Brenner 1995).
4.6.4 Dependence between sources in capture-recapture 
There are two types of dependence (Chao et al., 2001):
1. Local dependence (list dependence, local list dependence) within each individual. 
The inclusion of an individual in one source has a direct causal effect on their 
inclusion in other sources. For example, the probability of an individual attending
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a sickle cell disease clinic for treatment depends on the results of his blood tests for 
sickle cell disease. Consequently, ascertainment of cases from a sickle cell disease 
clinic and from sickle cell disease blood tests become dependent. In the current 
study, local dependence is likely to be low or absent as the identification of a child 
with CSE by the BPSU-like system, the telephone reporting system, or the audits 
of hospital admissions does not have a direct causal effect on inclusion in any of 
the others.
2. Heterogeneity between individuals. The ascertainment of sources may become 
dependent if the probability for capture is heterogeneous among individuals. For 
example, more severe cases are more likely to be reported by various sources than 
less severe cases and between subgroups of the population, there is varying access 
to medical care and hence varying likelihood of eventual diagnosis and 
registration. It is possible that such dependence exists in this study but to what 
extent is uncertain.
Lack of independence between sources leads to a bias in estimated rates. It is not 
possible to quantify dependence in the two-sample method and though most studies 
resolve this problem by simply ignoring any possible dependence, the practice is not 
ideal (Chao 1987; Chao et al., 2001). As a result, several models, applicable to k- 
sources, where k is at least three, incorporating dependence among samples have been 
proposed in the literature.
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4.6.5 Three or more sources model
These include ecological models, log-linear models (Agresti 1994; Coull and Agresti 
1999) and the sample coverage approach (Chao and Tsay 1998; Tsay and Chao 2001). 
For the purposes of this thesis, only the latter two models are used as they are mainly 
useful for two to five sources of data and are hence more applicable to 
epidemiological studies.
4.6.5.1 Log-linear Models
In log-linear models, data are considered as a form of an incomplete 2k contingency 
table (k is the number of lists) for which the cell corresponding to those individuals 
not listed by all samples is missing. A series of possible interactions between lists is 
modelled with resultant plausible corresponding estimates for each. How well the 
model fits the data is assessed using the deviance statistic, with the best models 
corresponding to those with the smallest deviance statistic (Chao et al., 2001). 
However, equally fitting models may give quite different estimates (Coull and Agresti 
1999) and as the number of lists increases, the number of adequate models and thus, 
model selection becomes more difficult (Hook and Regal 1995). Therefore, an 
alternative approach may be required.
4.6.5.2 Sample Coverage Approach
The sample coverage approach provides such an alternative model. The approach was 
originally proposed by Good and Turing (Good 1953) and has played a major role in 
the classical species estimation for heterogeneous populations. Fundamentally, the 
concept is that a good estimate of the sample coverage may be made even in the 
presence of two types of dependencies i.e. local dependence and or heterogeneity
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between individuals. Thus, an estimate of the population size can be derived through 
the relationship between population size and sample coverage. Three estimates are 
calculated corresponding to low sample coverage, high sample coverage and complete 
sample coverage (complete independence between lists) with the best model for the 
data corresponding to that with the smallest deviance statistic (Chao et al., 2001).
Therefore, by applying both log-linear modelling and sample coverage approach, a 
series of possible estimates of population size, along with their deviant statistics may 
be determined. Amongst best fit models, that which has the lowest (highest) estimate 
is considered the best estimate of the lower (upper) limit of the true size of the 
population. CARE -1, a program developed by Chao and Tsay (Chao et al., 2001) and 
capable of applying the Log-linear model and the Sample coverage approach was 
used for NLSTEPSS.
4.6.6 Number o f  sources required for capture-recapture
In epidemiological studies different ascertainment methods are usually used and 
therefore, as the number of sources increases, dependence measures increase. 
Increasing the number of sources often costs more and requires additional effort, but 
does not necessarily produce better results, particularly when different ascertainment 
methods are used (Offringa et al. 1991). Only three or four sources are recommended 
unless similar methods of ascertainment are applied (Chao et al., 2001).
4.6.7 Application o f  capture-recapture to NLSTEPSS
Three sources of identification of cases were used in this study i.e. “PHONE”, 
“FORMS” and “AUDITS” but audits were only conducted at a random sample of
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hospitals in the research network and at CATS. As independence between sources is 
not guaranteed in two source models and dependency can be accounted for in three 
source models, the candidate applied a three source capture-recapture model to the 
data. Using both log-linear and sample coverage approaches, estimates of the lower 
and the upper limit of the number of missed cases of CSE and degree of ascertainment 
in the random sample of three sources were initially calculated and the results were 
extrapolated to the data obtained from the two lists covering the entire research 
network . Consequently, in the current study, ascertainment- adjusted rates are 
presented as a range with an estimated lower limit and upper limit and a 
corresponding 95% confidence interval.
The previous sections of this chapter illustrate that through a multi-tiered notification 
system, exhaustive efforts were made to identify as many cases of childhood CSE as 
possible within North London during the study period. Despite these efforts, the 
candidate recognised the possibility of unascertained cases but by utilising capture- 
recapture methods, an estimate of the number of missed cases could be determined 
and ascertainment adjusted estimates of the incidence and occurrence of CSE could 
hence be calculated.
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PART TWO
A PROSPECTIVE POPULATION BASED STUDY OF 
CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD
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CHAPTER 5: INCIDENCE, AETIOLOGY, SEIZURE 
CHARACTERISTICS AND OUTCOME OF CONVULSIVE 
STATUS EPILEPTICUS IN CHILDHOOD IN NORTH LONDON
5.1 Introduction
In Chapters 1-4, the need for a paediatric population based study on status epilepticus, 
the feasibility of conducting such a study in North London and the methods for 
identification of cases and assessment of ascertainment were outlined. Status 
epilepticus may be convulsive or non-convulsive in nature and whilst convulsive 
status epilepticus is a clinical diagnosis, non-convulsive status epilepticus is an EEG 
diagnosis (Kaplan 1999; Drislane 2000; Husain et al., 2003; Ruegg and Dichter 2003). 
Therefore, as immediate EEG investigation is not universally available for children 
admitted to hospitals in North London, NLSTEPSS was restricted to episodes of 
convulsive status epilepticus (CSE).
From the systematic review of population-based studies on SE reported in Chapter 2, 
the incidence of status epilepticus in children is higher in the younger age groups, 
particularly in those aged less than one. There is also some evidence that the 
incidence of status epilepticus may be higher in non-white ethnic groups compared to 
white ethnic groups, raising the possibility that there may be innate or genetically 
determined biologic mechanisms for this increased incidence. A growing body of 
research suggests, however, that ethnicity has strong social dimensions that influence 
health. Demonstrated racial/ethnic "effects" may be intricately related to 
socioeconomic factors, because race/ethnicity interacts with and is confounded by
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social class or socioeconomic status and therefore studies on the effect of 
race/ethnicity on disease may be strengthened by the inclusion of socioeconomic 
factors. Within the published literature, there are no data on the independent effects 
of ethnicity and socioeconomic state on the incidence of status epilepticus.
There is evidence from animal and human studies that suggest that the morbidity and 
mortality associated with status epilepticus increases with increasing seizure duration 
(Aicardi et al., 1970; Meldrum et al. 1973; Dunn 1988; Yager et al., 1988; Logroscino 
et al., 1997; Logroscino et al., 2002; Hui et al., 2003). Therefore, identification of 
factors associated with longer duration of status epilepticus may provide the 
foundations for the development of interventions that could improve the outcome of 
status epilepticus by reducing seizure length.
In this chapter, through a prospective, paediatric, population based study, the 
frequency, aetiology, seizure characteristics and outcome of CSE in childhood are 
described and the following specific research questions are addressed:
1. What is the incidence, occurrence, aetiology and seizure characteristics of 
childhood CSE?
2. What is the relationship between ethnicity, socioeconomic status, age and 
incidence of childhood CSE?
3 . What are the factors associated with CSE lasting longer than 60 minutes compared 
to CSE lasting 30-60 minutes?
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4 .  What is the one year risk of recurrence of CSE?
5 .  What is the short term mortality associated with CSE?
5.2 Methods
5.2.1 Data collection tools
5.2.1.1 The questionnaire (admission proforma)
In order to increase the accuracy of the clinical history and treatment of episodes of 
CSE, a questionnaire was developed. This was to be used at the time of presentation 
to hospital with the intention that it would serve as an admission proforma for 
children with CSE. The questionnaire was revised following consultation with 
members of the Steering Committee and piloted for 6 weeks in Tubingen, Germany, 
among children with convulsive status epilepticus who were admitted to the 
University Hospital of Tubingen. The revised draft was sent to all members of the 
Collaborative Group for individual comments and further discussed at a Collaborative 
Group meeting. The final product, Appendix 10 was the final consensus view of the 
Collaborative Group.
5.2.1.2 Systems for identification o f cases o f  CSE 
These were described in detail in Chapter 4.
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5.2.2 Data management
In consultation with a database designer, a linked anonymised system for data storage, 
management and analysis was developed. All patient identifiable information and 
patient clinical data were stored in separate but linked databases designed in 
Microsoft Access 97. Patient identifiable information (PII) were entered into a 
password protected, electronic database held on a networked computer with access 
limited to the principal researchers and secured in a lockable room. Clinical data on 
patients were entered into a separate password protected, electronic database held on a 
non-networked computer with access limited to the principal researchers and kept in a 
separate lockable room from that which will held the PII database. Database 
passwords were changed at least six-monthly and electronic back up files were 
created at least weekly. Anonymised paper copies of admission proformas were 
stored in a lockable room. All confidential correspondence/data were shredded.
Every effort was taken to safeguard patient confidentiality.
5.2.3 Pilot phase o f  the project
The first three months of the project served as a pilot phase. Initially, accident and 
emergency physicians and neurophysiologists were also included in the BPSU-like 
surveillance scheme to prevent missed cases. However during the study it became 
apparent that all children with CSE would be referred to paediatric services and after 
three months following a Steering Group meeting, only paediatricians were sent 
monthly surveillance forms. In order to safeguard confidentiality, it was proposed in 
the initial study design that the principal researchers would collect data on the event 
through a structured telephone interview with the referring physician. During the 
study, it became evident that this was neither effective nor efficient and the data
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collection methodology was reviewed. After consultation with the Collaborative 
Group and the Steering Group, it was decided that the admission proforma would 
remain unchanged but data collection would principally be through examination of 
anonymised copies of admission proformas faxed to a secure number at the 
NLSTEPSS coordinating centre, with direct interviews (by telephone or face to face) 
with the medical, nursing, accident and emergency, or paramedics by the candidate if 
further information were necessary.
5.2.4 Ethical Approval
All committees that gave ethical approval of the study agreed with the candidate’s 
proposal that consent for entry into the study was not required. Verbal or written 
consent for inclusion in the study was not considered mandatory because:
1) NLSTEPSS was a non-interventional, surveillance study,
2) the data to be collected were part of standard information that should be 
obtained on children with CSE,
3) for research purposes, no direct contact was to be made between the researcher 
and the patients or their families.
As the candidate had clinical duties within the neurology service at one of the 22 
hospitals involved in the research, Great Ormond Street Hospital for NHS Trust, 
occasionally at Great Ormond Street Hospital for NHS Trust, the candidate had direct 
contact with children referred to the neurology service because of CSE. Such patients 
were included in the study but, as in every other patient in the study, every effort was 
made to safeguard patient confidentiality. Thus, only the minimum data required to 
identify patients were obtained and stored from notifications to NLSTEPSS.
Furthermore, all patient data were handled in accordance with the principles of the 
Caldicott Committee Report on the Review of Patient-Identifiable Information, those 
contained in the Data Protection Act 1991 and those outlined in the BPSU’s Guidance 
Statement on Patient Confidentiality. Patients eligible for inclusion in NLSTEPSS, 
were assigned a unique study identification number that was shared with NLSTEPSS 
research collaborators at their local hospital. All patient data stored in NLSTEPSS 
were anonymised but identifiable through study identification numbers. To facilitate 
possible follow up studies on the cohort of patients identified in NLSTEPSS, 
collaborators were asked to keep a record of study identification numbers of patients 
along with their demographic details. Copies of the study protocol were included in 
all applications to ethics committees. NLSTEPSS was approved by the London 
Multicentre Research Ethics Committee, a central ethics committee that considers 
applications for studies to be conducted in more than four hospitals. Ethical approval 
of the study was also given by Local Research Ethics Committees of all 22 hospitals 
involved in the study.
5.2.5 Definitions
5.2.5.1 Convulsive status epilepticus was strictly defined as a seizure with focal or 
generalised motor manifestations, or series of such seizures between which 
consciousness is not regained, which last for at least 30 minutes (Commission on the 
Terminology of the International League Against Epilepsy 1981; International League 
Against Epilepsy 1993). Children with CSE for whom fever was the only precipitant 
identified were included in the study. The following were excluded:
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a) episodes where there was insufficient documentation to confirm a seizure or series 
of seizures of duration of at least thirty minutes
b) seizures that lasted less than 30 minutes whether the seizures were terminated by 
emergency anti-epileptic drugs or not
c) multiple seizures during a 24 hour period each lasting less than 30 minutes and with 
periods of lucidity in between seizures
d) episodes of NCSE (seizure activity without significant clinical features but with 
EEG changes consistent with SE).
5.2.5.2 North London. North London was defined as in Chapter 3. Children whose 
primary home address was outside of North London were excluded.
5.2.5.3 Ase. All patients aged less than 16 years, excluding neonates, were included 
in NLSTEPSS. The characteristics of neonatal seizures differ greatly from seizures in 
older children and convulsive status epilepticus is rare in neonates. Therefore, 
neonates were excluded from the study.
5.2.5.4 Ethnicity. For each child clinical and demographic data, including ethnicity 
and home postcode were collected. All data were anonymised before analysis. As 
part of the regular hospital admission process, parents were asked to indicate the 
ethnicity of their child from a list of ethnic groups. The ethnic group categories were 
those used in Census 2001: White, Black, Asian, Other (includes mixed ethnicity).
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5.25.5 Socioeconomic Status. Home postcodes for each child were used to determine 
an Index of Multiple Deprivation 2004 (IMD 2004) score of socioeconomic 
deprivation for the local area (SOA) in which the child lived. The method of 
determining an IMD 2004 score using an individual’s home postal code was described 
in Chapter 3.
5.2.5.6 Aetiologies. Aetiologies of CSE were categorised using a modified version of 
the ILAE’s recommended classification system. As discussed in Chapter 1, Section 
1.3, in order to identify factors associated with prolonged febrile seizures that may 
lead to pathophysiological hypotheses on their mechanisms, there is an argument for 
considering prolonged febrile seizures as a distinct category of status epilepticus. For 
the purposes of NLSTEPSS, prolonged febrile seizure was considered as a distinct 
category. In addition, the designation "acute on remote symptomatic SE" was 
included in order to distinguish those children with previous neurological 
abnormalities with fever and illness related seizures, from those with prolonged 
febrile seizures. See Table 5.1 for details of the classification of aetiologies of CSE 
used in NLSTEPSS. Aetiologies were classified by the candidate and one of the 
candidate’s supervisors. Disagreements in classification were resolved by consensus 
or by third part adjudication.
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1. Prolonged Febrile Seizure -  CSE in a previously neurologically normal child 
aged between 6 months and five years during a febrile (temperature above 38 
°C) illness and in the absence of defined central nervous system (CNS) 
infection.
2. Acute symptomatic - CSE in a previously neurologically normal child, within 
a week of an identified acute neurological insult including head trauma, CNS 
infection, encephalopathy, cerebrovascular disease, metabolic derangements.
3. Remote symptomatic - CSE in the absence of an identified acute insult but 
with a history of a pre-existing CNS abnormality more than 1 week before.
4. Acute on remote symptomatic - CSE that occurred within a week of an acute 
neurological insult or febrile illness and occurred in a child with a history of 
previous neurological abnormality, including epilepsy. This category included 
children with cerebral palsy with a febrile illness not of CNS origin, and 
children with obstructed ventriculo-peritoneal shunts for hydrocephalus.
5. Idiopathic Epilepsy related - CSE that is not symptomatic and occurred in 
children with a prior diagnosis of idiopathic epilepsy or when the episode of 
CSE is the second unprovoked seizure that has led to a diagnosis of idiopathic 
epilepsy.
6. Cryptogenic Epilepsy related - CSE that is not symptomatic and occurred in 
children with a prior diagnosis of cryptogenic epilepsy or when the episode of 
CSE is the second unprovoked seizure that has led to a diagnosis of 
cryptogenic epilepsy.
7. Unclassified - CSE that cannot be classified into any other group.
Table 5.1: NLSTEPSS classification system of the aetiologies of CSE in childhood.
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The following acute symptomatic aetiologies were associated with CSE in the study: 
(1) acute bacterial meningitis, (2) viral CNS infections, (3) acute metabolic: any 
systemic dysfunction that resulted in metabolic disturbances including electrolyte 
imbalance, hypoglycaemia, or other metabolic abnormalities, (4) drug related'. 
included adverse drug reactions and drug overdoses, (5) head injury: injury requiring 
medical treatment or hospitalisation, (6) hypoxia/anoxia: respiratory insufficiency as 
indicated by central cyanosis and decreased oxygen saturation or decreased oxygen 
levels on blood gases or documented respiratory or cardio-respiratory arrest lasting at 
least 5 minutes preceding CSE, (8) fever, fever as the only identified precipitant but 
outside of the defined age range for prolonged febrile seizures could not be fulfilled. 
(9) cerebrovascular accident (CVA): included occlusive, embolic or haemorrhagic 
infarction.
Epilepsy was defined as two or more unprovoked seizures in a lifetime. Within the 
idiopathic/ cryptogenic epilepsy related aetiology categories, the following sub­
categories were also used: (1) epilepsy diagnosed before CSE, (2) epilepsy diagnosed 
at the time of CSE (CSE was the second unprovoked seizure that led to the diagnosis 
of epilepsy) and (3) epilepsy diagnosed after CSE (CSE was the first unprovoked 
seizure and subsequent seizures led to the diagnosis of epilepsy). Two month follow 
up data on seizure recurrence and results of epilepsy investigations were available for 
all patients who had a first unprovoked seizure. If the diagnosis of epilepsy was made 
within two months of the initial episode of CSE, for the purposes of this study, CSE 
was considered as the first unprovoked seizure that led to the diagnosis of epilepsy.
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5.2.5.7 Seizure types. The classification of CSE seizure type was based on the criteria 
of the International League Against Epilepsy as: primary generalised, focal with 
secondary generalisation and focal (International League Against Epilepsy 1993; 
Engel 2001). Generalised CSE types were subtyped into tonic, clonic and tonic-clonic 
seizures. Focal with secondarily generalised CSE included cases with focal features 
and whose final seizure type was tonic, clonic, or tonic-clonic. Focal CSE included 
those cases with motor seizures that did not generalise. Episodes of CSE that were a 
single seizure were characterised as continuous CSE and those that were serial 
seizures without recovery of consciousness between seizures were characterised as 
intermittent CSE.
Seizure types were classified independently by the candidate and one of the 
candidate’s supervisors. Disagreements in classification were resolved by consensus 
or by third part adjudication. The classification of seizure type was based on review 
of the documented description of events by the attending physicians on a standardised 
data collection form that also served as the hospital admission notes (the admission 
proformas) and through direct interview with attending paediatricians, emergency 
physicians, paediatric intensivists, paediatric neurologists, nurses, paramedics or 
members of the research team. Direct interview with parents was possible when a 
member of the research team was also the attending paediatrician, emergency 
physicians, paediatric intensivists, or paediatric neurologists. Where indicated, 
anonymised copies of the A&E, nursing, ambulance and intensive care notes were 
also reviewed. Most cases were notified to and evaluated by the research team within 
five days of the diagnosis.
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5.2.5.8 Incident cases. Incident cases were defined as lifetime first episodes of CSE.
5.2.5.9 Occurrence cases. Occurrence cases were defined as any case of CSE during 
the study period.
5.2.5.10 Recurrence. Children who had an incident episode of CSE during the first 
year and had at least one further episode of CSE, during the second year of the study 
were defined as having a recurrence of CSE. Recurrent episodes of CSE during a 
single admission were included.
5.2.5.11 Duration. Data on duration of CSE were obtained using the method for data 
collection for classification of seizure types described above. The admission 
proforma included the clock time noted by the parents at the first recognition of the 
seizure, the time the ambulance was called, time the ambulance arrived to the child, 
time of arrival to A&E and clock time of cessation of overt clinical seizure activity. 
When doubt existed, the shorter duration of seizure was used. Duration was defined 
as the interval between onset of CSE and cessation of clinical seizure activity.
5.2.5.12 Mortality. Mortality was defined as death associated with CSE, occurring 
during hospitalisation for CSE. All patients were followed up during hospitalisation 
or to the time of death. Survival was defined as alive following hospitalisation.
5.2.6 Case identification
The methods of identification of possible cases of CSE cases were described in 
Chapter 4. In the period May 1, 2002 to April 31, 2004, each reported case of CSE
- 9 3 -
was evaluated by the research team to verify fulfilment of inclusion criteria for the 
study i.e. residence in North London, aged less than 16 years and whether they met 
the strict definition of CSE or not. Residence within North London was validated by 
documenting children’s home postal code against an electronic database of postal 
codes within North London. Most cases (70%) that were excluded were children who 
resided outside of North London. Twenty percent of those excluded did not meet the 
definition of CSE; the remainder were outside the age range. Only the minimum 
information required to identify the patients whilst safeguarding confidentiality was 
requested of notifications.
5.2.7 Data collection
Once eligibility for the study was confirmed, each child was assigned a unique study 
identification number (study ID) that was given to the local researcher at the referring 
hospital. All subsequent data on each child were anonymised, using the study ID as 
the unique patient identifier. Local researchers were asked to keep a record of all 
patients notified to NLSTEPSS along with their assigned study ID to facilitate any 
subsequent follow up studies. Data on each eligible case were obtained in two phases. 
In the initial phase, data was obtained through review of anonymised copies of the 
standardised admission proforma during hospitalisation or within 2 weeks of 
notification. Where necessary, supplemental information was obtained through review 
of anonymised copies of A&E, nursing, ambulance and intensive care notes. Direct 
interview with attending paediatricians, emergency physicians, paediatric intensivists, 
paediatric neurologists, nurses, paramedics and parents facilitated a more accurate and 
detailed account of the clinical course and treatment of the CSE event. In the second 
phase of data collection, conducted six to eight weeks after the first phase, results for
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investigations not available during the first phase were obtained through local 
collaborators. All data on each CSE event were entered into a Microsoft Access 97 
database and included demographic data, detailed seizure history, seizure duration, 
previous medical history, perinatal history, development history, family history of 
seizures, details of treatment of CSE, aetiology of CSE, results of laboratory 
investigations and outcome.
5.2.8 Database validation
The data from audits in randomly selected hospitals described in Chapter 4 served to 
validate the information in the database.
5.2.9 Maintaining the interest o f  local collaborators
There were three collaborator’s meetings over the study period, but the candidate 
corresponded at least every two months by telephone and or e-mail with each 
collaborator giving updates on progress of the research, presentations at international, 
national conferences and papers arising from the research. In addition, collaborators 
were regularly sent cards and occasionally token gifts of wine for festive occasions 
(Christmas, Easter, anniversary of commencement date of the study).
5.2.10 Statistics.
Data analyses were conducted in SPSS Version 10 (Chicago, Illinois), Microsoft 
Office Excel 2003, Intercooled Stata 6.0, CARE-1 and StatXact v4.0.1. The degree of 
ascertainment of the study was investigated through a three source capture-recapture 
model using CARE-1 software in S plus (Chao et al., 2001). Details of the method 
were described in Chapter 4.
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The average annual incidence and occurrence of CSE for North London children 
between the period May 1, 2002 to April 31, 2004, were estimated using population 
data from UK Census 2001 as denominator and the average number of incident and 
occurrence cases per year as numerator. Crude, ascertainment adjusted, age-adjusted, 
ethnicity-adjusted, age-specific and ethnicity-specific, incidence and occurrence rates 
by sex, seizure type, duration and aetiology were calculated.
Age-adjusted and ethnicity-adjusted estimates were determined by directly adjusting 
crude estimates to the UK Census 2001 England and Wales paediatric population 
(Office of National Statistics 2004a; Office of National Statistics 2004b).
The relationships between incidence and age, socioeconomic status and ethnicity were 
investigated using Poisson multivariate regression analysis. To examine possible 
interaction effects of socioeconomic status with ethnicity/age, two way and three way 
interaction terms were tested in the multivariate analysis.
Predictors for factors associated with a duration of CSE greater than 60 minutes were 
investigated through forward stepwise multivariate logistic regression analysis with 
subsequent removal of nonsignificant variables with significant levels for entering and 
removing variables set at p=0.05 and p=0.1 respectively. The following variables 
were investigated: age, ethnicity, sex, socioeconomic status, prehospital treatment or 
not, interval between onset of CSE and arrival to A&E, treatment with emergency 
AED within 10 minutes of onset of CSE, treatment with emergency AED within 15 
minutes of onset of CSE, adequacy of first dose of AED, incident vs non-incident
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episode, treatment with more than 2 doses of benzodiazepines, focal features, febrile 
or not, intermittent vs continuous CSE and neurological state prior to episode of CSE. 
Only first episodes of all children who had CSE during the study period were included 
in the analysis on factors associated with duration of CSE greater than 60 minutes.
5.3 Results
South
wark Greenwich
Hounslow Lambeth
Wandsworth
Redbridg
Figure 5.1: Map of North London (area enclosed by red border) with distribution of 
incident cases of CSE from NLSTEPSS.
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5.3.1 Demographics
There were 226 children with 304 episodes of CSE (occurrence episodes) notified to 
NLSTEPSS between May 1, 2002 and April 31, 2004. Of these children, 176 
children had lifetime first (incident) episodes of CSE. There were 99 incident 
episodes of CSE in the first year of the study and 77 incident episodes in the second 
year. For further details on the number of episodes of CSE enrolled into the study 
each year, according to whether they were incident episodes or whether there were 
previous episodes of CSE, see Table 5.2.
Enrolment into NLSTEPSS Episodes of CSE 
Year 1 Year 2 Total
FIRST ENROLMENT
Incident Episodes 99 77 176
> one CSE before NLSTEPSS 44 6 50
REPEAT ENROLMENT 39 39 78
Total (Occurrence episodes) 182 122 304
Table 5.2: Number of episodes of CSE enrolled each year according to whether they 
were incident episodes or whether there were previous episodes of CSE. Fifty 
children who were initially enrolled in the study had at least one previous episode of 
CSE before NLSTEPSS. Each year there were 39 repeat episodes of CSE following 
initial enrolment.
Amongst incident episodes of CSE, 136 (77%) started out of hospital whilst 40 
commenced in hospital. This pattern was consistent for all occurrence episodes of 
CSE as amongst all CSE episodes, 240 episodes (79%) started out of hospital. Most 
children with CSE of out of hospital onset (83%) were taken to hospital by ambulance 
and the majority (97%) of children in the study presented to hospitals located within
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the boundaries of North London. The distribution of incident episodes of CSE 
according to aetiology is illustrated in Figure 5.1
5.3.2 Notifications
Over the two year study period, of the 176 incident cases notified, 146 were notified 
by PHONE, 92 by FORMS and 62 by both PHONE and FORMS.
5.3.3 Regional BPSU-like Surveillance Scheme
The mean monthly proportion of responders (74%) to the BPSU-like surveillance 
scheme was similar for both years of the study. Paediatricians based outside of North 
London (6%) and general paediatricians (6%) and paediatric intensivists (4%) in 
North London were the main groups of non-responders. For further details on the 
proportion of non-responders according to paediatric subspecialty and location of 
their hospital, see Figure 5.2.
e  3 0 . 0
20.0  -
ttL ■0.0  +■
Subspecia lty
A l l  H o s p i t a l s  ■  I n  N o r t h  L o n d o n  □  O u t s i d e  N o r t h  L o n d o n
Figure 5.2: Mean proportion of non-responders according to sub-specialty and 
location of their hospital.
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5.3.4 The incidence and occurrence o f CSE in North London
The crude incidence of CSE in childhood in North London is 14.5/100,000 children 
per year and the crude occurrence is 25.1/100,000 children /yr.
5.3.5 Age-specific incidence o f CSE
The incidence of CSE is highest among children aged less than 1 year of age 
compared to those aged 1 to 4, 5 to 9 and 10 to 15 years of age (see Table 5.3). This 
pattern is consistent for prolonged febrile seizures, acute symptomatic, remote 
symptomatic, acute on remote symptomatic and cryptogenic epilepsy related CSE but 
not for idiopathic epilepsy related or unclassified CSE. In the latter categories, 
children aged 1-4 have the highest incidence. The high incidence of CSE in those 
aged less than a year is particularly marked in the acute symptomatic group in which 
acute CNS infections account for half of cases (see Figure 5.3).
A e t i o l o g y  o f  A c u t e  S y m p t o m a t i c  C S E  ( n = 3 0 )
■  A B M
■  V i r a l  C N S
□  A c u t e  M e t a b o l i c
■  D r u g  R e l a t e d
■  H e a d  I n ju r y
■  H y p o x i a / A n o x i a  
0  F e v e r
■  C V A
Figure 5.3: Aetiology of Acute Symptomatic CSE.
ABM = acute bacterial meningitis Viral CNS = viral CNS infection
Acute Metabolic = acute metabolic disturbance CVA = cerebrovascular accident
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Age (y) Population Prolonged 
Febrile Seizure
Acute
Symptomatic
Remote
Symptomatic
Acute on Remote 
Symptomatic
Idiopathic 
Epilepsy Related
Cryptogenic 
Epilepsy Related
Unclassified Total Group
N I N I N I N I N I N I N I N I
<1 41397 15 18.1 14 16.9 4 4.8 5 6.0 1 1.2 2 2.4 1 1.2 42 50.7
1 -4 161056 41 12.7 8 2.5 12 3.7 17 5.3 8 2.5 0 0.0 8 2.5 94 29.2
5 -9 187261 0 0.0 6 1.6 8 2.2 5 1.3 8 2.1 1 0.3 3 0.8 31 8.3
10-15 215606 0 0.0 2 0.5 5 1.1 1 0.2 1 0.2 0 0.0 0 0.0 9 2.1
All 605320 56 4.6 30 2.5 29 2.4 28 2.3 18 1.5 3 0.2 12 1.0 176 14.5
Table 5.3: Age-specific number and incidence rate per 100,000 children/yr for CSE in childhood by aetiology for North London.
N = number I = incidence rate per 100,000 children/year
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5.3.5.1 Age-specific incidence o f CSE and sex.
The incidence of CSE is greater in males aged less than 1 year and 1 to 4 years of age 
compared to females of similar ages but across other age groups, males and females 
have similar incidence (see Figure 5.4).
60.0
£ o  40.0
g 2  30 0
10.0 -
J = L
I I I I
<1 l t o 4  5 to 9 10 to 14 15 10 to 15 All ages
Age (years)
■  Male 
B  Female 
□  All
Figure 5.4: Age-specific incidence rate of convulsive status epilepticus in childhood 
by sex in North London.
5.3.5.2 Age-specific incidence o f CSE and seizure characteristics 
Throughout the age-spectrum, focal onset of CSE is common (a third of all cases) but 
few remain focal (8%). The incidence of primary generalized CSE is twice that of 
any other seizure type and the incidence of intermittent and continuous CSE is similar 
among all age groups. Most seizures are tonic-clonic in nature and the incidence of 
tonic CSE peaks in children less than 1 year of age. CSE is not usually associated 
with epilepsy; 88% of CSE occur in the absence of epilepsy. When CSE is associated 
with epilepsy, there is a history of epilepsy in 62% of incident cases, or it is the 
second seizure (29%) or first seizure (10%) leading to the diagnosis of epilepsy. For 
further details on age specific incidence and seizure characteristics, see Table 5.3.
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Amongst children aged less than 5 years of age, the incidence of CSE in those who 
are previously normal is 1.6 (95% Cl 1.1-2.3, p=0.042) times that of those who have 
previous neurological abnormalities, but in older children (5-15 years), children with 
pre-existing neurological abnormalities are 4.1(95% Cl 1.8- 6.5, p = 0.005) times 
more likely to have incident CSE compared to those with previously normal 
neurology.
5.3.6 Age-adjusted incidence
The age-adjusted incidence of CSE is 13.2/100,000 children/yr. The age adjusted 
incidence in males is 1.2 (95% Cl 1.0 -  1.3, p = 0.05) times greater than in females. 
This difference is due in part to a greater incidence of prolonged febrile seizures and 
acute on remote symptomatic CSE among males compared to females. In males, the 
incidence of prolonged febrile seizures is 4.5/100,000/yr (95% Cl 3.7 -5.1/100,000/yr) 
compared with 3.1/100,000/yr (95% Cl 2.6 -3.6/100,000/yr) among females. The 
incidence of acute on remote symptomatic CSE among males is 2.5/100,000/yr (95% 
Cl 2.1 - 2.9/100,000/yr) versus 1.5/100,000/yr (95% Cl 1.2 -  1.8/100,000/yr) among 
females. By definition, prolonged febrile seizures occur in children aged less than 6 
years. Despite this, the age-adjusted incidence of prolonged febrile seizures is still 
greater than each of the other aetiologies of CSE. Higher incidence of CSE is seen in 
children who are previously neurologically normal or had acute on remote 
symptomatic CSE compared to other aetiologies o f CSE. Clonic (0.1/100,000/yr) and 
tonic (1.6/100,000/yr) CSE occurs infrequently when compared to tonic clonic 
(11.5/100,000/yr) CSE. The age-adjusted incidence of primary generalized CSE is 
greater than each other seizure types. (For further details on age-adjusted incidence 
and seizure characteristics, see Table 5.4).
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Age (y)
<1 1 - -4 5- 9 10- 15 0-15 Age-
adjusted
incidence
N I N I N I N I N I 95% Cl 95% Cl
AETIOLOGY
PFS 15 18.1 41 12.7 0 0.0 0 0.0 56 4.6 (2.8 -  6.4) 4.1 (3.7 - 4.8)
Acute Symp 14 16.9 8 2.5 5 1.4 2 0.5 30 2.5 (1 .3-3.6) 2.2 (1.9-2.5)
Remote Symp 4 4.8 12 3.7 8 2.2 5 1.1 29 2.4 (1.2-3.6) 2.3 (2.0 - 2.6)
Acute on Remote 5 6.0 17 5.3 5 1.4 1 0.2 28 2.3 (1.1 -3.5) 2.1 (1.8-2.4)
Idiopathic 1 1.2 8 2.5 8 2.2 1 0.2 18 1.5 (0.5 - 2.5) 1.4 (1.2- 1.7)
Cryptogenic 2 2.4 0 0.0 1 0.3 0 0.0 3 0.2 (-0.1 -0.6) 0.2 (0.1 -0.3)
Unclassified 1 1.2 8 2.5 4 1.1 0 0.0 12 1.1 (0.2- 1.9) 1.0 (0.8- 1.2)
EPILEPSY
No epilepsy 39 47.1 86 26.7 22 6.1 8 1.9 155 12.8 (10.0-15.7) 11.7 (11.0-12.3)
Before SE 3 3.6 2 0.6 7 1.9 1 0.2 13 1.1 (0.2- 1.9) 1.1 (0.9- 1.2)
At SE 0 0.0 6 1.9 0 0.0 0 0.0 6 0.5 (-0.1-1.1) 0.4 (0.3 - 0.6)
After SE 0 0.0 0 0.0 2 0.6 0 0.0 2 0.2 (-0.2 - 0.5) 0.2 (0.1 -0.3)
SEX
Male 24 56.6 51 31.2 16 8.4 4 1.8 95 15.4 (11.0-19.8) 14.0 (13.0-15.0)
Female 18 44.5 43 27.1 15 8.2 5 2.4 81 13.6 (9.4-17.8) 12.5 (11.5-13.4)
ONSET
Focal 16 19.3 33 10.2 11 3.0 3 0.7 63 5.2 (3.4-7.0) 4.8 (4.3 - 5.2)
Gen 25 30.2 61 18.9 20 5.5 6 1.4 112 9.3 (6.8-11.7) 8.5 (7.9-9.1)
Total 42 50.7 94 29.2 31 8.6 9 2.1 176 14.5 (11.5-17.6) 13.3 (12.6-14.0)
CHARACTER
Continuous 19 22.9 47 14.6 14 3.7 4 0.9 84 6.9 (4.8 -  9.0) 6.3 (5.8 -  6.8)
Intermittent 23 27.8 47 14.6 17 4.5 5 1.2 92 7.6 (5.4-9.8) 6.9 (6.4-7.4)
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Age (y)
<1 1 --4 5 --9 10--15 0-15 Age
adjusted
incidence
N I N I N I N I N I 95% Cl 95% Cl
FINAL SEIZURE TYPE
Focal 2 2.4 5 1.6 2 0.6 0 0.0 9 0.7 (0.1 -1.4) 0.7 (0.5 - 0.8)
Second Gen 14 16.9 26 8.1 9 2.5 3 0.7 52 4.3 (2.6 - 5.9) 3.9 (3.6-4.3)
Primary Gen 26 31.4 63 19.6 20 5.5 6 1.4 115 9.5 (7.0 - 12.0) 8.7 (8.2 - 9.3)
MOTOR TYPE
Tonic 8 9.7 10 3.1 3 0.8 2 0.4 23 2.0 (0.8 -3.2) 1.6 (1.2-1.8)
Clonic 0 0.0 2 0.6 0 0.0 0 0.0 2 0.2 (-0.2 - 0.5) 0.1 (0.1 -0.2)
Tonic Clonic 34 41.1 82 25.5 28 7.7 7 1.6 151 12.5 (9.7 -15.3) 11.5 (10.8-12.1)
DURATION (mins)
3 0 -6 0 17 20.5 36 11.2 17 4.7 1 0.2 71 5.9 (3.9 - 7.8) 5.4 (4.9 - 5.8)
6 1 -9 0 12 14.5 20 6.2 6 1.7 3 0.7 41 3.4 (1.9-4.9) 3.1 (2.8 - 3.4)
91 -  120 3 3.6 19 5.9 3 0.8 3 0.7 28 2.3 (1.1 -3.5) 2.1 (1.9-2.4)
>120 10 12.1 19 5.9 5 1.4 2 0.5 36 3.0 (1.6-4.3) 2.7 (2.4 - 3.0)
ALL 42 50.7 94 29.2 31 8.6 9 2.1 176 14.5 (11.5-17.6) 13.3 (12.6-14.0)
Table 5.4: Number, age-specific and age-adjusted incidence per 100,000 children per year according to features of incident episodes of CSE in 
North London. Age-adjusted to the 2001 England and Wales childhood population.
N = number I = incidence rate per 100,000 children/year.
PFS = Prolonged Febrile Seizure, Acute Symp = Acute Symptomatic, Remote Symp = Remote Symptomatic, Acute on Remote = Acute on 
Remote Symptomatic, Idiopathic = Idiopathic Epilepsy Related, Cryptogenic = Cryptogenic Epilepsy Related, Second Gen = Secondarily 
generalised, Primary Gen = Primary generalised
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5.3.7 Socioeconomic status, age, ethnicity and incidence of CSE 
Socioeconomic deprivation, younger age and non-white ethnicity are independently 
associated with an increased incidence o f CSE. For each one point increase in the 
Index of Multiple Deprivation 2004, there is a cumulative increased risk o f CSE by 
3%. The younger age group 0-4 is more susceptible than older age groups. Children 
of Asian and children o f other non-white ethnicity, but not black children are more 
likely to have an incident of CSE compared to white children. The incidence of CSE 
in black children is not different from that in white children (see Table 5.5).
Variable Incidence Coefficient P 95% Cl
IMD2004 1.03 0.003 1.01-1 .04
Age
0-4
5-7
1.00 (reference) 
0.30 <0.0005 0 .1 9 -0 .4 7
8-9 0.16 <0.0005 0.08 -  0.33
10-15 0.06 <0.0005 0 .03 -0 .12
Ethnicity
White
Black
1.00 (reference) 
1.30 0.230 0 .85-2 .01
Asian 2.06 <0.0005 1.43-2 .97
Other 1.88 0.007 1.19-2 .98
Table 5.5: Poisson multivariate regression of incidence o f CSE according to 
socioeconomic deprivation index, age and ethnicity.
There is evidence that the effect of socioeconomic deprivation on the incidence of 
CSE is less in Asian children compared to white children but overall, there was no 
evidence that the effect o f socioeconomic deprivation is different amongst ethnic 
groups (see Table 5.6).
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Variable Incidence
Coefficient
P 95% Cl
IMD 2004 1.03 0.007 1 .01-1 .06
Age
0-4 1.00 (reference) - -
5-7 0.30 <0.0005 0 .1 9 -0 .4 7
8-9 0.16 <0.0005 0.08 -  0.32
10-15 0.06 <0.0005 0 .0 3 -0 .1 2
Ethnicity
White 1.00 (reference) - -
Black 1.22 0.83 0.21-7.14
Asian 6.62 0.002 2 .0 -2 1 .9
Other 1.37 0.72 0.25-7.5
IMD 2004 * Ethnicity
IMD 2004* White 1.00 (reference)
IMD 2004* Black 1.00 0.97 0.95-1.05
IMD 2004* Asian 0.97 0.05 0 .9 3 -1 .0 0
IMD 2004* Other 1.01 0.71 0 .9 6 -1 .0 6
Table 5.6: Poisson multivariate regression of incidence o f CSE according to 
socioeconomic deprivation index, age, ethnicity, including two way interaction effects 
between socioeconomic deprivation index and ethnicity.
5.3.8 Ethnicity-specific incidence of CSE
The increased incidence of CSE in children o f Asian ethnicity and children of other 
non-white ethnicity, but not black children, may be partly explained by the 4 times 
greater incidence of prolonged febrile seizures in children of Asian (8.1/100,000/yr, 
95% Cl 3.2-13.0/100,000/yr) and Other (8.5/100,000/yr, 95% Cl 1.5-15.4) ethnic 
groups compared to white (2.5/100,000/yr, 95% Cl 0.7 -  4.2/100,000/yr) children.
The incidence of Remote symptomatic CSE peaks in Asian children and the incidence 
of Acute on Remote symptomatic CSE peaks in Asian and black children (See Figure 
5.5). There is a trend towards longer duration of CSE in children of non-white 
ethnicity compared to white children. For further details on ethnicity specific 
incidence and features of CSE, see Table 5.5).
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Figure 5.5: Ethnicity specific incidence of CSE according to aetiology.
PFS = Prolonged Febrile Seizure, Acute Symptomatic = Acute Symptomatic, Remote 
Symptomatic = Remote Symptomatic, Acute on Remote = Acute on Remote 
Symptomatic, Idiopathic = Idiopathic Epilepsy Related, Cryptogenic = Cryptogenic 
Epilepsy Related, Unclass = Unclassified
5.3.9 Ethnicity-adjusted incidence o f CSE
The ethnicity-adjusted incidence of CSE in childhood is 11.5/100,000 children/yr 
(95% Cl 11.1 - 12.0/100,000/yr). The highest ethnicity adjusted incidences are in 
prolonged febrile seizures and acute symptomatic CSE. As in age-adjusted incidence, 
the ethnicity-adjusted incidence of CSE is greater amongst males (12.2/100,000/yr, 
95% Cl 11.7 - 12.7/100,000/yr) compared to females (10.8/100,000/yr, 95% Cl 10.4 -
11.3/100,000/yr). For further details on ethnicity-adjusted incidence and features of 
CSE, see Table 5.7).
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White Black Asian Other All Groups Ethnicity
adjusted
incidence
95% Cl
N I N I N I N I N I
AETIOLOGY
PFS 17 2.8 6 2.7 21 8.1 12 9.1 56 4.6 3.2 (3.0 - 3.5)
Acute Symptomatic 13 2.2 5 2.3 7 2.7 5 3.8 30 2.5 2.2 (2.0 - 2.4)
Remote Symptomatic 13 2.2 4 1.8 10 3.9 2 1.5 29 2.4 2.3 (2.0 - 2.5)
Acute on Remote 10 1.7 8 3.7 8 3.1 2 1.5 28 2.3 1.8 (1.6-2.0)
Idiopathic 5 0.8 5 2.3 5 1.9 3 2.3 18 1.5 1.0 (0.9-1.1)
Cryptogenic 1 0.2 0 0.0 2 0.8 0 0.0 3 0.2 0.2 (0.1 -0.3)
Unclassified 4 0.7 3 1.4 4 1.5 1 0.8 12 1.0 0.9 (0.8 - 1.0)
EPILEPSY
No epilepsy 57 9.5 26 11.9 50 19.3 22 16.7 155 12.8 10.4 (9.9 -10.8)
Before SE 5 0.8 3 1.4 5 1.9 0 0.0 13 1.1 0.9
o
■
oo©
At SE 1 0.2 2 0.9 0 0.0 3 2.3 6 0.5 0.2 (0.2 - 0.3)
After SE 0 0.0 0 0.0 2 0.8 0 0.0 2 0.2 0.0 (0.0-0.1)
SEX
Male 34 11.1 16 14.6 30 22.7 15 22.4 95 15.4 12.2 (11.7-12.7)
Female 29 9.9 15 13.8 27 21.2 10 15.4 81 13.6 10.8 (10.4-11.3)
ONSET
Focal 26 4.3 14 6.4 16 6.2 7 5.3 63 5.2 4.5 (4.2 - 4.8)
Generalised 38 6.3 17 7.8 41 15.8 17 12.9 113 9.3 7.1 (6.8 - 7.5)
CHARACTER
Continuous 32 5.3 16 7.3 24 9.3 12 9.1 84 6.9 5.7 (5 .4-6.1)
Intermittent 31 5.2 15 6.9 33 12.7 13 9.9 92 7.6 5.8 (5 .5-6.1)
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White Black Asian Other All Groups Ethnicity
adjusted
incidence
N I N I N I N I N I
FINAL SEIZURE TYPE
Focal 3 0.5 2 0.9 4 1.5 0 0.0 9 0.7 0.6 (0.5 - 0.7)
Second Gen 23 3.8 11 5.0 12 4.6 6 4.6 52 4.3 3.9 (3.7-4.2)
Primary Gen 37 6.2 18 8.2 41 15.8 19 14.4 115 9.5 7.1 (6.7 - 7.4)
MOTOR TYPE
Tonic 10 1.7 3 1..5 6 2.3 4 3.0 23 2.0 1.8 (1.6 -2.0)
Clonic 1 0.2 0 0.0 0 0.0 1 0.8 2 0.2 0.2 (0.1 -0.2)
Tonic-Clonic 52 8.7 28 12.8 51 19.7 20 15.2 151 12.5 9.6 (9.2 -10.1)
DURATION (mins)
3 0 -6 0 33 5.5 13 5.9 17 6.6 8 6.1 71 5.9 5.6 (5.3 - 5.9)
6 1 -9 0 13 2.2 7 3.2 19 7.3 2 1.5 41 3.4 2.5 (2.3 - 2.7)
91 -  120 4 0.7 5 2.3 10 3.9 9 6.8 28 2.3 1.1 (1.0-1.3)
> 120 13 2.2 6 2.7 11 4.2 6 4.6 36 3.0 2.4 (2.2 - 2.6)
ALL 63 10.5 31 14.2 57 22.0 25 19.0 176 14.5 11.5 (11.1 - 12.0)
Table 5.7: Number, ethnicity-specific and ethnicity-adjusted incidence per 100,000 children per year according to features of lifetime first 
episodes of CSE in North London. Ethnicity adjusted to the 2001 England and Wales childhood population.
N = number of cases I = incidence rate per 100,000 children/year.
PFS = Prolonged Febrile Seizure, Acute Symptomatic = Acute Symptomatic, Remote Symptomatic = Remote Symptomatic, Acute on 
Remote = Acute on Remote Symptomatic, Idiopathic = Idiopathic Epilepsy Related, Cryptogenic = Cryptogenic Epilepsy Related, Second 
Gen = Secondarily generalised, Primary Gen = Primary generalised
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5.3.10 Boroughs and incidence
There is a wide range of incidence o f CSE amongst boroughs within North London. Crude 
incidence ranges from 0/100,000 children/yr in the City o f London (childhood population 
673) to 26.7/100,000 children/yr in Tower Hamlets (borough with the highest mean 
socioeconomic deprivation score. With the exception of the borough o f Newham, boroughs 
with higher mean socioeconomic deprivation scores (IMD 2004) and a higher proportion of 
non-white children were associated with higher incidence o f CSE. For further details, see 
Table 5.8
5.3.11 Features of incident cases of CSE in North London
CSE lasts longer than an hour in a significant proportion (60%) o f children with CSE, 
irrespective o f the underlying aetiology. Focal onset of CSE is common (36%) but most 
episodes of CSE with a focal onset will secondarily generalise, as the final seizure type was 
focal in only 5% of incident cases. In children with CSE associated with fever, there is some 
evidence that focal features are more common in children with acute CNS infection than 
children with prolonged febrile seizures (8/18 vs 12/56 respectively, p = 0.06). The 
overwhelming majority o f CSE in children is tonic-clonic (86%) in nature, with tonic CSE 
being the next most common (11%). For more details on the features o f incident cases in 
North London, see Table 5.9.
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Borough Mean 
IMD 2004
Childhood
Population
%
White
%
Black
%
Asian
%
Other
N Incidence 
(per 100,000,yr)
95% Cl
Barnet 16.09 63756 67 9 12 12 20 15.7 (6.0 - 25.4)
Brent 25.93 52169 30 28 30 11 20 19.2 (7.3-31.0)
Camden 34.65 32867 55 15 18 12 11 16.7 (2.7 - 30.7)
City Of London 15.32 673 67 4 18 12 0 0.0 (0 -0 )
Enfield 23.11 57793 69 14 8 8 11 9.5 (1.6-17.5)
Hackney 45.05 47430 47 30 12 11 17 17.9 (5.9 - 30.0)
Hammersmith 
& Fulham
27.79 27226 63 18 6 12 4 7.3 (-2.8 -17.5)
Haringey 37.69 44605 51 29 7 13 12 13.5 (2.7 - 24.2)
Harrow 13.57 41691 47 9 33 10 16 19.2 (5.9 - 32.5)
Islington 42.66 32242 60 19 8 13 4 6.2 (-2.4 - 14.8)
Kensington 
& Chelsea
21.65 24795 68 12 6 14 1 2.0 (-3.6 - 7.6)
Newham 40.53 63841 25 26 40 9 18 14.1 (4.9 - 23.3)
Tower Hamlets 45.75 44890 50 7 62 6 24 26.7 (11.6-41.9)
Waltham Forest 30.25 46868 50 20 20 10 10 10.7 (1.3-20.0)
Westminster 31.66 24474 56 12 15 17 8 16.3 (0.3 - 32.4)
All 605320 47 19 22 11 176 14.5 (11.5-17.6)
Table 5.8: Mean IMD 2004 score, childhood population, ethnic composition, number of incident cases in the study period, 
and crude incidence of CSE according to boroughs within North London.
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Prolonged 
febrile seizures
Acute
Symptomatic
Remote
Symptomatic
Acute on 
Remote
Idiopathic Cryptogenic Unclassified All
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
SEX
Male 34 61 15 50 13 45 17 61 10 56 1 33 5 42 95 54
Female 22 39 15 50 16 55 11 39 8 44 2 67 7 58 81 46
DURATION (mins)
30-60 27 48 11 37 12 41 8 29 8 44 0 0 5 42 71 40
61-90 9 16 6 20 9 31 8 29 5 28 2 67 2 17 41 23
91-120 9 16 6 20 3 10 6 21 1 6 0 0 3 25 28 16
>120 11 20 7 23 5 17 6 21 4 22 1 33 2 27 36 21
CHARACTER
Continuous 32 57 13 43 14 48 12 43 8 44 0 0 5 48 84 48
Intermittent 24 43 17 57 15 52 16 57 10 56 3 100 7 52 92 52
ONSET
Focal 12 21 14 47 9 31 15 54 4 22 1 33 6 50 63 36
Generalised 44 79 16 53 20 69 13 46 14 78 2 67 6 50 112 64
FINAL SEIZURE TYPE
Focal 1 2 3 10 4 14 1 4 0 0 0 0 0 0 9 5
Second Generalised 11 20 11 37 5 17 14 50 4 22 1 33 6 50 52 30
Primary Generalised 44 79 16 53 20 69 13 46 14 78 2 67 6 50 115 65
MOTOR TYPE
Tonic 3 5 7 24 2 7 5 18 1 6 1 33 4 33 23 13
Clonic 1 2 1 3 0 0 0 0 0 0 0 0 0 0 2 1
Tonic Clonic 52 93 22 73 27 93 23 82 17 94 2 67 8 67 151 86
ALL 56 100 30 100 22 100 28 100 18 100 3 100 12 100 176 100
Table 5.9: Features of life time first episodes of CSE in children in North London
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5.3.12 Occurrence of CSE
The crude occurrence rate of CSE in childhood in North London is 25.1/100,000/yr. 
Similar to the incidence of CSE, the occurrence of CSE is greatest in those aged less 
than 5 years (54.6/100,000/yr, 95% Cl 44.4 - 64.8/100,000/yr), particularly in those 
aged less than a year (64/100,000/yr, 95% Cl 39.6-88.4/100,000/yr). The age- 
adjusted occurrence of CSE is 25.4/100,000/yr (95% Cl = 22.5-28.2/100,000/yr). For 
details on age-specific occurrence rate of CSE see Table 5.10. The ethnicity -adjusted 
occurrence of CSE is 21.4/100,000/yr (95% Cl = 20.8-22.0/100,000/yr.
Age (y) Occurrence
number
Population Occurrence Rate 
(per 100,000/yr)
95% Cl 
(per 100,000/yr)
<1 53 41397 64.0 39.6-88.4
1 to 4 168 161056 52.2 41.0-63.4
5 to 9 59 187261 15.8 10.1-21.5
10 TO 15 24 215606 5.6 2 .4 -8 .8
All 304 605320 25.1 21.1-29.1
Table 5.10: Age-specific occurrence rate per 100,000 children per year.
Age-adjusted occurrence = 25.4/100,000/yr (95% Cl = 22.5-28.2/100,000/yr). 
Age-adjusted to the paediatric population of England and Wales 2001.
5.3.13 Ascertainment adjustment using capture-recapture
Over the 2 year study period, 73 incident episodes of CSE that presented to any of the 
six randomly selected hospitals from the research network were identified. Of these 
62 were notified to NLSTEPSS by PHONE/FORM and 11 were only identified by the 
yearly reviews. For details of the number of cases identified by any of the three 
sources, please see Figure 5.6.
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Figure 5.6: Number of incident episodes of CSE identified in 6 randomly selected 
hospitals in North London according to source of identification.
The three source capture-recapture estimate of the number of incident episodes of 
CSE that presented to the six randomly selected hospitals was 77-84 (95% Cl 74 to 
100). Case ascertainment at these 6 hospitals was estimated between 74-81% (95% 
Cl 62 -  84%).
Extrapolating these ascertainment data to the entire dataset, overall ascertainment in 
NLSTEPSS was 74-81% (95% Cl 62 -  84%). The ascertainment adjusted estimates 
of incidence and occurrence of CSE in childhood in North London and England & 
Wales are presented in Table 5.11. Ascertainment by PHONE was 62 - 68% (95% Cl 
52 - 70%) and ascertainment by FORMS was 39-43% (95% Cl 33 - 44%).
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Frequency of CSE Rate 
(per 100,000/yr)
95% Cl of Rate 
(per 100,000/yr)
Ascertainment 
adjusted Rate 
(per 100,000/yr)
95% Cl of 
ascertainment 
adjusted rate 
(per 100,000/yr)
Ascertainment 
adjusted N
95% Cl 
Ascertainment 
adjusted N
North London
Incidence
Occurrence
(Crude) 14.5 
(Crude) 25.1
11.5-17.6
21.1-29.1
17.9-19.6
30.9-33.9
17.3-23.4 
29.8 - 40.5
107-118
186-204
104 - 141 
179-243
England & Wales
Age-adjusted incidence 
Ethnicity-adjusted incidence
13.2
11.5
12.5-13.9 
11.1 - 12.0
16.3 -17.8 
14.2-15.5
15.7-21.3
13.7-18.5
1710-1877
1489-1626
1647-2234 
1437 - 1940
Age-adjusted occurrence 
Ethnicity-adjusted 
occurrence
25.4
21.4
22.5-28.2
20.8-22.0
31.4-34.3
26.4-28.9
30.2-41.0 
25.5 -  34.5
3293 - 3598 
2769-3031
3168-4300 
2677 - 3619
Table 5.11: Frequency of incidence and occurrence of CSE in childhood in North London and projection for England &Wales.
Age and Ethnicity adjusted incidence and occurrence rates for England and Wales were determined by directly adjusting the North London 
incidence and occurrence rates to the UK Census 2001 paediatric population of England and Wales. Through three source capture-recapture 
methods, minimum and maximum estimates of the degree of ascertainment in NLSTEPSS were obtained. Thus, ascertainment adjusted rates are 
presented as a range of values with the lower values reflecting the rates adjusted using maximum ascertainment estimates. Between 104 and 141 
children in North London are estimated to have a lifetime first episode of CSE each year and there are approximately 179 -  243 episodes of CSE 
in children in North London each year. Extrapolating this data to the paediatric population of England and Wales, and adjusting for age and 
ethnicity, approximately 2677 -  4300 episodes of CSE will occur in children throughout England and Wales each year.
-  11 6 -
5.3.14 Aetiology o f incident CSE
Prolonged febrile seizures are the most common type of CSE in childhood. Half of 
children with incident episodes are previously neurologically normal. Only 12% of 
children with incident CSE have idiopathic or cryptogenic epilepsy. CNS infections 
are the most common cause of acute symptomatic CSE. For further details on the 
aetiology of incident episodes of CSE see Figure 5.7
Aetiology of incident episodes of CSE
2% 7%
16% 17%
■  P rolonged Febrile Seizure ■  A cute Sym ptom atic
□  R em ote Symptomatc □  Acute on  R em ote Sym ptom atic
■  Idiopathic ep ilep sy  related ■  C ryptogenic ep ilep sy  related
■  U n classified
Figure 5.7: Aetiology of Incident episodes of CSE
5.3.15 Population risk o f acute bacterial/viral CNS infection in incident episodes o f 
CSE associated with fever
The population risk of acute bacterial/viral CNS infection in children with an incident
episode of CSE associated with fever is 19% (95% Cl 11- 27%).
5.3.15.1 Risk o f Acute Bacterial Meningitis
There were 95 children with incident episodes of CSE associated with fever (above 
38°C on presentation). Of these, 11 (12%, 95% Cl 6-18%) children had acute
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bacterial meningitis confirmed on diagnostic cerebro-spinal fluid (CSF) sampling 
(nine S. pneumoniae, two N. meningitides). The median age of the children (6 male) 
was 0.6 yrs (range 0.1-3.9 yrs). In none of these children was meningismus reported.
5.3.15.2 Risk of Acute Viral CNS infection
In a further seven (8%, 95% Cl 2-13%) children, the final diagnosis was viral CNS 
infection. The median age of these children (3 male) was 1.2 yrs (range 0.6-8.7).
Viral CNS infection was confirmed by diagnostic CSF sampling in three children (one 
HHV6, one HHV7 and one HSV). One child had MRI features and EEG features 
consistent with HSV encephalitis, one child who was confused and had abnormal 
behaviour immediately prior to CSE had enterovirus isolated from his blood sample 
and had EEG features consistent with encephalitis. Two children had EEG features 
supportive of encephalitis but no viruses were isolated in their CSF. None of these 
children had meningismus.
5.3.15.3 Risk of CNS infection in neurologically normal children compared to those 
with pre-existing neurological abnormality
In a subgroup analysis of the 95 children with incident episodes of CSE associated
with fever, 73 were previously neurologically normal and 22 had pre-existing
neurological abnormality. Of the 18 children with an acute CNS infection, only one
had a previous neurological abnormality; shunted obstructed hydrocephalus due to
neonatal intraventricular haemorrhage. Previously neurologically normal children
with incident CSE associated with fever are 7.0 (95% Cl 0.9 -  55.6) times more likely
to have an acute CNS infection compared to children with incident CSE associated
with fever but had a pre-existing neurological abnormality.
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5.3.16 Outcome of CSE
5.3.16.1 Duration
The mean duration of CSE is 94 mins (median 70 mins, range 30 -  975mins). The 
median duration of CSE is shorter (Mann-Whitney U-test, p=0.045) if CSE has an out 
of hospital onset (mean 86 mins, range 30-975 mins) compared to onset in hospital 
(mean 121 mins, range 30 -  900 mins).
5.3.16.1.1 Factors associated with CSE lasting longer than 60 minutes 
Intermittent rather than continuous CSE, longer interval between onset of CSE and 
arrival in A&E, lack of prehospital treatment and more than 2 doses of 
benzodiazepines were independently associated with CSE lasting more than 60 
minutes. There was no significant interaction between administration of more than 2 
doses of benzodiazepines and lack of prehospital treatment i.e. there was no evidence 
that the effect of administration of more than 2 doses of benzodiazepines on the 
increased likelihood of CSE lasting longer than 60 minutes was different whether part 
of that treatment was given prehospital or not. Children that were not treated in the 
prehospital setting were 2.4 times more likely to have CSE lasting longer than 60 
minutes than those that were treated (p=0.028, 95% Cl 1.1-5.3). For each minute’s 
delay from onset of CSE to arrival in A&E, the risk of CSE lasting longer than 60 
minutes increases by 5% (p=0.003, 95% Cl 2-8%). For further details on the factors 
associated with CSE duration >60 minutes, see Table 5.12.
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Variables P Odds Ratio 95% Cl for Odds Ratio
Lower Upper
Intermittent CSE 0.004 3.1 1.4 6.6
Time to AE (mins) 0.003 1.05 1.02 1.08
No Prehospital 0.028 2.4 1.1 5.3
treatment
More than 2 doses 
benzodiazepines
0.001 3.6 1.7 7.9
Table 5.12: Multivariate logistic regression model for factors associated with CSE 
lasting longer than 60 minutes compared to CSE lasting 30-60 minutes.
5.3.16.2 Recurrence
The one year risk of recurrence following an incident episode of CSE was 17% (n=17, 
95% CI= 10-25%). Median age at time of incident episode of CSE was 2.1 years 
(range 0.4-12.8 years). Seven children had one further episode, seven had two further 
episodes, two had four further episodes and one child had nine further episodes within 
one year after incident episode of CSE. The child with nine further episodes of CSE 
had a focal area of cortical dysplasia. The risk of recurrence is highest (47%), when 
incident CSE is due to a remote symptomatic aetiology (n=7). Amongst 30 incident 
episodes of prolonged febrile seizures during the first year of the study, 17% (n=5) 
had at least one further episode of prolonged febrile seizures within a year of incident 
CSE. Children with a pre-existing neurological abnormality were 2.8 (95% Cl 1.2- 
6.8, p = 0.041) times more likely to have a recurrence within one year of incident CSE 
compared to children who were previously neurologically normal.
5.3.16.3 Mortality
During the study period, seven children died during hospitalisation. Of these, six had 
no previous episode of CSE (M: F = 3:3, median age l.lyrs, range 0.18 -  5.15yrs).
- 120-
The other child was male and was aged 13.4 yrs. Case fatality amongst incident 
episodes of CSE = 3.4% (95% Cl = 2.7 -  4.1%) and in-hospital mortality rate was 
5/one million children/yr. Three children had acute bacterial meningitis, one had 
glutaric aciduria type I and three children (including the child who had a previous 
episode of CSE) had an undiagnosed progressive neurodegenerative abnormality.
5.4 Discussion
5.4.1 Incidence o f CSE in NLSTEPSS compared to other population based studies
5.4.1.1 Introduction
Though there have been six other population based studies on SE, five have been 
primarily based on adult populations and one was restricted to an adult population. 
Research in a paediatric population is required for an understanding of the 
epidemiology of CSE in childhood. This is the first population based study on CSE in 
that is based on a paediatric population.
The data from this study suggest that the incidence of CSE in childhood in North 
London is 18-20/100,000 children/yr (95% Cl 17 -  23/100,000 children/yr), which 
contrasts with the range of incidence of SE (4-38/100,000 children/yr) reported in 
previous population based studies.
5.4.1.2 Effect of differences in study designs and methods
Continuing the arguments on the incidence of SE across adult and childhood age 
groups in Chapter 2, the lowest previously reported incidence of SE in childhood is 
very likely to be an underestimate of the true incidence of SE. The lowest incidence
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was reported in a California based study that, as in NLSTEPSS, was confined to cases 
of convulsive status epilepticus (Wu et al. 2002). Cases of CSE were retrospectively 
identified by a search for specific ICD codes within a database of discharge abstracts 
for all admissions to non-federal hospitals in California. Errors in hospital discharge 
coding and the non-inclusion of federal hospitals may have resulted in an 
underestimate of the true incidence of CSE, a likely possibility acknowledged by the 
researchers themselves. The study with the highest reported incidence of SE in 
childhood involved the prospective identification of patients with all forms of SE in 
hospitals in Richmond, Virginia. However, only 29 children were identified over the 
2 year study period (Delorenzo et al. 1996) and therefore the 95% confidence interval 
of the incidence of SE from that study is wide at 18-57/100,000/yr. The higher 
incidence of SE in that study by the Richmond Group, compared to other groups, has 
been attributed to higher ascertainment of cases and to a larger proportion of non­
white residents in Richmond; the incidence of SE being higher in non-white people. 
However, in Chapter 2, the candidate hypothesised that differences in ascertainment 
may not be the only explanation for the higher incidence of SE reported in the 
Richmond study. The population based study of SE in Hessen, Germany, had similar 
ascertainment, similar methodological quality score and included NCSE and CSE as 
in the Richmond study (Knake et al., 2001). However, the ascertainment adjusted 
incidence of SE in the Hessen study was a third of that in the Richmond study. The 
findings from NLSTEPSS support the hypothesis that ascertainment may not be the 
sole explanation for the higher incidence of SE reported by the Richmond group, as 
the ascertainment adjusted incidence in NLSTEPSS is still only half of that in the 
Richmond study. The ascertainment in Richmond was a mean of 60% compared to
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74-81% (95% Cl 62-84%) in the current study. Thus, the higher incidence in the 
Richmond study is unlikely to be due to better ascertainment.
5.4.1.3 Effect of differences in ethnic and socioeconomic composition 
The current study confirms the observation in other studies that the incidence of CSE 
in non-white populations is higher than white populations (DeLorenzo et al., 1996; 
Coeytaux et al., 2001) but in a subgroup analysis of ethnic groups within the 
NLSTEPSS population, there was no difference in the incidence of CSE amongst 
black children compared to white children. This is in stark contrast to the three fold 
difference in the Richmond study. NLSTEPSS is the first study to examine the 
independent effects of socioeconomic status and ethnicity on the incidence CSE. After 
taking socioeconomic status into account, Asian children and children of other non­
white ethnicity, but not black children, have a significantly higher incidence of CSE 
compared to white children in NLSTEPSS. Independent of age and ethnicity, there is 
a particularly strong relationship between the incidence of CSE and socioeconomic 
status, thereby suggesting that socioeconomic status is a risk factor for developing 
CSE independently of ethnicity.
Increasing frequency associated with lower socioeconomic status is seen in a range of 
other conditions such as epilepsy, asthma, diabetes, depression, cancer and 
meningococcal disease (Acheson et al., 1998; Heaney et al., 2002; Basagana et al., 
2004; Feldman et al., 2004; Williams et al., 2004). The precise pathophysiological 
mechanisms through which socioeconomic status might increase the risk of CSE are 
not clear but overcrowding, poor nutrition, infections, trauma, birth defects and 
perinatal complications are also more common in socioeconomically deprived groups.
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These socioeconomic risk factors provide plausible explanations for a higher 
incidence of CSE in those that are less well off. Another factor to be considered is 
delayed access to medical services, as previous studies have illustrated that families of 
lower socioeconomic status have delayed access to acute medical care (Weissman et 
al., 1991; Freeman and Corey 1993; Committee on Pediatric Emergency Medicine 
2000; Feinberg et al., 2002). In NLSTEPSS, on univariate linear regression analyses, 
the intervals between (1) onset of CSE and calling emergency services and (2) calling 
emergency services and arrival of the ambulance service to the patient, were 
independent of the socioeconomic status of the patient (p= 0.4 and p=0.8 
respectively). Therefore, delayed access to medical services is an unlikely reason for 
a higher incidence of CSE in children of lower socioeconomic status. The higher 
incidence of CSE in Asian children, independent of socioeconomic status hints at the 
possibility that genetic as well as environmental factors may have a role. Thus, it is 
possible that the higher incidence of SE observed in the Richmond study attributed to 
the racial composition of the population (57% black, 38% white) is confounded by the 
socioeconomic composition of Richmond. Richmond, relative to the other municipal 
localities of Virginia (Chesterfield, Hanover and Henrico), has the highest percent of 
children under age 18 living in poverty (32% compared to 4-8% for the other 
localities of Virginia), the highest percent of female householders with children under 
age 5 living in poverty and the lowest median household income 
(http://oncampus.richmond.edu/connect/issues/demographics/moeser- 
cen2000_files/ffame.html).
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5.4.1.4 Effect of differences in inclusion criteria amongst studies 
The diagnostic criteria of non-convulsive status epilepticus remain controversial and 
an EEG is required to confirm the diagnosis. The clinical characteristics and 
management of CSE and NCSE are different (Lacey 1988; Jordan 1994; Treiman 
1996) and it may therefore be more useful to investigate the epidemiology of these 
forms of SE independently rather than pooling them. Widespread EEG facilities in 
A&E are not available in North London, therefore NLSTEPSS was confined to 
episodes of CSE. In the Richmond, Rochester and Swiss studies, episodes of NCSE as 
well as CSE were included but NCSE was not defined. Complex partial status 
epilepticus, partial status epilepticus, absence status epilepticus and subtle status 
epilepticus have all been terms used synonymously with NCSE (Drislane 2000;
Chang et al., 2001). If these subtypes are excluded in the Richmond, Rochester and 
Swiss studies, the remaining subcategories of SE may reflect episodes of CSE and the 
incidence of CSE in childhood from these studies would range between 10- 
27/100,000/yr (95% Cl 8-43/100,000/yr), which is comparable to that estimated in 
NLSTEPSS. For further details on the estimated incidence of CSE in these studies, 
see Table 5.13.
Research Group Incidence of CSE in childhood 
(per 100,000/yr)
95% Cl
Richmond 27 10.7-43.3
Rochester 12.6 8.5-16.7
Swiss 10.0 7.5-12.4
North London 14.5 11.5-17.5
Table 5.13: Estimates and associated 95% Cl of the incidence of CSE in childhood in 
the Richmond, Rochester, Swiss and North London studies.
Estimates for the Richmond, Rochester and Swiss studies were obtained by excluding 
cases of complex partial/ partial/ absence/ subtle status epilepticus.
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5.4.2 Treatment and incidence of CSE
The incidence of CSE (seizure or series of seizures lasting at least thirty minutes) may 
be affected by treatment of CSE as there is evidence that early treatment of seizures is 
more likely to result in seizure termination (Knudsen 1979; Sykes and Okonofua 
1988). Therefore, it may be hypothesised that in populations in which prehospital 
treatment is advocated, a proportion of patients with seizures will have seizure 
termination within thirty minutes of seizure onset and thus, not develop status 
epilepticus. In North London, the London Ambulance Service has a policy that 
children with seizures should be given emergency anti-epileptic drug therapy before 
arrival to hospital (London Ambulance Service 2003). The treatment of CSE in North 
London will be characterised in the next chapter.
5.4.3 Ascertainment-adjusted incidence of CSE in childhood
Identification of cases using a single source is likely to result in an underestimation of 
cases and a multi-source identification system may therefore have a better 
ascertainment (Allison et al., 2003). Identification of cases of CSE through a search 
of the admission database for relevant ICD codes is simple and convenient, but is 
prone to possible systematic and non systematic errors in coding resulting in missed 
cases. Similarly, though the effectiveness of the BPSU has been demonstrated, the 
ascertainment of cases from the BPSU has been estimated to 45% (Rahi and Dezateux 
1999). In NLSTEPSS, the candidate used three sources for identification of cases of 
CSE and applied three source capture-recapture methodologies to estimate the degree 
of ascertainment. The advantages and validity of using capture-recapture has been 
described in detail in Chapter 4. Independently, each source may have
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underestimated the number of cases of CSE, but by using this method, the number of 
cases not identified by any of the three sources may be estimated.
During the first year, 69% of episodes of CSE first enrolled into NLSTEPSS were 
incident episodes but in the second year, 93% of episodes of CSE first enrolled into 
the study were incident episodes. These data suggest that in the second year, 
paediatricians were more likely to notify incident episodes of CSE to NLSTEPSS than 
non-incident episodes.
The overall completeness of ascertainment in NLSTEPSS is 74-81% (95% Cl 62 -  
84%). To develop a full picture of the epidemiology of CSE in childhood, complete 
ascertainment is desirable, but a number of population based studies have illustrated 
the difficulties with this (Folstein et al., 1987; Hebert et al., 1995; Palli et al., 1998; 
Calle-Pascual et al., 2001; Knake et al., 2001; Tilling et al., 2001; Roche et al., 2002; 
Pillaye and Clarke 2003). Ascertainment of cases of congenital cataracts through the 
British Paediatric Surveillance Scheme was 45% (Rahi and Dezateux 1999), which is 
similar to the estimated ascertainment of the BPSU-like regional monthly surveillance 
scheme used in NLSTEPSS. A study on completeness of tuberculosis notification in 
the United Kingdom estimated ascertainment at 51-62% (Pillaye and Clarke 2003).
As discussed previously in Chapter 4, a study on the prevalence of Huntington’s 
disease that used at least 14 distinct sources, including advertising to find cases, 
ascertainment was 60-75% (Folstein et al., 1987). A study on the incidence of stroke 
in the UK estimated ascertainment at 88% (Tilling et al., 2001). Amongst population 
based studies on status epilepticus, mean ascertainment of cases was 60% in the 
Richmond study (DeLorenzo et al., 1996) and in the study by Knake and colleagues in
-  1 2 7 -
Germany, the mean ascertainment was 58% (Knake et al., 2001). Therefore, 
ascertainment in NLSTEPSS, though not complete, is high.
Three source capture recapture models (loglinear approach and sample coverage 
approach) were used rather than a two source model in order to take into account 
possible dependency between sources. The final estimate of the completeness of 
ascertainment is therefore a range of values that reflect the best fit models for the 
loglinear and sample coverage approach rather than a single estimate. There may be 
some debate over the validity of applying the capture-recapture methodology to a 
sample (six) of all the hospitals involved in the study and extrapolating the data to the 
entire population. However, the six hospitals represent a high proportion (43%) of the 
hospitals in North London and they were randomly chosen, suggesting that the sample 
is likely to be appropriate for the whole of North London. Thus, the ascertainment- 
adjusted incidence of CSE in childhood from NLSTEPSS is 18-20/100,000/yr (95%
Cl 17- 23/100,000/yr).
Taking the results of the current study, put in the context of what is already known 
about status epilepticus in other population-based studies, it is likely that there is no 
single true incidence of CSE in childhood and the incidence in populations will vary 
depending on their socioeconomic and ethnic composition. Studies to identify 
specific socioeconomic and or genetic factors associated with CSE are required to 
pinpoint potential targets for primary and secondary prevention of CSE. Until EEG 
testing of all children with suspected NCSE in A&E is widespread practice, the true 
incidence of NCSE and SE in general will remain elusive.
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5.4.4 Previous neurological status, age and incidence of CSE
The results of the current study, NLSTEPSS, confirms that the highest incidence of 
CSE in childhood is in those aged less than 5 years (Phillips and Shanahan 1989; 
DeLorenzo et al., 1996; Shinnar et al., 1997). In NLSTEPSS, when CSE occurred in 
children aged less than 5 years, they were more likely to have been previously 
neurologically normal and were most likely to have had a prolonged febrile seizure. 
However, when CSE occurred outside of this age group i.e. occurred in children aged 
five years of age or older, there was a four fold greater likelihood that the child had an 
underlying neurological abnormality, including epilepsy, rather than being previously 
neurologically normal. Together, these results suggest that a life time first episode of 
CSE in children aged 5 years or older in a previously neurologically normal child is 
not common and should raise the suspicion of an underlying neurological 
abnormality, including epilepsy in such children.
5.4.5 Prolonged febrile seizures and mesial temporal sclerosis
Prolonged febrile seizures make up a significant proportion of SE in childhood 
accounting for up to a third of SE in children. Only one previous study has reported 
this sub-group as a distinct category (Hesdorffer et al., 1998), with all other studies 
that included prolonged febrile seizures, categorised prolonged febrile seizures under 
acute symptomatic causes in accordance with the ILAE guidelines. The recognition 
of prolonged febrile seizures as a distinct category is important since there is evidence 
that suggests that the natural history of febrile seizures may be different from that of 
other acute symptomatic causes of status epilepticus; mortality is less, intellectual 
outcome is better and the risk of developing epilepsy is less in subjects with 
prolonged febrile seizures compared to those with other acute symptomatic SE
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(Ellenberg and Nelson 1978; Maytal et al., 1989; Verity and Golding 1991; Verity et 
al., 1993). There is a longstanding hypothesis that prolonged febrile seizures may 
cause mesial temporal sclerosis, the most common structural substrate for epilepsy 
requiring surgical intervention (Cavanagh and Meyer 1956; Abou-Khalil at al. 1993). 
To date, data from prospective outcome studies of prolonged febrile seizures have 
been inconclusive about whether prolonged febrile seizures cause mesial temporal 
sclerosis. Studies of prolonged febrile seizures all report a higher risk of epilepsy in 
these children compared to the general population. However, they have not 
specifically addressed whether an increased risk of temporal lobe epilepsy occurs and 
no imaging data are available on these cohorts. Hence, the incidence of MTS cannot 
be assessed (Annegers et al., 1987; Verity et al., 1993; Berg and Shinnar 1996). 
Recent MRI studies have demonstrated abnormalities in the hippocampus consistent 
with acute changes in the hippocampus within 5 days of prolonged febrile seizures 
(Scott et al., 2002; Scott et al., 2003). Therefore, children with prolonged febrile 
seizures are an important group to identify and study and prolonged febrile seizures 
cannot be considered a completely benign event. Longer term longitudinal MRI 
studies, are required to further investigate the hypothesis that prolonged febrile 
seizures may cause mesial temporal sclerosis.
There is accumulating evidence that the likelihood of brain damage following 
prolonged febrile seizures may have a genetic component. A family history of febrile 
seizures is a well recognized major risk factor for febrile seizures in offspring 
(Waruiru and Appleton 2004). A clear genetic component to SE was demonstrated in 
twin studies by Corey and colleagues (Corey et al., 1998; Corey et al. 2004). The 
researchers reported a risk of SE of 38% among the co-twins of monozygotic twins
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who experienced SE. A polymorphism at the interleukin-ip (IL-ip) locus has been 
reported in patients with temporal lobe epilepsy with MTS, suggesting that genetic 
factors may contribute to the development of MTS after a prolonged febrile seizure 
(Kanemoto et al., 2000; Kanemoto et al., 2003). IL-ip has been implicated in the 
mechanism of fever generation, in lowering seizure threshold and in prolonging 
seizures (Crumrine 2002). Despite all these observations suggesting a role for 
possible genetic factors in the occurrence of prolonged febrile seizures and of seizure- 
induced injury, little is known about the precise genes involved or the mechanism by 
which their influence might be exerted. The higher incidence of prolonged febrile 
seizures in non-white but not black children compared to white children suggest that 
the search for such candidate genes may be best directed initially at these ethnic 
groups. The genetic mechanisms involved in the susceptibility to prolonged febrile 
seizures and the genetic mechanisms responsible for predisposing to seizure-induced 
injury, offer exciting areas for future research.
5.4.6 Acute bacterial meningitis in children with CSE with fever
Children with CSE and fever are an important subgroup of children with CSE. They 
include children with prolonged febrile seizures, acute symptomatic CSE due to CNS 
infections and acute on remote symptomatic CSE. In NLSTEPSS, children with CSE 
with fever account for half of all incident cases of CSE. Studies of CSE with fever 
may exclude cases with acute bacterial meningitis to comply with the definition of 
febrile seizures, but that is a retrospective judgement not appropriate to the emergency 
management of such cases. Although there are clinical guidelines on the emergency 
management of the child with CSE (The Advanced Life Support Group 1997; The
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Advanced Life Support Group 2000; Appleton et al., 2000) and the child with a first 
short seizure with fever (American Academy of Pediatrics 1996), there remains 
uncertainty about the role of parenteral antibiotics, the role of lumbar puncture and the 
population risk for acute bacterial meningitis in children with CSE with fever.
5.4.6.1 Population risk of acute bacterial meningitis in CSE with fever vs short febrile 
seizure
Two recently published review articles reported that only 0.4-1.2% of children who 
have a short seizure associated with fever will have unexpected acute bacterial 
meningitis (ABM) (Offringa and Moyer 2001; Carroll and Brookfield 2002). Thus, it 
has been suggested that investigation for ABM is not required in this group, unless 
other evidence of meningitis is present. However, the data from NLSTEPSS would 
indicate that the population-risk of acute bacterial meningitis, in children with CSE 
and fever, is higher than would be expected in a population of children who had short 
seizures with fever (12% vs 1.2%). Therefore, for management purposes, they should 
be considered as distinctly different patient populations.
5.4.6.2 The role of antibiotics in children with CSE with fever
The recently published guideline for the management of a child with a seizure 
recommends antibiotic treatment for children who were drowsy before the seizure, 
have altered consciousness for more than an hour after seizure, or have meningismus 
(Armon et al., 2003). None of the patients in this series with proven acute bacterial 
meningitis had signs of meningismus but these can be subtle in children aged less than 
a year and most of the children were in that age group. In addition, signs of
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meningismus may be attenuated after seizures and or treatment with emergency anti­
epileptic drugs. Given the high likelihood of acute bacterial meningitis in patients 
with CSE with fever, the guideline for use of parenteral antibiotics should be extended 
to include this population of patients. In addition, from reviews on the treatment and 
outcome of acute bacterial meningitis, there is evidence that early treatment of acute 
bacterial meningitis may decrease morbidity and mortality (Aronin et al., 1998; 
Beaman and Wesselingh 2002; Welch and Nadel 2003).
5.4.63 The role of lumbar puncture in children with CSE with fever 
The national guidelines for the management of seizures with fever in the United 
Kingdom issued in 1991 and the "practice parameter" for first simple febrile seizures 
of the American Academy of Pediatrics (AAP) published in 1996, both recommend 
lumbar puncture to exclude acute bacterial meningitis in children with short seizures 
with fever when there are clinical signs of meningitis and strongly recommend lumbar 
puncture in children under 12 months even in the absence of clinical signs of 
meningitis (Aicardi et al., 1970; Maytal et al., 1989). Recent publications in Archives 
of Disease in Childhood have contributed to a further debate on the role of lumbar 
puncture in febrile seizures. Riordan and Cant's review on indications for and 
contraindications to lumbar puncture concluded that unless there is a specific 
contraindication, lumbar puncture should be performed if meningitis is suspected 
(Riordan and Cant 2002). A leading article by Kneen and colleagues, in support of 
lumbar puncture, highlighted the possible detriment to patient care through declining 
use of lumbar puncture over the past two decades (Kneen et al., 2002). On the other 
hand, Carroll and Brookfield challenged the need for lumbar puncture. The authors 
examined the current guidelines and the available evidence for lumbar puncture
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following a short seizure with fever and concluded by advocating fewer lumbar 
punctures for children with short seizures with fever because of the low risk (1.2%) of 
acute bacterial meningitis, particularly in the absence of signs of meningitis (Carroll 
and Brookfield 2002). However, this recommendation relates to children with short 
seizures with fever and such an approach may not be applicable to children with CSE 
with fever. Through NLSTEPSS, the candidate has illustrated that acute bacterial 
meningitis is common in children with CSE with fever and may not be clinically 
apparent. Thus, the controversy discussed above is of lesser importance in this group 
of patients.
5.4.6.4 Management strategies for children with CSE with fever 
On the basis of the data from the current study, the hypothesises that the most 
appropriate management for children with CSE with fever is to start parenteral 
antibiotics early, perform a lumbar puncture when there are no contraindications, base 
duration and type of therapy on CSF findings and observe closely for potential early 
complications of acute bacterial meningitis is generated. Several other alternative 
management strategies may be hypothesised but as each has significant cons (Dodge 
and Swartz 1965; Rennick et al., 1993; Wylie et al., 1997; Feigin and Pearlman 1998; 
Pollard et al. 1999; Offfinga and Moyer 2001; Riordan and Cant 2002; Armon et al., 
2003) they may not be appropriate. These include: (1) a period of observation before 
initiation of treatment; (2) observation and consideration of routine blood 
investigations for evidence of inflammation; (3) lumbar puncture in the immediate 
post-ictal period before commencing antibiotics; (4) early intravenous antibiotics but 
no lumbar puncture
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5.4.6.5 Conclusions on acute bacterial meningitis and CSE with fever 
The signs for meningismus may be absent in children with CSE with fever due to 
acute bacterial meningitis. The likelihood of acute bacterial meningitis in children 
with incident CSE associated with fever estimated from NLSTEPSS is 12%, but this 
should be considered as a minimum estimate, as lumbar puncture was not universally 
performed in patients with incident CSE with fever. It is therefore possible that some 
patients whose episode of CSE was classified as a prolonged febrile seizure may have 
had a CNS infection. Therefore, there should be a high index of suspicion for acute 
bacterial meningitis in the child with CSE with fever. Early treatment with parenteral 
antibiotics, delayed lumbar puncture when there are no contraindications and close 
observation for signs of raised intracranial pressure may be the most appropriate 
management.
5.4.7 Seizure characteristics of CSE in childhood
In the current study, focal features were present in 20% of children with prolonged 
febrile seizures and in 44% of children with acute CNS infection (p= 0.06). These 
data are consistent with the view that the presence of focal features in a previously 
neurologically normal, febrile child with CSE should create a suspicion for acute CNS 
infection. In this cohort of patients, a focal onset of CSE occurred in 36% of incident 
episodes of CSE but the final seizure type was a generalised seizure in 95% of 
children. These results are in keeping with the view that a focal onset of CSE is 
common but most episodes of CSE will secondarily generalise. Similar proportions 
of children with CSE are likely to have intermittent compared to continuous seizures 
and clinicians should bear this in mind when assessing seizure termination.
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5.4.8 Duration of CSE
The observed median duration of CSE in the population of children in this study is 94 
minutes, which is sufficient to increase the potential morbidity and mortality 
associated with CSE (Dunn 1988; Scholtes, Renier and Meinardi 1996; Logroscino et 
al., 1997; Waterhouse et al., 1999; Hui et al., 2003). In NLSTEPSS, children who 
receive prehospital treatment have a reduced seizure length and therefore it is possible 
that widespread prehospital treatment of seizures that start out of hospital would 
reduce the likelihood of a 60 minute seizure. It is not within the scope of the study to 
examine this hypothesis directly as the study excluded children who had seizures 
lasting less than 30 minutes. However, most seizures that last longer than 5 minutes, 
are unlikely to stop spontaneously within the next few minutes and will continue for 
at least 30 minutes unless there has been an appropriate therapeutic intervention 
(DeLorenzo et al., 1999; Lowenstein et al., 1999; Shinnar et al., 2001a). There are 
published data that suggest that only a small proportion of children with seizures 
lasting at least 30 minutes will have spontaneous termination of their seizures 
(Shinnar et al., 2001a) and the results of NLSTEPSS support this view as only 5 
children (3% of incident cases of CSE) in this study did not require treatment for 
seizure termination. Increasing seizure duration is associated with increasing 
difficulty in seizure termination and early intervention is therefore indicated (Knudsen 
1979; Shinnar et al., 2001a). It may be argued that patients who have a seizure lasting 
5 minutes are already likely to have failure of the usual mechanisms of seizure 
termination and are in the early stages of SE. Thus for treatment purposes, a 
definition of SE stating a time of 5 minutes may be appropriate (Lowenstein et al., 
1999). The patients in NLSTEPSS had seizure activity lasting at least 30 minutes and 
therefore had seizures that were difficult to terminate. As prehospital treatment
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shortens the overall duration of seizures in this group of patients, it is conceivable that 
prehospital treatment of all seizures that last at least 5 minutes may decrease the 
ultimate duration of seizure activity. The data from NLSTEPSS also suggest that if 
prehospital treatment is not available then rapid transport to A&E and earlier 
intervention, may also reduce the likelihood of seizures lasting longer than 60 minutes 
and that children that fail to respond to 2 doses of benzodiazepine should be regarded 
as having CSE refractory to further benzodiazepines and should not receive further 
doses.
The observed duration of CSE in this cohort of patients is of concern because of the 
potential associated morbidity and mortality. What is the risk of epilepsy following 
CSE? What is the risk of temporal lobe epilepsy associated with mesial temporal 
sclerosis following prolonged febrile seizures? What is the cognitive outcome 
following CSE? What is the long term mortality associated with CSE? These are all 
important questions that go beyond the scope of this study, but follow up studies on 
the cohort of patients in this study may address those questions appropriately.
5.4.9 Recurrence
The data from NLSTEPSS confirm that there is a significant one year risk of 
recurrence of CSE, including prolonged febrile seizures, particularly when there is an 
underlying remote symptomatic aetiology. Other studies have reported similar 
recurrence rates of CSE (DeLorenzo et al., 1996; Hesdorffer et al., 1998; Knake et al., 
2001). The risk of recurrence has profound consequences in view of animal and 
experimental data showing that seizures in early life predisposes the developing brain 
to more damaging effects from further seizures later in life, and that factors such as
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the presence of prior neurological abnormalities, aetiology of the seizures, recurrent 
seizures and genetic predisposition may affect the range and severity of changes in the 
brain substrate (Maher and McLachlan 1995; Germano and Sperber 1997; Corey et 
al., 1998; Dube et al., 1998; VanLandingham et al., 1998; Kanemoto et al., 2000).
5.4.10 Mortality
The 3% mortality associated with CSE observed in NLSTEPSS is similar to the 
results of other recent studies (Celesia 1983; Maytal et al., 1989; Hauser 1990; Wu et 
al., 2002). Thus, the short term mortality associated with CSE is lower than the 11% 
reported in the earlier landmark study of Aicardi and Chevrie (Aicardi et al., 1970) 
but remains significant. In addition, the data from NLSTEPSS is consistent with that 
of other studies that aetiology of CSE is a major factor that influences the short term 
mortality (Maytal et al., 1989; Logroscino et al., 1997; DeLorenzo et al., 1999;
Garzon et al., 2003). All the children in NLSTEPSS who died had either acute or 
remote symptomatic CSE. In a primarily adult based population, Logroscino and 
colleagues found that short term mortality was highest for acute symptomatic SE 
which accounted for 90% of deaths (Logroscino et al., 1997). In a later study, the 
same group of researchers found that long term mortality was highest in those patients 
who had remote progressive symptomatic abnormalities such as pre-existing brain 
tumours or degenerative abnormalities (Logroscino et al., 2002). What this study 
provides is that in children, acute or remote symptomatic CSE, in similar proportions, 
are associated with the highest short term mortality.
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5.4.11 Discussion summary
In summary, the data reported from the current study, NLSTEPSS, show that CSE in 
childhood is not uncommon and is higher in children that are socioeconomically 
deprived, in Asian and other non-white, but not black, children compared to white 
children and in children aged less than 5 years. The data also suggest that children 
aged 5 years and older with incident episodes of CSE should be investigated carefully 
for possible underlying neurological abnormalities, including epilepsy. Prolonged 
febrile seizures are the most common cause of incident episodes of CSE in childhood 
but it is a diagnosis of exclusion. As the risk of acute CNS infection in children with 
an incident episode of CSE associated with fever is at least 12%, there should be a 
high index of suspicion for acute CNS infections in such patients. The corollary of 
that finding is that there should be a low threshold for empirical treatment for acute 
CNS infections and close monitoring for raised intracranial pressure in children with 
an incident episode of CSE with fever. One in every six children with an incident 
episode of CSE will have a further episode of CSE within a year of the initial episode 
and there remains a significant risk of death (three per hundred) associated with 
incident episodes of CSE in childhood. Emergency anti-epileptic drug treatment may 
improve the outcome of CSE by decreasing seizure duration. In the next chapter, the 
emergency treatment of CSE in children from NLSTEPSS is characterised.
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CHAPTER 6: TREATMENT OF CSE IN CHILDHOOD
6.1 Introduction
The outcome of CSE may also be influenced by treatment through its effect on seizure 
duration, but there is limited published data on the treatment of CSE in childhood. 
Consequently, treatment guidelines for the emergency treatment of CSE are based on 
clinical experience and sparse evidence (Appleton et al. 2000; The Advanced Life 
Support Group 2000). The provision of standardised guidelines for the treatment of 
CSE, similar to treating cardiac arrest, is associated with improved quality of 
emergency care and outcome (Shepherd 1994), but provision of such a guideline does 
not guarantee that it will be adhered to (Begg 1992; Meyer et al., 1997; Belfer et al., 
2001; Levenson 2001; Puder and Keller 2003; Gilbert et al., 2003; Chiang et al.,
2004; Johansson et al., 2004). In the United Kingdom (UK), the Advanced Paediatric 
Life Support (APLS) guideline for the management of CSE is the widely accepted 
national standard for treatment of CSE but there is ambiguity in that guideline with 
respect to whether prehospital treatment should be administered and if it is 
administered, whether A&E physicians should count the administered doses of 
benzodiazepines as part of the recommended two doses. In the systematic review of 
the epidemiology of status epilepticus described in Chapter 2, two of the studies 
reported that a significant proportion of patients were not treated, or inadequately 
treated, prior to arrival to hospital. Together, these data lead to the hypotheses that in 
the general childhood population (1) a significant proportion of children with CSE are 
not treated in the prehospital setting (2) prehospital treatment may decrease the 
duration of CSE (3) and that physicians who disregard prehospital treatment may give 
more doses of benzodiazepine than those who take prehospital treatment into account.
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Benzodiazepines are the preferred first line drugs for the treatment of CSE because 
they have a quick onset of action and are effective (Lowenstein and Alldredge 1998; 
Treiman 1998), but there is a risk of respiratory depression associated with their use 
which is increased when more than 2 doses are administered (Dieckmann 1994; 
Norris et al., 1999; Rainbow et al., 2002; Stewart et al., 2002).
In sheep, CSE is associated with centrally mediated respiratory depression (Johnston 
et al., 1995) and central apnoea has been reported in a case report of near sudden 
unexplained death in epilepsy (So et al., 2000). In a study on admissions to a 
paediatric intensive care unit for status epilepticus, 13% of the children required 
admission because of respiratory depression but a number of these children had not 
been treated with benzodiazepines (Lacroix et al., 1994). Therefore, respiratory 
depression is not uncommon with status epilepticus and may be a consequence of 
treatment, of the seizure itself or of some other factor(s). Identification of factors 
associated with respiratory depression in convulsive status epilepticus may assist in 
the development of strategies to minimise the risk of respiratory depression in status 
epilepticus.
The APLS recommended first line AEDs are lorazepam administered intravenously or 
diazepam administered rectally but there is no previous study that has examined the 
effectiveness and safety of these agents administered by these routes. Paediatric 
studies comparing lorazepam to diazepam in the treatment of convulsive status 
epilepticus show that children treated with intravenous lorazepam were less likely to 
require additional doses or an additional AED for seizure termination and were also 
more less likely to develop respiratory depression than children treated with
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intravenous diazepam (Giang and McBride 1988; Chiulli et al., 1991; Appleton et al., 
1995). There are data from paediatric studies that also suggest that treatment of 
convulsive status epilepticus with rectal diazepam is as efficacious, without an 
increased risk of respiratory depression, as treatment with intravenous diazepam 
(Knudsen 1979; Albano et al., 1989; Dieckmann 1994; Alldredge et al., 1995). 
Therefore, as intravenous lorazepam is better than intravenous diazepam, and that 
rectal diazepam is as efficacious as intravenous diazepam, this leads to the leads to the 
hypothesis that intravenous lorazepam may be better first line therapy than rectal 
diazepam for the treatment of convulsive status epilepticus in childhood.
The APLS guideline recommends rectal paraldehyde as the second line agent for the 
treatment of convulsive status epilepticus following initial treatment with 
benzodiazepines. Rectal administration of drugs may result in inadequate therapeutic 
brain levels and it may be more appropriate to administer an intravenous drug if 
intravenous access is available. Intravenous phenytoin is a widely used second line 
agent (Scott and Neville 1999). There are no published data on the likelihood of 
seizure termination with rectal paraldehyde compared to intravenous phenytoin as 
second line treatment for convulsive status epilepticus in childhood.
Although the results of randomised controlled trials are generally considered as “best 
evidence”, in some situations only observational studies may be conducted. Due to 
difficulties with consent, randomised controlled trials on the treatment of CSE in 
children are rare. In the absence of randomised controlled trials, non-interventional 
studies, such as the current study, may provide the best level of evidence and thus 
provide important data on the optimum treatment of CSE. From NLSTEPSS the
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treatment of convulsive status epilepticus of out of hospital onset is described with 
particular attention to the following questions:
• What proportion of children with convulsive status epilepticus of out of 
hospital onset are not treated in the prehospital setting?
• In the general childhood population, what are the factors associated with 
respiratory depression in convulsive status epilepticus?
• In the general childhood population, are children with CSE being treated with 
inadequate doses/ more doses to those recommended in the APLS guideline 
for the emergency management of CSE?
• As first line treatment of convulsive status epilepticus, is intravenous 
lorazepam associated with a greater likelihood of seizure termination and a 
lesser risk of respiratory depression than treatment with rectal diazepam?
• As second line treatment of convulsive status epilepticus, is intravenous 
phenytoin associated with a greater likelihood of seizure termination than 
rectal paraldehyde?
6.2 Methods
6.2.1 Case ascertainment, data collection and data validation
The methods for case ascertainment, data collection and data validation were
described in Chapter 4.
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6.2.2 Definitions
6.2.2.1 APLS recommended first line AED
As the APLS guideline is considered the national guideline for the emergency 
treatment of CSE in childhood, the emergency management of CSE in this study 
population was compared to the APLS guideline current during the study period i.e. 
the third edition (The Advanced Life Support Group 2000). In APLS, 3rd Ed, 
lorazepam (administered intravenously) or diazepam (administered rectally) is the 
recommended first line drug.
6.2.2.2 APLS recommended second line AED
Paraldehyde (administered rectally) is the recommended second line drug (see Figure
6.1 for further details on the APLS guideline for the treatment of CSE, 3rd Edition).
6.2.2.3 Adequate doses for emergency AEDs
An adequate dose for intravenous (iv) lorazepam is defined as 0.1 mg/kg, for rectal 
(pr) diazepam it is 0.5mg/kg, for pr paraldehyde it is 0.4ml/kg, for iv phenytoin it is 
18mg/kg and for iv phenobarbitone it is 15-20mg/kg (see Figure 6.1). The weight 
used for calculating adequate doses was that estimated by emergency medical 
personnel. To allow for any errors in estimating the adequate dose of emergency 
AED, any administered dose outside 80%-120% of these doses, were considered to be 
inadequate (low) or high.
6.2.2.4 Response to AED
Positive response to an AED was defined as termination of overt clinical seizure 
activity within 10 minutes of administration of the AED.
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Yet No
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10 min J . J.N o
vascular access ?
vascular access ?
lorazepam 
0.1 mg/kg IV/IO
Diazepam 
0.5 mg/kg PR
lorazepam 
0.1 mg/kg IV/IO
Airway 
High flow oxygen 
Don‘1 ever forget glucose
RSI
4 mg/kg IV/IO
Paraldehyde 
0.4 ml/kg PR 
Le. OJml/kg of prepared solution
Phenytoin 
18 mg/kg IV/IO over 20 min 
or if already on Phenytoin, give Phenobarbitone 
15-20 mg/kg IV/IO over 10 min
3 rd  £ 4 M m i
Figure 6.1: APLS algorithm (3rd ed.) for treatment of convulsive status epilepticus.
6.2.2.5 Reasons for admission to PICU
Primary reasons for admission to PICU were classified into one of the following 
categories: for continuing overt clinical seizure activity, for respiratory depression 
following cessation of clinical seizure activity, for altered consciousness (Glasgow 
Coma Scale less than 8), for safety of transfer to PICU and for other reasons.
6.2.3 Statistics
Data analysis was conducted in SPSS Version 10 (Chicago, Illinois) and StatXact 
v4.0.1. Only first episodes of all children who had CSE during the study period were 
included in analyses on factors associated with treatment with more than 2 doses of
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benzodiazepines, factors associated with respiratory depression and differences in 
outcome between groups of children treated with different first and second line AEDs.
Forward stepwise multivariate logistic regression was used to investigate factors 
associated with respiratory depression and factors that may affect the likelihood of 
being treated with more than 2 doses of benzodiazepines rather than 1 or 2 doses. The 
critical level for entering and removing variables was set at p=0.05 and p=0.1 
respectively. The following variables were investigated: age, ethnicity, sex, 
neurological state prior to episode of CSE, interval between onset of CSE and arrival 
to A&E, incident vs non-incident CSE, onset in hospital or onset out of hospital, CSE 
associated with fever or not, intermittent versus continuous CSE, presence of focal 
features or not, prehospital treatment or not, treatment with first AED within 10 
minutes of onset of CSE, treatment with first AED within 15 minutes of onset of CSE, 
adequacy of dose of first AED, treatment with more than 2 doses of benzodiazepines 
than 1 or two doses and duration of CSE greater than 60 minutes compared to 30 -  60 
minutes.
Chi square, Fishers exact and Mann-Whitney U-testing were carried out to examine 
the differences in seizure and patient characteristics amongst children treated with 
intravenous lorazepam or rectal diazepam as first line AED, and differences in seizure 
and patient characteristics amongst children treated with intravenous phenytoin or 
rectal paraldehyde as second line AED. Differences in seizure termination and risk of 
respiratory depression between treatment groups were investigated using StatXact 
v4.0.1. The 95% confidence intervals for the differences in proportions between 
groups and associated p-values are presented.
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6.3 Results
6.3.1 Seizure termination without treatment
There were 240 CSE events of out of hospital onset. Of these, 5 (3 males, median age
6.3 yrs, range 0.65-8.02 yrs) spontaneously terminated. All five children had incident, 
intermittent episodes of CSE (median duration 61 mins, range 60-80 mins) and were 
brought to hospital by ambulance (median interval between onset and arrival to 
hospital 64.5 mins, range 30- 110 mins). One child had prolonged febrile seizures, one 
had acute bacterial meningitis, one had idiopathic epilepsy related CSE and two had 
remote symptomatic CSE.
6.3.2 First Line treatment of CSE
6.3.2.1 Initial treatment commenced prehospital
Of the 235 episodes of CSE of out of hospital that required treatment for seizure 
termination, 131 (56%) were incident and 104 were non-incident cases. Prehospital 
treatment was less likely to be administered in incident cases of CSE compared to non 
incident cases (63/131 vs 87/104, 95% Cl 23.3 -  47.9%, p = 0.002). Three children 
with CSE were given their first treatment at school but in all other cases of CSE, 
initial treatment was administered by the child’s parents at home or by paramedics. A 
greater proportion of children with incident episodes of CSE were treated initially by 
paramedics (50/63) compared to children with non-incident cases of CSE who were 
more likely to be treated initially by their parents at home (64/84), p < 0.0005).
Rectal diazepam was the first anti-epileptic medication administered in 96% of all 
cases treated in the prehospital setting but the dose was adequate in only 21% of cases 
and the dose was inadequate in 66% of cases (see Table 6.1). Adequacy of the first
- 1 4 7 -
dose of prehospital treatment was independent o f whether CSE was incident CSE or
not (16/63 vs 14/84 respectively, 95% Cl - 26.2 -  6.6%, p = 0.31).
Step AED Dose Prehospital N (%)
Overall 
(prehospital and hospital) 
N (%)
FIRST LINE
Treated 147 (63) 235(100)
Diazepam
Dose low 93 (66) 125 (66)
Dose adequate 29 (21) 45 (24)
Dose high 4(3) 5(3)
Dose unknown 15(11) 14(7)
Total 141(96) 189 (80)
Lorazepam
Dose low - 3(8)
Dose adequate - 32 (89)
Dose high - 1(3)
Dose unknown - 0(0)
Total - 36(15)
Other 6(4) 10(4)
SECOND LINE
Treated 79 (34)
Paraldehyde
Dose low - 11 (26)
Dose adequate - 31 (72)
Dose high - 1(2)
Dose unknown - 0(0)
Total - 43 (54)
Phenytoin
Dose low - 3(9)
Dose adequate - 29 (91)
Dose high - 0(0)
Dose unknown - 0(0)
Total - 32(41)
Phenobarbitone
Dose low - 3(75)
Dose adequate - 1(25)
Dose high - 0(0)
Dose unknown - 0(0)
Total - 4(5)
Table 6.1: Details of choice of first line and second line AEDs and adequacy of their 
doses in the treatment of CSE of out of hospital onset in children in North London 
(n=235).
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The median interval between seizure onset and to call the emergency services was 7 
minutes (range 0 to 495 minutes), the median interval between calling emergency 
services and arrival of a paramedics to the child was 11 minutes (range 5 to 19 
minutes) and the median interval from onset to administration of the first prehospital 
dose of AED was 11 mins (5 minutes if administered by parents at home, 20 minutes 
if administered by paramedics, range 0-460 mins). The median interval between onset 
and arrival to A&E was 36 mins (range 5-509 mins).
6.3.2.2 Initial treatment in A&E
In those 88 CSE events that were not treated in the prehospital setting, 64 (73%) were 
taken to hospital by ambulance. The median interval between onset and arrival to 
A&E overall was 34 mins (range 5-514 mins) and 39 mins (range 10 -514) if brought 
by ambulance. Similar proportions of children who were not treated before arrival to 
hospital were treated with rectal diazepam (55%) and intravenous lorazepam (41%) as 
the first line AED in hospital. Those that were treated with intravenous lorazepam 
were 16 (95% Cl 4.8-53.1%, p = 0.02) times more likely to receive an adequate dose 
compared to those that received rectal diazepam.
6.3.2.3 Rectal diazepam or intravenous lorazepam as first line AED
6.3.2.3.1 Prehospital treatment given
In children with CSE of out of hospital onset and treated with a single dose of rectal 
diazepam before arrival to A&E and then given a second dose of benzodiazepine in 
A&E, similar proportions responded to the second dose (had seizure termination) with 
intravenous lorazepam as those treated with rectal diazepam (14/46 vs 7/26, 95% Cl 
for difference -29.3 to 20.5%, p = 0.78). Of the 21 children who responded to the
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second dose of benzodiazepine, 16 were treated with an inadequate first dose and 5 
were treated with an adequate first dose in the prehospital setting. The likelihood of 
seizure termination was similar whether the second dose was adequate or not (p=0.9). 
The median age, male to female ratio, median interval between onset and arrival to 
accident and emergency, proportion of episodes that were intermittent compared to 
continuous and the proportion of episodes that were prolonged febrile seizures were 
similar between groups. Children who were treated with rectal diazepam as the 
second dose of benzodiazepine were more likely to have had CSE with focal features 
and non-incident CSE compared to those who were treated with intravenous 
lorazepam. For further details on clinical characteristics according to treatment group, 
see Table 6.2.
6.3.2.3.2 No prehospital treatment given
In children with CSE of out of hospital setting and not treated in the prehospital 
setting, initial treatment with intravenous lorazepam was associated with a greater 
likelihood of seizure termination compared to those given rectal diazepam (16/36 vs 
6/50 respectively, 95% Cl for difference, 11.0 -  53.9%, p= 0.005) without an 
increased risk of respiratory depression (7/36 vs 8/50, 95% Cl for difference -16.7 -  
27.3%, p= 0.79. However, those that were treated with intravenous lorazepam were 
more likely to be treated with an adequate dose of AED (32/36 vs 13/50, 95% Cl for 
difference 43.4 -  78.9%, p=0.002). An adequate first dose of AED and intravenous 
lorazepam rather than rectal diazepam as initial treatment were variables significantly 
associated with seizure termination on univariate logistic regression, but were not 
independently significant on multivariate analysis. The mean interval between onset 
and arrival to A&E was greater in the group of children treated with intravenous
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lorazepam compared to those treated with rectal diazepam (67 vs 47 mins, Mann- 
Whitney U-test, p = 0.04) but the median age, male:female ratio and other seizure and 
patient characteristics were similar in both groups. For further details on clinical 
characteristics according to the two treatment groups, see Table 6.3.
Diazepam (%) Lorazepam (%) Total (%)
Age (yrs)
Mean 3.9 4.8
Median 3.3 3.4 -
Range 0.3-11.1 0 .7-15 .9 -
Mann-Whitney U-test, p  =0.5
Sex
Male 12 (46) 17(37) 29 (38)
Female 14 (54) 29 (63) 43 (62)
Chi-square =0.6, df=  1, p  = 0.44
Time to A&E(mins)
Mean 55 36 -
Median 32 31
Range 10-492 1 0 -94 -
Mann-Whitney U-test, p  =0.5
Character
Intermittent 11 (42) 18(39) 29 (41)
Continuous 15(58) 28 (61) 43 (59)
Chi-square =0.07, df = J,p =0.8
Aetiology
PFS 4(15) 9(20) 13(18)
Not PFS 22 (85) 37 (80) 59 (82)
Fishers Exact Test Chi-square = 0.20, df=  1, p  = 0.65
Seizure type
Focal 16(62) 15 (33) 31(43)
Generalised 10(38) 31 (67) 41 (54)
Chi-square = 5.7, df=  1, p =0.017
Incident/Non-Incident
Incident 6 (23) 28 (61) 34 (47)
Non-Incident 20 (77) 18(39) 38(53)
Chi-square = 9.5., df=  1, p =0.002
All 26(100) 46(100) 72(100)
Table 6.2: Patients’ characteristics and their seizure characteristics according to the 
first benzodiazepine given in hospital after initial treatment with single dose of rectal 
diazepam in the prehospital setting.
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Diazepam (%) Lorazepam (%) Total (%)
Age (yrs)
Mean 3.6 
Median 2.1 
Range 0.16-15.5 
Mann-Whitney U-test, p  = 0.44
3.8
2.1
0.32-13.3
-
Sex
Male 26 (52) 
Female 24 (48) 
Chi-square = 0.71, p  =0.4
22 (61) 
14(39)
48 (56) 
38(44)
Time to A&E(mins)
Mean 47 
Median 30 
Range 5-514 
Mann-Whitney U-test, p  = 0.04
67 
42 
10-450
-
Character
Intermittent 25 (50) 
Continuous 25 (50) 
Chi-square = 0.71, p  =0.40
19 (53) 
17(47
42 (49) 
44(51)
Aetiology
PFS 32 (64) 
Not PFS 18(36) 
Chi-square = 0.64, p  =0.42
26 (72) 
10(28)
58 (67) 
28 (33)
Seizure type
Focal 16 (68) 
Generalised 34 (32) 
Chi-square = 0.50, d f=  1, p  = 0.48
27 (75) 
9(25)
61 (71) 
25 (29)
Incident/Non-Incident
Incident 39 (78) 
Non-Incident 11 (22) 
Chi-square = 0.37, df = 1, p  = 0.54
30 (83) 
6(17)
69 (80) 
17(20)
ALL 50(100) 36(100) 86(100)
Table 6.3: Patients’ characteristics and their seizure characteristics according to the 
first benzodiazepine given in hospital when there was no prehospital treatment.
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6.3.3 Second Line Treatment of CSE
6.3.3.1 Choice of AED and adequacy of dose
Second line AED was administered in 79 (34%) children. Rectal paraldehyde (54%) 
and intravenous phenytoin (41%) were the preferred second line AEDs and when 
used, their dose was frequently adequate. Similar proportions of children treated with 
rectal paraldehyde or intravenous phenytoin were given adequate doses. For further 
details on the first and second line choice of AEDs and adequacy of doses, please see 
Table 6.1.
6.3.3.2 Rectal paraldehyde or intravenous phenytoin as second line AED
In children with CSE of out of hospital setting and who required second line AED 
therapy, 75 were treated with either rectal paraldehyde or intravenous phenytoin as 
second line treatment. Second line treatment with intravenous phenytoin was 
associated with a greater likelihood of seizure termination than treatment with rectal 
paraldehyde (26/32 vs 12/43 respectively, 95% Cl for difference 31.8-72.87%, 
p=0.02). Similar proportions of children were treated with adequate doses (29/32 vs 
31/43, 95% Cl for difference -42.5 to 3.2%, p = 0.11) and similar proportions of 
children were treated with more than 2 doses of benzodiazepines compared to 
treatment with 1 or 2 doses (20/32 vs 23/43, 95% Cl for difference -42.5 to 3.2%, p = 
0.82). The median age, male to female ratio, mean interval between onset of CSE and 
arrival to the accident and emergency department, proportion of episodes that were 
intermittent compared to continuous, and the proportion of episodes that were 
prolonged febrile seizures were also similar between treatment groups. For further 
details of clinical characteristics according to treatment group, see Table 6.4.
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Paraldehyde (%) Phenytoin (%) Total (%)
Age (yrs)
Mean 3.4 3.5
Median 2.2 2.0
Range 0.3 -15.3 
Mann-Whitney U-test, p  = 0.11
0.2-15.9
Sex
Male 22(51) 22 (68) 44 (59)
Female 21 (49) 
Chi-square = 2.1, p  =0.15
10(32) 31 (41)
Time to A&E(mins)
Mean 51 60
Median 34 45
Range 10 - 240 
Mann-Whitney U-test, p  = 0.69
10-514
Character
Intermittent 20 (47) 16(50) 36 (48)
Continuous 23 (53) 
Chi-square = 0.06, p  =0.80
16(50) 39 (52)
Aetiology
PFS 9 (22) 8(25) 17(23)
Not PFS 34 (79) 
Chi-square = 0.12, p  =0.73
24 (75) 58 (70)
Seizure type
Focal 14 (33) 9(28) 23 (31)
Generalised 29 (67) 
Chi-square = 0.19, p  =0.66
23 (72) 52 (69)
Incident/Non-Incident
Incident 37 (86) 30 (93) 67 (89)
Non-Incident 6 (14) 
Fishers Exact Test, p  = 0.48
2(7) 8(11)
Doses of Benzodiazepines administered
1 or 2 doses 20 (47) 12 (37) 32 (43)
>2 doses 23 (53) 
Chi-square = 0.95, p  =0.33
20 (63) 43 (57)
Table 6.4: Patients’ characteristics and their seizure characteristics according to the 
choice of second line emergency AED.
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6.3.4 Respiratory depression and CSE
Of the 226 children with initial episodes of CSE, all 36 (16%) children that developed 
respiratory depression required admission to PICU. The children treated with more 
than 2 doses of benzodiazepines were more likely to have respiratory depression than 
those treated with 1 or 2 doses (20/89 vs 16/131, chi square = 4.07,p  = 0.044). 
Treatment with more than 2 doses of benzodiazepines rather than 1 or 2 doses was the 
sole significant factor on multivariate logistic regression analysis of possible factors 
of CSE associated with respiratory depression. Of note, on univariate logistic 
regression, adequacy of the initial dose of benzodiazepine administered was not 
associated with respiratory depression (p= 0.36).
6.3.5 Factors associated with treatment with more than two doses of benzodiazepines 
Half the number of children that required treatment for termination of CSE were 
treated with more than the maximum two doses of benzodiazepines recommended in 
the APLS guideline. On multivariate logistic regression the following variables were 
independently associated with treatment with more than 2 doses of benzodiazepines: 
prehospital treatment vs no prehospital treatment, inadequate vs adequate first dose of 
AED, CSE lasting >60 mins rather than CSE lasting 30-60 mins, and admission to 
PICU. There is a significant interaction effect between prehospital treatment and 
inadequate vs adequate dose of the first AED. An adequate first dose was associated 
with an 11.4 fold increase in the likelihood of being treated with more than 2 doses of 
benzodiazepines (p< 0.0005, 95% Cl 3.8-34.5) when given in the pre hospital setting. 
However, if the first dose was inadequate, the likelihood of having more than 2 doses 
of benzodiazepine increased by a similar amount regardless of whether it was given in
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hospital (3.4-fold), or prehospital (3.1-fold). For further details on factors associated 
with treatment with more than two doses of benzodiazepines, see Table 6.5.
Variables P Odds Ratio 95% Cl for Odds Ratio 
Lower Upper
Duration > 60 mins 0.007 2.2 1.3 3.9
Prehospital treatment 
with an adequate dose of 
first AED vs no 
prehospital treatment
<0.0005 11.4 3.8 34.5
Prehospital treatment 
with inadequate dose of 
first AED vs no 
prehospital treatment
<0.0005 3.1 0.78 11.6
Inadequate vs Adequate 
dose of first AED overall
<0.0005 3.4 1.1 10.2
Admission to PICU 0.02 2.1 1.1 3.9
Table 6.5: Multivariate logistic regression of factors associated with treatment of CSE 
with more than 2 doses of benzodiazepines rather than one or two doses.
6.4 Discussion
In NLSTEPSS, 37% of children with CSE of out of hospital onset are not treated in 
the prehospital setting. This is significant as the data from the previous chapter show 
that lack of prehospital treatment is associated with increased likelihood of CSE 
lasting longer than 60 minutes than 30-60 minutes and previous studies have reported 
increasing morbidity and mortality associated with increasing duration of CSE. The 
data from Chapter 5 also show that treatment with more than two doses of 
benzodiazepines is associated with an increased likelihood of CSE lasting longer than 
60 minutes than 30 to 60 minutes.
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In the current study, treatment with more than two doses of benzodiazepines is not 
only associated with increased seizure length, it is also associated with the 
development of respiratory depression. The development of respiratory depression 
associated with treatment with more than two doses of benzodiazepines has been 
reported previously (Stewart et al., 2002). Following an initial dose, subsequent 
treatment with at least two more doses of benzodiazepines may result in high serum 
levels with resultant respiratory depression; the higher the initial dose, the higher the 
serum level. However, in the current study, adequacy of the initial dose of 
benzodiazepines was not associated with the development of respiratory depression. 
The most likely explanation for this unexpected finding is that the study had 
insufficient power. Alternatively, children who do not respond to an adequate initial 
dose of AED are more likely to have refractory CSE and respiratory depression occurs 
as a result of seizure activity rather than treatment.
In the current series, prehospital treatment is associated with administration of more 
than 2 doses of benzodiazepine. Children treated with an adequate initial dose are 
more likely to be treated with more than two doses of benzodiazepines than those 
treated with an inadequate initial dose. The associations between treatment with more 
than two doses of benzodiazepines, increased seizure length and respiratory 
depression have already been described in the current study. Several factors may 
contribute to these observations. The first is that physicians who disregard prehospital 
treatment may give more than the maximum two doses of benzodiazepine in the 
APLS guideline than those who do take prehospital treatment into account. This may 
be due to a lack of specificity of the entry point into the treatment algorithm of the
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APLS guideline. The issue becomes more ambiguous because the British Paediatric 
Neurology Association (BPNA) guideline for treatment of CSE recommends that 
prehospital treatment should be ignored (Appleton et al. 2000) which, on the basis of 
the current data, may increase the risk of respiratory depression and contribute to 
increased seizure duration. Thus, the entry point into the guidelines for the 
management of CSE needs to be clarified. It may also be hypothesised that children 
who do not respond to an adequate initial prehospital dose of AED, and ultimately 
have seizure activity lasting at least thirty minutes, are more likely to have refractory 
CSE compared to those who were inadequately or not treated. Conversely, children 
inadequately treated in the prehospital setting are likely to respond to treatment in the 
hospital setting, suggesting that seizure duration would have been shorter in a 
significant proportion of children if the initial dose were adequate. In NLSTEPSS, 
22% of children who were given a single inadequate initial dose of benzodiazepine in 
the prehospital setting had seizure termination after a second dose of a benzodiazepine 
in hospital. It is therefore possible that this 22% of children may have had shorter 
seizure duration had they been given an adequate initial dose. If this hypothesis is 
true, an adequate initial prehospital dose of AED may be important in the 
management of convulsive status epilepticus.
On this basis, the current state of treatment of childhood CSE is worrying as only one 
in twelve children with CSE of out of hospital onset are treated with an adequate first 
dose of prehospital treatment, and four in ten children are treated with more than two 
doses of benzodiazepines. It would appear that parents are aware of the importance of 
early treatment of CSE since non-incident episodes of CSE are more likely to be 
treated initially by parents rather than by paramedics, but the doses they give are
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frequently inadequate. Administration of an inadequate dose is also common when 
initial treatment is administered by paramedics. Half of children with incident 
episodes of GSE have no previous neurological abnormality so it is not surprising that 
if prehospital treatment is given to children with incident episodes of CSE, it is 
usually administered by paramedics. Though 83% of incident episodes of CSE are 
transported to hospital by ambulance, only half of these children will receive 
prehospital treatment, of which only a quarter will get an adequate first dose. Thus, 
only one in ten children with incident CSE and transported to A&E by ambulance will 
get an adequate first dose of prehospital treatment. The reason(s) for not giving any 
or inadequate prehospital treatment is unclear and should be investigated, but 
differences in the APLS guideline for the treatment of CSE compared to that used by 
the London Ambulance Service and staffing levels of paramedics may contribute 
significantly to problems with prehospital treatment.
The APLS guideline recommended dose of rectal diazepam of 0.5mg/kg is consistent 
with the pharmacokinetics of the drug. In pharmacokinetic studies of rectal diazepam 
in children, 0.4 -  0.5 mg/kg is required to attain therapeutic anti-epileptic serum levels 
within ten minutes of administration (Mattila et al., 1981; Ogutu et al., 2002). In the 
London Ambulance Service’s guideline, diazepam by the intravenous route or rectal 
route is recommended but the use of intravenous therapy is limited by the difficulty in 
achieving intravenous access in children particularly in those aged less than 5 years, 
the peak age group for convulsive status epilepticus in childhood. No child in this 
study was given intravenous therapy by paramedics. The dose of rectal diazepam 
recommended in the London Ambulance Service’s guideline is based on the child’s 
age rather than weight (2.5 mg for children aged less than 1 year, 5 mg for those aged
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1-5 years and 10 mg for those aged 6-12 years) (London Ambulance Service 2003), 
but the data from the current study suggest they are not compliant with their own 
guideline. Sixty percent of the children aged 1-5 years in the current study treated by 
paramedics were treated with 2.5 mg rather than 5 mg as recommended in the LAS 
guideline. Even if the LAS guideline had been strictly adhered to, a proportion of 
children would still not have received an adequate per kilogram dose to achieve 
therapeutic anti-epileptic levels. Rectal diazepam is only available in prepackaged, 
set doses, making it difficult to accurately vary the dose according to the patient’s 
weight and therefore, may contribute to difficulty with administration of an adequate 
first dose. Furthermore, paramedics are not always dispatched to 999 calls related to 
children with seizures. The London Ambulance Service considers CSE in childhood 
as a Category A emergency i.e. immediately life-threatening condition and as a 
policy, attempts to dispatch a paramedic trained to administer emergency rectal 
diazepam for such calls (London Ambulance Service 2004). However, if a paramedic 
is not immediately available, ambulance technicians are dispatched to transport the 
child to hospital for initiation of treatment as soon as possible (Wright 2005). In the 
current study, the median time to be transported to A&E by ambulance from the onset 
of CSE was 39 minutes, which is long enough to increase the difficulty with seizure 
termination and mortality associated with CSE (Knudsen 1979; Hui et al., 2003). 
Therefore, strategies to improve prehospital treatment of CSE by London Ambulance 
Service personnel need to be considered.
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The results from the current study provide important comparative data on intravenous 
lorazepam or rectal diazepam as first line treatment and intravenous phenytoin or 
rectal paraldehyde as second line treatment for CSE in childhood. With the exception 
of a longer interval between onset of CSE and arrival to A&E, the clinical 
characteristics of children that are given initial therapy in hospital with intravenous 
lorazepam or rectal diazepam are similar and therefore, it is reasonable to compare the 
treatment outcome between both groups. If children are not given prehospital 
treatment, in A&E, intravenous lorazepam should be preferred to rectal diazepam as 
first-line rescue therapy. Despite a longer duration before initial treatment, seizure 
termination is more likely with intravenous lorazepam than rectal diazepam without 
increased risk of respiratory depression. In NLSTEPSS, a ten minute interval from 
administration of an AED to seizure termination was used to assess seizure 
termination in response to treatment because the pharmacokinetics of the AEDs being 
examined (intravenous lorazepam, rectal diazepam, intravenous phenytoin and rectal 
paraldehyde) indicate therapeutic levels are attained within 10 minutes of 
administration (Knudsen 1977; Walker et al. 1979; Franzoni 1983; Graves 1987;
Giang et al. 1988; Walton et al. 1990; Brown et al. 1991). It is beyond the scope of 
this study to determine whether the increased likelihood of seizure termination 
observed with treatment with intravenous lorazepam is due to its intrinsically better 
seizure terminating properties or due to a greater likelihood of being treated with an 
adequate dose. It is possible that administration of an adequate dose of rectal 
diazepam may improve its efficacy in seizure termination, but methods to improve the 
likelihood of treatment with an adequate dose will need to be explored.
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The median age, male to female ratio, doses of benzodiazepines administered as first 
line therapy and other patient and seizure characteristics were similar between 
children treated with rectal paraldehyde or intravenous phenytoin as second line 
therapy for CSE. When first-line therapy has failed, the APLS recommended second 
line drug is rectal paraldehyde but intravenous phenytoin is a commonly used second 
line treatment worldwide (Scott and Neville 1999). To the candidate’s knowledge, 
this is the first study that suggests that one is superior to the other. In NLSTEPSS, 
treatment with intravenous phenytoin was associated with a greater likelihood of 
seizure termination compared to treatment with rectal paraldehyde. The sample size 
for this comparison of second line agents was small (N=33), but the data do suggest 
that paraldehyde should not be given as rescue therapy in children with intravenous 
access.
Randomised controlled trials are expensive, difficult to conduct and particularly in 
children, fraught with difficulties surrounding consent. Together, these factors make 
randomised controlled trials on the treatment of CSE in children rare. As outlined in 
Chapter 2, although randomised controlled trials are considered as the highest level of 
evidence, there is growing recognition that data from observational studies are useful 
evidence and in the absence of randomised controlled trials, observational studies may 
be the highest level of evidence on the optimum treatment of CSE (Cook et al., 1995; 
Appleton et al., 2000; Scottish Intercollegiate Guidelines Network 2005). Therefore, 
the data from NLSTEPSS provide important clinical data on the optimum treatment of 
CSE in childhood and should be utilised in the revision of emergency management 
strategies for CSE.
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The frequency, aetiology, seizure characteristics, treatment and short term outcome of 
convulsive status epilepticus in a general childhood population were described in this 
and the preceding chapter. Children referred to a tertiary centre may represent those 
with the severe end of the spectrum of convulsive status epilepticus, with those 
requiring admission to a paediatric intensive care unit (PICU) being the most severely 
affected. Thus, further evaluation of children admitted to PICU for convulsive status 
epilepticus may provide some insight into determinants of severity.
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PART THREE 
PICU AND CSE IN CHILDHOOD
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CHAPTER 7: PICU AND CONVULSIVE STATUS EPILEPTICUS
7.1 Introduction
Status epilepticus (SE) is the most common neurological emergency in childhood 
(Leppik 1985; DeLorenzo et al., 1996). Children requiring admission to a paediatric 
intensive care unit (PICU) for CSE may represent children with the most severe forms 
of CSE. Thus, identification of factors associated with admission to PICU for CSE 
may provide some insight into determinants of severity of CSE and the likelihood of 
refractory CSE, and facilitate the development of appropriate strategies to improve the 
outcome of CSE. However, studies on admission to PICU for CSE are rare. In the 
only previously published study on admissions to a paediatric intensive care unit for 
CSE (Lacroix et al., 1994), 6% of cases died during hospitalisation compared to 3.4% 
(95% Cl 2.7 -  4.1%) in the general childhood population in NLSTEPSS and 78% had 
neurological deficits at one year follow up. Together these data suggest that there is 
significant morbidity and mortality associated with CSE requiring admission to PICU. 
Therapeutic regime may improve the morbidity and mortality associated with CSE by 
decreasing seizure duration but in the only published study on admission to PICU for 
CSE, there was sparse information on the pre-PICU treatment of CSE. Therefore, a 
study that examines the pre-PICU treatment of CSE is required.
The aims of the study reported in this chapter are (1) to characterise the clinical 
features of children with CSE requiring admission to PICU, (2) to identify factors 
associated with admission to PICU for CSE, (3) to compare the emergency pre-PICU 
treatment of CSE to a national guideline for the management of CSE, the APLS 
guideline and (4) to characterise the course of CSE in children admitted to PICU.
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7.2 Methods
7.2.1 Subjects
Subjects eligible for this study were children admitted to a PICU for convulsive status 
epilepticus. The children were recruited into a larger study of convulsive status 
epilepticus in childhood described in the previous chapter. They are divided into two 
groups: (1) prospective and (2) retrospective. As previously stated, children younger 
than 29 days of age or who had already attained their 16th birthday were excluded.
7.2.2 Data Collection
7.2.2.1 Prospective Group
The prospective part of the study included all children from NLSTEPSS who were 
admitted to any of the five paediatric intensive care units involved in the population 
based study in the period May 1, 2002 to April 31, 2004. The methods for case 
identification and data collection from NLSTEPSS were described in Chapter 5.
7.2.2.2 Retrospective Group
The retrospective aspect of the study consisted of children who were admitted to a 
paediatric intensive care unit in North London at Great Ormond Street Hospital for 
Children NHS Trust (GOSH) between April 1, 1998 and March 31, 2001. GOSH is a 
tertiary paediatric institution in the UK and it’s PICU is the main PICU in North 
London. The study was approved by the GOSH and Institute of Child Health 
Research Ethics Committee. The diagnoses and demographics for all patients 
admitted to GOSH's PICU are documented in an admission database. Survival 
outcome of all admissions is also included. The admission database and discharge
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summaries of admissions during the period April 1, 1998 to March 31, 2001 were 
searched. All potential cases of CSE were identified using the terms: status, epilep*, 
fit*, seizure* and convuls*, where * indicates that any combination of letters may end 
the word. The case notes of these potential cases of CSE were systematically 
reviewed. Episodes of non-convulsive status epilepticus (NCSE) were excluded. 
Cases with insufficient history or documentation to meet the definition of CSE were 
excluded. Clinical and demographic data were extracted and recorded using a 
standard data collection form designed by the candidate (see Appendix 11). As data 
from this group were obtained from a single institution, results are presented 
separately for the prospective and overall group.
7.2.3 Definitions
7.2.3.1 Convulsive Status Epilepticus
The definition of convulsive status epilepticus was that described in Chapter 5 i.e. “a 
seizure with focal or generalised motor manifestations, or series of such seizures 
between which consciousness is not regained, which last for at least 30 minutes”.
7.2.3.2 Seizure type and aetiologies
Seizure type and aetiology were classified independently by the candidate and one of 
the candidate’s supervisors. Disagreements on classifications were resolved by 
consensus or by third party adjudication. CSE seizure types were categorised as 
generalised from onset, focal with secondary generalisation, or focal (Commission on 
Classification and Terminology of the International League Against Epilepsy, 1989). 
CSE aetiologies were classified using the scheme proposed by the candidate in 
Chapter 2 i.e. “prolonged febrile seizures, acute symptomatic, acute on remote
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symptomatic, remote symptomatic, idiopathic epilepsy related, cryptogenic epilepsy 
related or unclassified.
7.2.3.3 First and second line AEDs
The pre-PICU emergency management was compared to the APLS guidelines current 
during the study period i.e. the third edition for the prospective group and the second 
and third editions for the retrospective group (The Advanced Life Support Group 
1997; The Advanced Life Support Group 2000). The second and third editions of the 
APLS guidelines recommend either lorazepam (administered intravenously) or 
diazepam (administered intravenously/rectally) as the first line drug and paraldehyde 
(administered rectally) as the second line drug (see Figure 7.1 for further details on 
the APLS guidelines).
Ye* No
* 1 0
Yes
X  No
> 1 year > 1 year
vascular access ?
vascular access ?
Phenytoin 
16 mg/kg IV
Lorazepam 
0.1 mg/kg IV/IO
Diazepam 
0.5 mg/kg PR
Lorazepam 
0.1 mg/kg IV/IO
Diazepam 
0.4 mg/kg IV or PR
Diazepam 
0.4 mg/kg IV or PR
Paraldehyde
0.2 ml/kg PR In aracNs oR
Paralyse and VenMate 
Thiopentone Infusion
Airway 
High flow oxygen 
Don't ever forget glucose
RSI wRh Thiopentone 
4 mg/kg IV/IO
Paraldehyde 
0.4 m|/kg PR 
l.e. 0.8ml/kg of prepared solution
Phenyfofet
16 mg/kg IV/IO over 20 min 
or W already on Phenytoin, give Ptienobarbitone 
15-20 mg/kg IV/IO over 10 min
Figure 7.1: APLS algorithms for treatment of convulsive status epilepticus (The 
Advanced Life Support Group 1997; The Advanced Life Support Group 2000).
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7.2.3.4 Adequate doses o f first and second line AEDs
7.2.3.4.1 Prospective Group
The adequate dose for intravenous lorazepam is defined as 0.1 mg/kg, for rectal 
diazepam it is 0.5mg/kg, for rectal paraldehyde it is 0.4ml/kg, for intravenous 
phenytoin it is 18mg/kg and for intravenous phenobarbitone it is 15-20mg/kg (see 
Figure 7.1). The weight used for calculating adequate doses was that estimated by 
emergency medical personnel. To allow for any errors in estimating the adequate 
dose of emergency AED, any administered dose outside 80%-120% of these doses, 
were considered to be inadequate (low) or high.
7.2.3.4.2 Retrospective Group
The adequate dose of first line and second line drugs was defined as a mean of the 
recommended doses in the second and third editions of the APLS (see Figure 7.1). 
Thus, the adequate dose for lorazepam was 0.1 mg/kg and for diazepam 0.45mg/kg. 
The weight used for calculating adequate doses was that documented as the estimated 
weight used by emergency medical personnel or the measured weight of the child. 
Where there were differences between weights, the estimated weight was used to 
determine adequacy of the dose of AED. Allowing for difference in the 
recommended doses between both APLS guidelines, if the administered dose was 
outside 80%-120% of the defined adequate doses, it was considered to be inadequate 
(low) or high. The adequate dose of rectal paraldehyde was determined as above and 
was 0.3ml/kg. Using the same rationale as above, if the administered dose was less 
than 50% or greater than 150% of the defined adequate dose, it was considered to be 
low or high.
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7.2.3.5 Reasons for admission to PICU
Primary reasons for admission to PICU were classified into one of the following 
categories: continuing overt clinical seizure activity, respiratory depression following 
cessation of clinical seizure activity and decreased consciousness level (Glasgow 
Coma Scale less than 8).
7.2.4 Statistics
Statistical analyses were conducted in SPSS version 10 (Chicago, Illinois). Kruskal- 
Wallis ANOVA was used to investigate differences in age according to aetiology of 
CSE and difference in duration of ventilation according to aetiology of CSE. Chi- 
Square testing was carried out to examine the relationships between number of doses 
of benzodiazepine and respiratory depression after seizure termination.
In order to minimise bias, only data from the prospective group were used to identify 
possible predictors for the need for admission to PICU for CSE. Possible predictors 
were investigated through forward stepwise multivariate logistic regression analysis. 
The critical level for entering and removing variables was set at p=0.05 and p=0.1 
respectively. The following variables were investigated: age, ethnicity, sex, incident 
vs non-incident episode, neurological state prior to episode of CSE, febrile or not, 
onset in hospital versus onset out of hospital, intermittent vs continuous CSE, focal 
features or not, interval between onset of CSE and arrival to A&E, treatment with 
emergency AED within 10 minutes of onset of CSE, treatment with emergency AED 
within 15 minutes of onset of CSE, adequacy of dose of first AED, treatment with 
more than 2 doses of benzodiazepines and respiratory depression or not. Repeat 
episodes of CSE were excluded from this analysis.
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7.3 Results
7.3.1 Population and Seizure characteristics
The study population consisted of 184 children with 213 episodes of CSE. Amongst 
these children, 93 were prospectively identified and had 115 episodes of CSE. The 91 
children with 98 episodes of CSE from the retrospective group accounted for 4% of 
all admission to Great Ormond Street Hospital for Children NHS Trust’s PICU over 
the three year study period. The median age of the children was 2.1 yrs (range 0.1 - 
15.9) and the male to female ratio was 1:1. In the prospective group, the median age 
of the children was 2.0 yrs (range 0.1-15.9) and the male to female ratio was 1:1. 
There is no difference in the median age of children when compared according to 
aetiology (Kruskal-Wallis ANOVA, p = 0.27, see Figure 7.2). Most children were 
under five years of age (83%) and 75% had incident episodes of CSE.
18
P F C  R e m o t e  E p i le p s y  R e l a t e d
A c u t e  A c u t e  o n  R e m o t e
A ETIO LO G Y  OF CSE
Figure 7.2: Box and Whisker Plot of aetiology of CSE according to age.
The box indicates upper and lower quartiles, the central line within the box is the 
median and the points at the end of the "whiskers" represent the 2.5% and 97.5% 
values of the range. An asterisk represents an outlier. There is no difference in the 
median age between aetiologies (Kruskal-Wallis ANOVA, p=0.30).
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7.3.2 Primary reasons for intubation and ventilation
In 51% of children, intubation and ventilation were necessary in order to give 
medication required to terminate CSE, in 47%, intubation and ventilation were 
necessary for respiratory insufficiency following successful termination of clinically 
recognised seizure activity and in 3%, intubation and ventilation were necessary 
because the children had reduced consciousness (Glasgow Coma Scale score less than 
8).
7.3.3 Aetiology of CSE
Similar proportions of CSE occurred in children who had been previously 
neurologically normal compared to those with pre-existing neurological 
abnormalities. Approximately one quarter of children admitted to PICU for CSE have 
prolonged febrile seizures and another quarter have acute symptomatic CSE.
Amongst those children admitted to PICU for acute symptomatic CSE, most have a 
CNS infection or an acute metabolic disturbance (see Table 7.1 for further details on 
aetiology of acute symptomatic CSE).
7.3.4 Onset of CSE and Final seizure type
Onset of CSE was focal in 38% of children but only 8% of episodes remained focal.
In the prospective group, the onset of CSE was focal in 38% of children and 9% of 
episodes remained focal.
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7.3.5 Duration of CSE
The mean duration of CSE was 90 (range 30-435) minutes. The mean duration of 
CSE in the prospective group was 109 (range 30-660) minutes.
Aetiology of Acute 
Symptomatic CSE
All Prospective only
N % N %
CNS infection 32 68 14 58
Acute Metabolic Disturbance 6 13 4 17
Following Hypoxic Episode 2 4 0 0
Subdural Haemorrhage 1 2 0 0
Drug related 1 2 1 4
Head Injury 3 6 3 13
Cerebrovascular Accident 1 2 1 4
Fever 1 2 1 4
All 47 99 24 100
Table 7.1: Aetiology of Acute Symptomatic CSE
The clinical characteristics of the study population are summarised in Table 7.2. The 
data for the prospective group are presented separately but are substantially similar.
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All Prospective
PATIENT CHARACTERISTICS 
Age
Median (yrs) 2.1 2.0
Range (yrs) 0.1-15.9 0.1-15.9
<5 yrs (%) 83 80
M:F 1:1 1:1
CHARACTERISTICS OF CSE
Incident CSE (%) 77 74
Reasons for Intubation and Ventilation (%)
Control of Seizures 51 49
Respiratory Depression 47 44
GCS <8 3 6
Aetiology of CSE (%)
PFS 28 24
Acute 22 21
Remote 14 17
Acute on Remote 14 20
Idiopathic Epilepsy Related 15 10
Cryptogenic Epilepsy Related 3 2
Unclassified 4 6
Onset
Focal 38 38
Generalised 62 62
Final Seizure Type
Focal 8 9
Generalised 92 91
Duration
Mean (mins) 90 109
Range (mins) 30-435 30-660
Table 7.2: Clinical characteristics of children admitted to PICU for CSE
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7.3.6 Emergency pre-PICU treatment of Status Epilepticus 
108 children (59% of children admitted to PICU for CSE), of whom 60 were 
prospectively identified, did not receive prehospital emergency AEDs. In this group 
of children, the median interval between seizure onset and administration of the first 
AED in A&E was 35 minutes (n=57, range 10-515 mins) and the median interval 
between arrival in A&E and seizure termination was 48 minutes (n=58, range 5-180 
mins). In the group of children who were prospectively identified, the median interval 
between seizure onset and administration of the first AED in A&E was 35 minutes 
(n=28, range 15-515 mins) and the median interval between arrival in A&E and 
seizure termination was 45 minutes (n=31, range 5-180 mins).
When the overall emergency pre-PICU treatment (prehospital and hospital) was 
assessed, almost all episodes of CSE (99%) were treated with diazepam or lorazepam 
as first line AED but their dose was frequently lower (48% of episodes) than that 
recommended. Of 130 children that were treated with second line AED, paraldehyde 
was administered in half of episodes. In these, the dose was adequate in 59%.
The choice and adequacy of doses of first and second line AEDs in the pre-PICU 
treatment of CSE is summarized in Table 7.3
-  1 7 5 -
Emergency AED Treatment All
Prehospital 
N (%)
Overall 
N (%)
Prospective Groun
Prehospital Overall 
N (%) N (%)
FIRST LINE AED 184(100) 184(100) 93 (100) 93 (100)
Treatment Given 76 (41) 184(100) 33 (35) 93(100)
Diazepam/Lorazepam 75 (99) 178(97) 32 (97) 88 (95)
Dose low 49 (65) 85 (48) 21(66) 48 (55)
Dose adequate 23 (31) 89 (50) 10(30) 39 (44)
Dose high 3(4) 4(2) 1(3) 1(1)
Dose unknown 0(0) 0(0) 0(0) 0(0)
Other 1(1) 6(3) 1(3) 5(5)
NIL Treatment 108(59) 0(0) 60 (65) 0(0)
SECOND LINE AED 130(100) 130(100) 46(100) 46(100)
Paraldehyde - 68 (52) - 25 (54)
Dose low - 16(24) - 7(28)
Dose adequate - 40 (59) - 17(68)
Dose high - 12(18) - 1(4)
Dose unknown - - 0(0)
Phenytoin - 61(47) - 21(45)
Dose low - 3(5) - 2(9)
Dose adequate - 55 (91) - 19(91)
Dose high - 2(3) - 0(0)
Dose unknown - 1(2) - 0(0)
Phenobarbitone 1(1) 0(0)
Dose low - 0(0) - 0(0)
Dose adequate - 1(100) - 0(0)
Dose high - 0(0) - 0(0)
Dose unknown - 0(0) - 0(0)
Table 7.3: Emergency pre-PICU treatment of Status Epilepticus.
Approximately 6 out of 10 ten episodes of CSE will not be treated in the prehospital 
setting. Benzodiazepines are the most commonly used first line AED but the dose is 
frequently low. Similar proportions of episodes of CSE given second line treatment 
will be treated with paraldehyde and phenytoin but those treated with phenytoin are 
more likely to receive an adequate dose (chi square = 16.3, p<0.0005).
- 1 7 6 -
7.3.7 Respiratory depression and number of doses of benzodiazepines 
Of the 87 children who developed respiratory depression following seizure 
termination, 54 (62%) were treated with more than two doses of benzodiazepines. 
Children given emergency pre PICU treatment that included more than 2 doses of 
benzodiazepines were more likely to develop respiratory depression than those treated 
with one or two doses (y2 = 3.97, p= 0.046). See Table 7.4 for further detail on the 
relationship between number of doses of benzodiazepines and respiratory depression.
Doses of Benzodiazepine Respiratory Insufficiency Total
No Yes
lor 2 51 33 84
>2 46 54 100
Total 97 87 184
Table 7.4: The relationship between the number of administered doses of 
benzodiazepine with respiratory depression after seizure termination 
/ =  3.97, p= 0.046).
7.3.8 Factors associated with admission to PICU
This analysis was confined to the prospective group to exclude any potential bias that 
could have resulted from the inclusion of the retrospective group. The following 
factors were independently associated with admission to PICU for CSE on 
multivariate regression analysis: respiratory depression, CSE duration > 60 mins 
compared to CSE lasting 30 -  60 minutes, onset of CSE in hospital rather than out of 
hospital, incident CSE rather than non-incident CSE and children with previously 
normal neurology compared to those with a previous neurological abnormality. 
Treatment with more than 2 doses of benzodiazepines was significant on univariate
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analysis (p=0.03) but not on multivariate analysis. Children with CSE lasting longer 
than 60 minutes were 4 times more likely to be admitted to PICU compared to those 
whose CSE lasted between thirty and sixty minutes (95% Cl 2.2-8.5, p<0.0005). 
Children with CSE that started in hospital were almost three times more likely (95% 
Cl 1.4 -  5.3, p= 0.004) to require admission to PICU than CSE of out of hospital 
onset and children who had never had a previous episode of CSE were 2.5 times more 
likely to be admitted to PICU than those who had previous episodes (95% Cl 1.3 -  
4.9, p=0.009). Children who were previously neurologically normal were twice as 
likely to be admitted to PICU as those that had an underlying neurological 
abnormality (95% Cl 1.2 -  4.4, p=0.008). For further details on factors associated 
with admission to PICU for CSE, see Table 7.5
Variables P Odds Ratio 95% Cl for Odds Ratio
Lower Upper
Respiratory Depression <0.00005 238 29.5 1925.7
CSE duration >60 mins <0.00005 4.3 2.2 8.5
In hospital onset 0.004 2.7 1.4 5.3
Incident CSE 0.009 2.5 1.3 4.9
Previously normal 
neurological status
0.008 2.3 1.2 4.4
Table 7.5: Multivariate logistic regression model for factors associated with admission 
to PICU for CSE
7.3.9 Outcome
7.3.9.1 PICU course of CSE
Data on the PICU course of CSE was only available for the retrospective group. In 
this group of children, the median duration of ventilatory support was 15 hours (n=86,
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range 2-168 hrs) and was independent of aetiology (Kruskal Wallis ANOVA, 
p=0.16). Median length of stay on PICU was one day (range 1-13 days).
7.3.9.2 Mortality
Twelve children (7% of children admitted to PICU for CSE) died. All but one child 
had no prior episodes of CSE. Five children had acute bacterial meningitis, five 
children (including the child with previous CSE) had non -specific progressive 
neurodegenerative disease, one had acute hepatic failure and one had a brain tumour.
7.4 Discussion
The purpose of the current study was to characterise a population of children requiring 
admission to PICU within the context of an episode of CSE to provide a framework 
for strategies that reduce requirement for admission to PICU. The need for intensive 
care management of CSE may be related to severity of CSE and there may be 
particular clinical characteristics of such cases that are distinct from those in cases of 
CSE in the general population. Admissions to PICU for CSE may also be due to 
inadequate pre-PICU emergency treatment.
The data from this study suggest that the clinical factors associated with admission to 
PICU for CSE are the development of respiratory depression, CSE lasting longer than 
60 mins, CSE that starts in hospital, incident episodes of CSE and previously normal 
neurological status. On this evidence strategies to reduce the risk of respiratory 
depression and to reduce the likelihood of CSE of duration longer than 60 minutes 
may contribute to a reduction in admissions to PICU for CSE.
In comparison with the Canadian PICU study (Lacroix et al., 1994), a greater
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proportion of children with CSE in this series was admitted to PICU for respiratory 
insufficiency following seizure termination (48% vs 8%). Compared to a prospective 
study of children presenting to A&E with seizures, this study reports a similar 
proportion of children requiring ventilation for respiratory depression associated with 
administration of benzodiazepines (48% vs 57%) (Hui et al., 2003). The data from 
the current PICU study, suggest that respiratory depression is more likely in children 
who are treated with more than two doses of benzodiazepines and treatment with 
more than two doses of benzodiazepines was associated with prehospital treatment. 
These findings are consistent with those from the population based study reported in 
Chapter 6 and provide further support for the view that not taking prehospital 
treatment into account will contribute to the risk of respiratory depression associated 
with CSE. Therefore, the entry point into the guidelines for the management of CSE 
needs to be clarified to minimise the risk of treatment with more than two doses of 
benzodiazepines.
The number of doses of benzodiazepine is not the only concern relating to the 
emergency pre PICU treatment of CSE. There are also treatment delays and poor 
adherence to recommended doses. The data from this series suggest that only one in 
every eight children with CSE admitted to PICU is appropriately treated prior to 
arrival in A&E. When the overall emergency pre-PICU treatment is assessed, the 
doses of APLS recommended first and second line drugs are commonly low. In 
previous studies, including NLSTEPSS, prehospital treatment is one of the factors 
associated with a shorter duration of CSE (Alldredge et al., 1995; Alldredge et al., 
2001) and thus, it is conceivable that widespread prehospital treatment may decrease 
admissions to PICU for CSE.
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Rectal paraldehyde is the APLS recommended second line therapy for CSE but 
similar proportions of children admitted to PICU for CSE were treated with rectal 
paraldehyde or intravenous phenytoin as second line therapy prior to arrival to PICU. 
Intravenous phenytoin , although not in the APLS guideline as a second line drug, is 
widely considered to be an appropriate second-line agent (Scott and Neville 1999). 
There is no previously published evidence that either is superior to the other as a 
second line drug (Logroscino et al., 2002) but data from NLSTEPSS suggest that 
second line treatment with intravenous phenytoin is more likely to result in seizure 
termination than treatment with rectal paraldehyde. Therefore admissions to PICU for 
CSE may be reduced if intravenous phenytoin rather than rectal paraldehyde is 
preferred second line therapy for the treatment of CSE in childhood.
Should a seizure continue for longer than forty minutes after the initiation of 
treatment, the APLS guideline suggests induction of anaesthesia with thiopentone and 
endotracheal intubation and ventilation. In A&E, medical teams managing children 
with CSE are adhering to this forty minutes time line, as the observed interval 
between arrival to hospital and seizure termination is similar. Thus, in order to limit 
seizure duration strategies to improve prehospital management need to be considered.
The use of intravenous agents in the prehospital setting is limited by the difficulty in 
gaining intravenous access in children, especially in those aged less than 5 years 
(Lillis and Jaffe 1992). Rectal preparations, as are currently used, are limited by 
concerns over social unacceptability or inconvenience of administering rectal drugs. 
Recent studies on benzodiazepines by the buccal (Scott et al., 1998; Scott et al. 1999) 
or nasal (O’Regan et al., 1996) route have reported similar efficacy to rectal 
diazepam without increased risk of adverse effects. Thus, there may be alternative
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medications that are easier and more socially acceptable to administer.
Implementation of such agents may result in improvement in the number of children 
successfully treated in the prehospital setting and thereby reduce the number of 
children requiring intensive care treatment for CSE.
7.5 Conclusions
In this chapter, the candidate aimed to characterise a population of children requiring 
admission to PICU for CSE to provide a framework for strategies that reduce the 
requirement for admission to PICU and to provide some insights into determinants of 
severity of CSE. The study population is made of a prospective group obtained 
through NLSTEPSS and a retrospective group obtained from admissions to the largest 
and busiest PICU in North London. Therefore, the retrospective group is likely to be a 
representative sample of children from North London that require intensive care.
The data from the study in this chapter suggest that CSE that starts in hospital, 
incident episodes of CSE and previously normal neurological status may be important 
clinical markers for an increased likelihood for admission to PICU. Strategies to 
reduce the risk of respiratory depression and to reduce the likelihood of CSE of 
duration longer than 60 minutes may contribute to reduction in admissions to PICU 
for CSE. Lack of prehospital treatment increases the likelihood of CSE lasting longer 
than 60 minutes and it may be hypothesised that widespread prehospital treatment 
may reduce the likelihood of such seizures. Since the administration of more than two 
doses of a benzodiazepine is associated with an increased risk of respiratory 
depression, prehospital treatment should be taken into account during further 
treatment. It is proposed that guidelines for the management of CSE should be revised 
to take into account the above findings.
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PART FOUR 
CONCLUSIONS AND FUTURE DIRECTIONS
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CHAPTER 8: CONCLUSIONS
The overall aims of this study were, through a population based study on a paediatric 
population, to characterise the frequency, aetiology and short term outcome of CSE in 
childhood and to identify possible factors associated with longer duration of CSE and 
admission to PICU. A population based study was conducted because data from 
hospital based studies may result in biased information which may not be applicable 
to the general population. The systematic review of the epidemiology of CSE 
reported in Chapter 2 illustrates that all previously available population based 
information on CSE is biased towards an adult population rather than a paediatric 
population, but data from adults may not be directly applicable to children. Therefore 
this study was confined to a paediatric population. In order to maximise 
ascertainment of cases, a multi source identification system was utilised and capture- 
recapture methodology was used to estimate the degree of ascertainment. Longer 
duration of CSE is associated with increasing morbidity and mortality of CSE 
(Aicardi et al., 1970; Meldrum et al. 1973; Yager et al., 1988; Dunn 1988; Logroscino 
et al., 1997; Logroscino et al., 2002; Hui et al., 2003) and admission to PICU is 
associated with CSE refractory to treatment (Walker et al., 1995; Walker et al., 1996; 
Sahin et al., 2001; Sahin and Riviello 2001). Therefore, identification of factors 
associated with longer duration of CSE and admission to PICU for CSE may provide 
the basis for the development of strategies to improve the outcome of CSE.
The results of the North London convulsive STatus Epilepticus in childhood 
Surveillance Study (NLSTEPSS), show that in North London, the ascertainment
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adjusted incidence of CSE in childhood is estimated to be 17-23/100,000 children /yr 
and the ascertainment adjusted occurrence is 30-41/100,000 children /yr.
Extrapolating these data to the population of England and Wales, an estimated 1450 to 
2250 children per year will have a life time first episode of CSE and there are least 
2700 to 4300 episodes of CSE that require attendance to hospital for emergency 
treatment. Factors that influence the overall incidence of CSE are ascertainment 
methods, age, sex, ethnicity and socioeconomic status. The results of this study 
confirm the greater likelihood of underascertainment in single sources of 
ascertainment compared to multiple sources and demonstrate the effectiveness of 
using capture-recapture for more than the commonly used two sources. The incidence 
of CSE is higher in children aged less than 5 years compared to those 5 years and 
older, with the peak incidence in those aged less than one year. The incidence is also 
higher in males compared to females and in non-white, but not black, children 
compared to white children and in children of lower socioeconomic status compared 
to those of higher socioeconomic status. Previous studies have reported a higher 
incidence in non-white populations than white populations (DeLorenzo et al., 1996; 
Coeytaux et al., 2001) but the role of socioeconomic status has not been previously 
reported. This is the first study which has demonstrated the independent effects of 
socioeconomic status and ethnicity on the incidence of CSE and hence, results of 
previous studies that reported ethnic/race differences in the incidence of CSE 
(DeLorenzo et al., 1996; Coeytaux et al., 2001) may have been confounded by the 
socioeconomic composition of their study populations. The data from NLSTEPSS 
also suggest that widespread use of prehospital treatment of seizures may decrease the 
incidence of CSE. NLSTEPSS, was restricted to children who ultimately had seizures 
lasting at least thirty minutes. Most seizures lasting less than five minutes will
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terminate spontaneously and increasing seizure duration is associated with increasing 
difficulty in seizure termination (Knudsen 1979; Sykes and Okonofua 1988; Shinnar 
et al., 2001a). Thus, the group of children in NLSTEPSS had difficult to control 
seizures. Prehospital treatment in this group of children decreased the likelihood of 
CSE lasting longer than 60 minutes than 30-60 minutes. Therefore, it is possible that 
prehospital treatment of all seizures that last at least five minutes will decrease the 
likelihood of seizures lasting at least thirty minutes.
The above data are consistent with genetic, environmental and prehospital treatment 
influences on the development of CSE and therefore, even using similar quality study 
methodologies, studies may obtain different estimates of the incidence of CSE 
according to the study population. The highest crude incidence of convulsive status 
epilepticus in children in the published literature has been reported by the Richmond, 
Virginia group, (27/100,000 children /yr) and has been largely attributed to the 
prospective nature of the study, high ascertainment and a higher incidence in a black 
population than a white population; Richmond has a predominantly black population. 
As only 29 children were recruited into the two year study period, the estimate lacks a 
high degree of precision; the 95% confidence interval of the incidence is 11 - 
43/100,000 children/yr. Ascertainment in the current prospective study is at least as 
good as the Richmond study, but the crude incidence is lower than that reported in the 
Richmond group and there is no difference in the black population compared to the 
white population. It is possible that the differences in the relationship of ethnicity and 
incidence of CSE between the two studies are due to differences in the categorisation 
of ethnicity. In the UK, families are defined as belonging to an ethnic group 
according to whatever they consider their ethnic group. Nonetheless, taking the data
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from this study into account and that Richmond has a poor population, the candidate 
proposes that the higher incidence reported by the Richmond group is less attributable 
to degree of ascertainment but significantly attributable to the socioeconomic 
composition of the population and the higher incidence reported in the black 
population has been confounded by this factor.
Prolonged febrile seizures account for a third of incident episodes of CSE and are the 
most common form of CSE in childhood. This distinct form of CSE occurs only in 
childhood and has been largely ignored in previous population based studies. As 
discussed in Chapter 1, a classification system, such as that recommended by the 
ILAE, that includes prolonged febrile seizures in the same category as SE due to an 
identified acute CNS infection, may be inappropriate for paediatric epidemiological or 
outcome studies. The morbidity and mortality associated with prolonged febrile 
seizures is low (Nelson and Ellenberg, 1978; Maytal et al., 1990; Verity et al., 1993; 
Shinnar et al., 2001b; Wu et al., 2002), which is in sharp contrast to the high 
morbidity and mortality associated with acute CNS infections (Goldacre 1976; 
Shaltout et al., 1989; Dagan 1994; Berg et al., 1996; Pongbhaesaj et al., 2004; Tyler 
2004). Therefore, the results of studies on status epilepticus in childhood that utilise 
the current ILAE classification, may erroneously amplify the severity of outcome of 
prolonged febrile seizures and conversely, dilute the severity of acute neurological 
insults. In NLSTEPSS, the candidate has illustrated that it is possible to use an 
alternative classification system for the aetiologies of convulsive status epilepticus, 
one in which prolonged febrile seizures is considered a distinct category. In 
NLSTEPSS, there were no deaths associated with prolonged febrile seizures whilst 
three children with acute bacterial meningitis died i.e. the case fatality of prolonged
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febrile seizures was 0% and the case fatality of acute symptomatic CSE was 9%. Had 
prolonged febrile seizures not been considered a distinct category, case fatality 
associated with acute symptomatic CSE would have been three times lower. 
Investigating the morbidity associated with CSE was not an aim of this study, but is 
an important question that may be addressed in future studies.
The precise pathophysiological mechanisms for prolonged febrile seizures are 
unknown but there is evidence of a genetic predisposition. By using the alternative 
classification system used in NLSTEPSS, the candidate was able to identify a distinct 
group of patients with prolonged febrile seizures. In a subgroup analysis, Asian 
children had the highest incidence of prolonged febrile seizures. Thus, to understand 
the genetic mechanisms surrounding prolonged febrile seizures, it is possible that 
initial investigations may be best directed at an Asian population.
Children with pre-existing neurological abnormalities may have a lower seizure 
threshold compared to those who are neurologically normal and in the course of an 
intercurrent illness, it may be impossible to distinguish whether CSE is due to the 
underlying abnormality, the intercurrent illness, or both. Therefore, in an attempt to 
distinguish such children from neurologically normal children with prolonged febrile 
seizures, the candidate included the designation “acute on remote symptomatic” 
amongst the aetiologies of CSE. Through the classification used in NLSTEPSS, the 
candidate has successfully been able to identify three distinct groups of children with 
CSE associated with fever. Follow up studies on these distinct groups will provide a 
much clearer picture on their outcome. The three main features of febrile seizures 
associated with the subsequent development of epilepsy are prolonged duration,
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recurrent seizures and focal features (Seki et al., 1981; Annegers et al., 1987; Maher 
and McLachlan 1995; Shinnar et al., 2001b; Trinka et al., 2002). Up to twenty 
percent of children with any two features and up to fifty percent of children with all 
three features will develop epilepsy (Annegers et al., 1987). Since a quarter of 
children with prolonged febrile seizures in this study had focal features, it is 
anticipated that a significant number will develop epilepsy. The data from this study 
also demonstrate that there is a significant risk of acute CNS infection in children with 
lifetime first episodes of CSE and therefore there should be a low threshold for 
empirical treatment with parenteral antibiotics and antiviral agents.
In NLSTEPSS, aetiologies of CSE were classified according to strict definitions and 
classification was reliant on clinical features of patients on presentation and the results 
of all investigations. This study was observational and as the degree of investigation 
varied, the candidate recognises that it is entirely possible that some of the children 
may have been classified into a different category if their investigations were 
different. To minimise this likelihood, all outstanding results of investigations 
requested by the consultant(s) managing the child were collated within six to eight 
weeks after initial presentation to hospital.
This study provides epidemiological evidence which strongly supports the role of 
prehospital treatment in the emergency management of CSE in childhood. CSE 
frequently has an onset out of hospital and there are animal and human studies 
supporting the hypothesis that delayed treatment of seizures is associated with 
increasing difficulty in seizure termination. In addition, delayed treatment is 
associated with increased risk of death (Hui et al., 2003). In this study, lack of
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prehospital treatment was independently associated with CSE lasting longer than 60 
minutes compared to CSE lasting between 30 to 60 minutes. Therefore, widespread 
prehospital treatment of CSE may improve the outcome of CSE but prehospital 
treatment is not yet universal practice. In many parts of the USA and Canada, patients 
have traditionally been transported to hospital as soon as possible for initiation of 
treatment in the emergency room (Emergency Paediatrics Section 1996; Alldredge et 
al., 2001; Lowenstein et al., 2001). A recent seminal study by Alldredge and 
colleagues has demonstrated the benefit and safety of prehospital treatment with 
intravenous therapy in adults (Alldredge et al., 2001) but in children the use of 
intravenous agents is limited by the difficulty in gaining intravenous access, 
especially in those aged less than 5 years, the age group most likely to have CSE.
Only recently in the USA has there been a widespread emerging use of rectal 
diazepam in the prehospital treatment of CSE.
Rectal preparations, as are currently used, are limited by concerns over social 
unacceptability or inconvenience of administering a rectal drug. Recent studies on 
benzodiazepines by the buccal or nasal route have reported similar efficacy and even 
superior efficacy to rectal diazepam without increased risk of adverse effects 
(O’Regan et al. 1996; Scott et al., 1998; Scott et al. 1999; Camfield 1999; Whitehouse 
et al., 2005). Thus, there may be alternative medications that are easier and more 
socially acceptable to administer.
It is not only important to begin treatment in the prehospital setting, the initial dose 
also needs to be adequate. Prepackaged preparations of non intravenous emergency 
AEDs, as are currently available, make it difficult to titrate adequate doses of the
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emergency AEDs. Alternative graduated preparations of emergency AEDs may 
increase the likelihood of administration of adequate doses of AEDs. Failing that, 
carers and or emergency personnel may need to consider practical ways to deliver a 
titred, adequate dose of a suitable emergency AED. One such possibility is to 
measure the dose of AED with a syringe before administration. Thus, prehospital 
treatment with an adequate first dose of a suitable emergency AED may improve the 
outcome of CSE but who should administer such treatment? The data from 
NLSTEPSS suggest that parents are willing to treat children in the prehospital setting 
if emergency treatment is available to them. More than half of children who had a 
previous episode of CSE were treated initially by their parents at home in subsequent 
episodes of CSE and in children with a previous neurological abnormality and an 
incident episode of CSE (n=78), 17% were treated initially by their parents at home. 
None of the children in this North London cohort developed obvious respiratory 
depression following initial treatment of CSE at home, however most received an 
inadequate dose. In children with pre-existing neurological abnormalities, previous 
studies have demonstrated the effectiveness of home treatment with emergency AEDs 
in the early termination of seizures, but there is a risk of respiratory depression 
(Hoppu and Santavuori 1981; Camfield et al., 1989; Kriel et al., 1991). On the basis 
of these findings, it would seem reasonable to make emergency AEDs more widely 
available for parents with children with pre-existing neurological abnormalities. 
However, as there is a risk of respiratory depression and use of AEDs for potentially 
harmful non-medical reasons, paediatricians will need to be selective in determining 
which parents are allowed to administer emergency AEDs. Half of children with CSE 
are previously neurologically normal, and therefore initial treatment of such children 
may only be administered by emergency medical personnel. However, in this study,
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approximately half of incident cases transported to hospital by ambulance were not 
given any prehospital treatment, despite the existence of a stated treatment guideline 
by the London Ambulance Service for children with CSE. Thus, strategies to improve 
prehospital treatment by ambulance personnel need to be explored.
The data from this study confirms the previously reported increased likelihood of 
respiratory depression associated with treatment with more than two doses of 
benzodiazepines (Dieckmann 1994; Norris et al., 1999; Rainbow et al., 2002; Stewart 
et al., 2002). In addition, the data suggest that children that fail to respond to 2 doses 
of benzodiazepine have CSE refractory to benzodiazepines and should not receive 
further doses. Therefore, it is proposed that the use of benzodiazepines in the 
emergency treatment of CSE in childhood should be limited to two doses. In their 
current state, the UK national treatment guidelines for the emergency treatment of 
CSE in childhood are ambiguous as to whether prehospital treatment should be taken 
into account or state that it should be disregarded (Advanced Life Support Group 
2002; The Advanced Life Support Group 2005). The data from this study would 
suggest that clinicians in A&E should regard prehospital treatment as part of the 
emergency treatment of CSE in childhood and therefore, if two doses of 
benzodiazepines have been given prior to arrival at hospital, the initial treatment in 
hospital should be second line therapy.
Randomised controlled trials are expensive, difficult to conduct and in children, are 
fraught with difficulties with consent. These factors make RCTs in children rare and 
the likelihood of RCTs investigating intravenous lorazepam or rectal diazepam as first 
line emergency AED and intravenous phenytoin or rectal paraldehyde as second line
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emergency AED for the treatment of CSE in childhood, is small. In the absence of 
RCTs, observational studies may be the highest level of evidence for the optimum 
treatment of CSE in childhood. The data from the current observational study suggest 
that in A&E, intravenous lorazepam may be better first line therapy than rectal 
diazepam and children with intravenous access should not be treated with rectal 
paraldehyde as second line rescue therapy.
If the treatment data from Chapters 6 and 7 are considered together, they indicate that 
guidelines for the management of CSE may need to be revised to take into account 
their findings and a new guideline proposed by the candidate is illustrated in Figure 
8 . 1.
In summary, the results of this study support the view that CSE in childhood is 
common and that prolonged febrile seizures are the most common type of CSE in 
childhood. In order to further understand the pathophysiological mechanisms of 
prolonged febrile seizures, including the genetic mechanisms, an attempt to categorise 
such forms of CSE in a distinct group should be considered. Genetic, environmental 
and treatment factors may influence the incidence and outcome of CSE. Prehospital 
treatment may improve the outcome of CSE by decreasing the duration of CSE and 
there are data that suggest that first and second line emergency treatment of CSE by 
the intravenous route is superior to treatment by the rectal route. This study also 
provides information on the significant risk of admission to PICU (half of incident 
cases and a third of all occurrences of CSE), the significant risk of recurrence within a 
year (one in six children with an incident episode of CSE) and the short term mortality 
associated with CSE (case fatality of 3%). However, the neurocognitive outcome, the
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risk of subsequent development of epilepsy, the risk of mesial temporal sclerosis and 
the long term mortality associated with CSE in childhood remain unclear and further 
research addressing these areas is needed.
The Management of Convulsive Status Epilepticus
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Figure 8.1: Proposed treatment guideline for convulsive status epilepticus in 
childhood.
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CHAPTER 9: FUTURE DIRECTIONS
To investigate the neurocognitive outcome, the risk of subsequent development of 
epilepsy, the risk of mesial temporal sclerosis and long term mortality associated with 
CSE in childhood, longitudinal studies on a cohort of children with CSE are required. 
The cohort of patients identified in NLSTEPSS would be suitable for such studies but 
more patients would be required to increase the sample size. This could be achieved 
by an extension of the ascertainment methodology already used in NLSTEPSS. 
Longitudinal studies on the morbidity associated with CSE may include MRI 
investigations and comprehensive neurological and neurocognitive assessments of 
children with CSE.
There is already ongoing magnetic resonance (MR) research based in North London 
examining the hypothesis that there is a causative relationship between prolonged 
febrile seizures and mesial temporal sclerosis (Scott et al., 2002; Scott et al., 2003) but 
the possible association of other forms of CSE and MTS has not been investigated.
To date, the research has been centred on a small number (14) of patients who were 
investigated with MRI within 5 days of a prolonged febrile seizures and 4-8 months 
thereafter. MR studies on a large cohort of children with CSE could provide 
longitudinal MR data at discrete short, medium and long term time intervals on a 
much greater number of children with all forms of CSE. A time line on the 
pathological changes that occur in the different forms of CSE could be established and 
would provide the basis for the development of potential anti-epileptic and or 
neuroprotective strategies. MR investigations could be coordinated to allow for 
neurological and neurocognitive assessments on the same day.
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Prehospital treatment is associated with a shorter duration of seizure activity in this 
population of children who all had seizures ultimately lasting at least 30 minutes and 
therefore had difficult to control seizures. This leads to the hypothesis that widespread 
prehospital treatment of seizures that do not spontaneously terminate within five 
minutes may decrease overall duration of seizure activity and decrease the potential 
morbidity and mortality associated with prolonged seizure activity. Audits of 
prehospital treatment of children transported to A&E by ambulance for seizures 
would provide important data addressing this hypothesis. In addition, audits of 
prehospital treatment of children with seizures may identify factors for non-treatment 
or inadequate treatment of seizures in the prehospital setting. Such data may serve as 
the basis for development of strategies to improve prehospital treatment of seizures.
The data from the current study provides evidence in support of the role of prehospital 
treatment in the management of seizures. Within the published literature there is only 
one randomized controlled trial comparing possible prehospital emergency treatment 
of seizures in children (Scott et al. 1999). In that study, which was conducted in a 
population of children with severe epilepsy, enrolled in a residential school, buccal 
midazolam was found to be at least as effective as rectal diazepam. However, it is 
unclear whether it would be effective in the community, in younger children and 
children who were previously healthy. To explore the most effective treatment of 
seizures in the prehospital setting, large community based randomised controlled trials 
will need to be conducted.
There is accumulating evidence for the likelihood of brain damage following 
prolonged febrile seizures having a genetic component. A family history of febrile
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seizures is a major risk factor for febrile seizures in offspring (Waruiru and Appleton 
2004); there is a 38% risk of SE amongst co-twins of monozygotic twins who 
experienced SE (Corey et al., 1998; Corey et al. 2004); polymorphisms in the 
interleukin-1 gene, a gene that encodes a proinflammatory cytokine that modulates 
neurotoxic neurotransmitters, are associated with TLE and hippocampal sclerosis 
(Kanemoto et al., 2000; Kanemoto et al., 2003). Despite these data regarding possible 
genetic factors in the occurrence of prolonged febrile seizures and of seizure-induced 
injury, little is known about the precise genes involved or the mechanism by which 
their influence might be exerted (Cendes et al., 1998; Heils et al., 2000; Kobayashi et 
al., 2001; Baulac et al., 2001; Depondt et al., 2002; Jin et al., 2003; Kobayashi et al.,
2003). Identification of family pedigrees with a history of prolonged febrile seizures 
from the NLSTEPSS cohort would facilitate linkage studies. Multi-centre 
international collaboration amongst research groups with cohorts of children with 
CSE would improve the likelihood of detection of gene polymorphisms associated 
with prolonged febrile seizures and seizure induced brain injury.
In the present work, lower socioeconomic status was independently associated with an 
increased incidence of CSE, suggesting potential environmental influences on the 
development of status epilepticus. However, the precise socioeconomic factors that 
predispose to an increased risk of CSE remain uncertain. Younger maternal age (<25 
years), high school education or less, low income, maternal smoking and alcohol 
consumption during pregnancy, single marital status, little contact with neighbours 
and depression are associated with an increased risk of perinatal problems (Peacock et 
al., 1995; Phares et al., 2004). Maternal smoking and alcohol consumption during 
pregnancy are also associated with the development of febrile seizures during
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childhood (Cassano et al., 1990; Nelson and Ellenberg 1990). A study involving 
detailed structured interviews of families of a cohort of children with CSE may 
provide some insight into possible environmental factors associated with an increased 
risk of CSE.
The North London convulsive STatus EPilepticus in childhood Surveillance Study is a 
major epidemiological study. The results will advance the understanding of 
convulsive status epilepticus and may provide the foundations for improvement in the 
management of convulsive status epilepticus. Data obtained may serve as the basis 
for the development of preventative and improved treatment strategies and have lead 
to the generation of hypotheses surrounding the causal pathways and mechanisms 
underlying convulsive status epilepticus in childhood. The prospects for research 
addressing these areas as well as the morbidity associated with CSE are very exciting 
with the potential of making significant improvements to the lives of children.
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CHAPTER 11: APPENDICES
Appendix 1: Glossary of definitions for the systematic review of population based 
studies of status epilepticus described in Chapter 2.
DEFINITIONS 
1. Status Epilepticus
All studies considered SE as a single seizure or series of seizures without recovery of 
consciousness between seizures lasting at least thirty minutes. The Californian study 
by Wu and colleagues (Wu et al., 2002) excluded non-convulsive SE.
2. Incident cases
The Rochester study (Hesdorffer et al., 1998) defined incident cases as lifetime first 
cases of SE. The Californian study (Wu et al., 2002) defined incident cases as cases 
that were admitted to hospital for the first time with SE in the seven-year study 
period. Incident cases were not clearly defined in the other studies.
3. Age groups
The age groups in the individual study groups are listed in Table A.I.
4. Aetiology
The Californian group's study listed aetiologies (Wu et al., 2002) while five studies 
(DeLorenzo et al., 1996; Hesdorffer et al., 1998; Knake et al., 2001; Coeytaux et al., 
2001; Trevathan et al. 2002) used a classification system for aetiologies which was 
similar across research groups. Aetiologies were classified as either provoked (acute
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symptomatic) or unprovoked. Unprovoked aetiologies were either remote 
symptomatic or idiopathic/cryptogenic (unknown aetiology) (DeLorenzo et al., 1996; 
Hesdorffer et al., 1998; Coeytaux et al., 2001; Knake et al., 2001). In two studies, 
remote symptomatic aetiologies were further classified into those with static CNS 
lesions and those with progressive CNS lesions (Hesdorffer et al., 1998; Coeytaux et 
al., 2001). In two studies, SE was associated with multiple aetiologies (DeLorenzo et 
al., 1996; Knake et al., 2001). prolonged febrile seizures, defined as SE occurring in a 
febrile illness among children in the absence of another acute symptomatic cause, 
including CNS infection, was classified as a special class of acute symptomatic SE in 
the Rochester and North London groups (Hesdorffer et al., 1998; Treiman et al., 
1998).
5. Association with epilepsy
Epilepsy was defined in two of the studies and was defined as two or more seizure 
episodes in a lifetime (DeLorenzo et al., 1996; Coeytaux et al., 2001).
6. SE Seizure Types
The classification of SE type was similar in all studies except the Waterhouse study 
from the Richmond Group that classified SE into continuous or intermittent. All 
studies divided seizure types initially into partial seizures and generalised seizures. 
Except for the Waterhouse study, all studies further divided the partial seizure group 
into simple partial, complex partial, and partial with secondary generalisation and 
generalised seizures were divided into tonic, clonic, tonic-clonic, myoclonic, and
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absence/non-convulsive status epilepticus. Two studies had a separate categorisation 
for seizures that were diagnosed on EEG findings only (subtle SE) (DeLorenzo et al., 
1996; Coeytaux et al., 2001), one had a category for unknown seizure type (Knake et 
al., 2001), and one had a hemi-convulsive seizure category (Coeytaux et al., 2001).
7. Recurrence of SE
The Richmond Group defined recurrence as another episode of SE occurring within a 
two-year follow-up period following an initial episode of SE. The Knake study 
defined recurrence as further episodes of SE during the 2 year study period. The 
Rochester Group did not define recurrence but their retrospective study examined a 
twenty year period.
8. Short term mortality
Three studies defined mortality as the proportion of deaths within 30 days of the cases 
of incident episode of SE (DeLorenzo et al., 1996; Hesdorffer et al., 1998; Knake et 
al., 2001), one study defined it as the proportion of deaths within 60 days of the 
incident episode (Waterhouse et al. 1999), and three studies defined it as the 
proportion of hospital deaths (Coeytaux et al., 2001; Trevathan et al., 2002; Wu et al., 
2002).
9. Long term mortality
The Rochester group defined long term mortality as the number of deaths after initial 
survival for 30 days after intial episode of SE within the population, within 10 years.
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Age Groups Richmond Rochester Germany Switzerland California St. Louis
Children
Adults
Elderly
31 days - 15 yrs 
16 - 59 yrs 
60 yrs and over
Birth - 14 yrs 
15-64 yrs 
65 yrs and over
Excluded 
18-59 yrs 
60 yrs and over
Birth - 14yrs 
15-59 yrs 
60 yrs and over
Birth - 19 yrs 
20-54 yrs 
55 yrs and over
31days - 16yrs 
17-65 yrs 
65 yrs and over
Table A .l: Age groups according to research group.
Appendix 2: Dimensions of Deprivation for IMD 2004 (Office of National Statistics
2004)
Dimensions of 
Deprivation for 
IMD 2004
Weighting Indicators
Income deprivation 22.5% Adults and children in Income Support households (2001).
Adults and children in Income Based Job Seekers 
Allowance households (2001).
Adults and children in Working Families Tax Credit 
households whose equivalised income (excluding housing 
benefits) is below 60% of median before housing costs 
(2001).
Adults and children in Disabled Person's Tax Credit 
households whose equivalised income (excluding housing 
benefits) is below 60% of median before housing costs 
(2001).
National Asylum Support Service supported asylum 
seekers in England in receipt of subsistence only and 
accommodation support (2002).
Employment
deprivation
22.5% Unemployment claimant count (JUVOS) of women aged 
18-59 and men aged 18-64 averaged over 4 quarters 
(2001).
Incapacity Benefit claimants women aged 18-59 and men 
aged 18-64 (2001).
Severe Disablement Allowance claimants women aged 18- 
59 and men aged 18-64 (2001).
Participants in New Deal for the 18-24s who are not 
included in the claimant count (2001).
Participants in New Deal for 25+ who are not included in 
the claimant count (2001).
Participants in New Deal for Lone Parents aged 18 and 
over (2001).
Health deprivation 
and Disability
13.5% Years of Potential Life Lost (1997-2001).
Comparative Illness and Disability Ratio (2001).
Measures of emergency admissions to hospital (1999-002).
Adults under 60 suffering from mood or anxiety disorders 
(1997-2002).
Education, skill 
and training 
deprivation
13.5% Average points score of children at Key Stage 2 (2002).
Average points score of children at Key Stage 3 (2002).
Average points score of children at Key Stage 4 (2002).
Proportion of young people not staying on in school or 
school level education above 16 (2001).
Proportion of those aged under 21 not entering Higher 
Education (1999-2002).
Secondary school absence rate (2001-2002).
Proportions of working age adults (aged 25-54) in the area 
with no or low qualifications (2001
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Housing and 
Services
9.3% Household overcrowding (2001)
LA level percentage of households for whom a decision on 
their application for assistance under the homeless 
provisions of housing legislation has been made, assigned 
to SOAs (2002).
Difficulty of Access to owner-occupation (2002).
Road distance to GP premises (2003).
Road distance to a primary school (2001-2002).
Road distance to a Post Office (2003)
Road distance to a supermarket or convenience store 
(2002).
Crime 9.3% Burglary (4 recorded crime offence types, April 2002- 
March 2003).
Theft (5 recorded crime offence types, April 2002-March 
2003, constrained to CDRP level).
Criminal damage (10 recorded crime offence types, April 
2002-March 2003).
Violence (14 recorded crime offence types, April 2002- 
March 2003).
Living
Environment
deprivation
9.3% Social and private housing in poor condition (2001).
Houses without central heating (2001).
Road traffic accidents involving injury to pedestrians and 
cyclists (2000-2002).
IMD 2004 score = Sum of weighting X dimension scores = (0.225 x Income) + (0.225 
x Employment) + (0.135 x Education) + (0.135 x Health) + (0.093 x Housing) + 
(0.093 Crime)+ (0.093 Environment)
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Appendix 3: Age and Ethnic composition of England and Wales and North London. 
(Office of National Statistics 2004; Office on National Statisitics 2004)
White
(%)
Mixed
(%)
Asian 
_ (%)
Black
(%)
Other
(%)
Total
(%)
ENGLAND AND WALES
Males 0-15 4,679,281
(20)
167,766
(52)
333,065
(29)
149,000
(28)
43,029
(21)
5,372,141
(21)
16-59 13,866,586
(60)
144,649
(44)
717,602
(62)
330,436
(61)
150,677
(73)
15,209,950
(60)
60+ 4,558,423
(20)
12,726
(4)
100,894
(9)
58,594
(H )
13,198
(6)
4,743,835
(19)
ALL 23,104,290
(100)
325,141
(100)
1,151,561
(100)
538,030
(100)
206,904
(100)
25,325,926
(100)
Females 0-15 4,446,880
(18)
162,837
(48)
318,981
(28)
146,988
(24)
40,909
(17)
5,116,595
(19)
16-59 14,030,974
(57)
158,613
(47)
714,639
(64)
397,830
(66)
183,646
(77)
15,485,702
(58)
60+ 5,938,722
(24)
14,443
(4)
88,556
(8)
56,729
(9)
15,243
(6)
6,113,693
(23)
ALL 24,416,576
(100)
335,893
(100)
1,122,176
(100)
601,547
(100)
239,798
(100)
26,715,990
(100)
All 0-15 9,126,161
(19)
330,603
(50)
652,046
(29)
295,988
(26)
83,938
(19)
10,488,736
(20)
16-59 27,897,560
(59)
303,262
(46)
1,432,241
(63)
728,266
(64)
334,323
(75)
30,695,652
(59)
60+ 10,497,145
(22)
27,169
(4)
189,450
(8)
115,323
(10)
28,441
(6)
10,857,528
(21)
ALL 47,520,866
(100)
661,034
(100)
2,273,737
(100)
1,139,577
(100)
446,702
(100)
52,041,916
(100)
NORTH LONDON
Males 0-15 153790
(16)
24073
(47)
65937
(28)
54978
(31)
9378
(20)
308156
(21)
16-59 635463
(67)
25184
(49)
148794
(63)
102681
(59)
43781
(92)
947012
(65)
60+ 159478
(17)
2376
(5)
22564
(9)
17722
(10)
3110
(7)
205250
(14)
ALL 948731
(100)
51633
(100)
237295
(100)
175381
(100)
47378
(100)
1460418
(100)
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Females 0-15 146770
(15)
23584
(42)
63661
(27)
54369
(26)
8780
(16)
297164
(19)
16-59 643284
(64)
29773
(53)
151156
(65)
137100
(65)
43781
(78)
1005094
(64)
60+ 215799
(21)
2569
(5)
19286
(8)
18470
(9)
3719
(7)
259843
(17)
ALL 1005853
(100)
55926
(100)
234103
(100)
209939
(100)
56280
(100)
1562101
(100)
All 0-15 300560
(15)
47657
(44)
129598
(27)
109347
(28)
18158
(18)
605230
(20)
16-59 1278747
(65)
54957
(51)
299950
(64)
239781
(62)
78671
(76)
1952106
(65)
60+ 375277
(19)
4945
(5)
41850
(9)
36192
(9)
6829
(7)
465093
(15)
ALL 1954584
(100)
107559
(100)
471398
(100)
385320
(100)
103658
(100)
3022519
(100)
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Appendix 4: Forest plot of strategies to improve the response to postal questionnaire. 
Pooled odds ratios and 95% confidence intervals for the 40 different strategies, 
divided into eight categories, are illustrated. The combined trials included more than 
1000 participants (Edwards et al 2002).
S**egy 
Incentives
Monataiy incentive v no incentive
No of trials 
(No of participants)
40 (46474)
Odds ratio
(86% a )
2 02 (1 79 to 2 27)
Incentive wrth questionnaire v incentive on retim 10 (13 713) ■" ♦ —1 1 71 (1.29102.26)
Non-monetary incentive v no ncantive 45 (44 708) ♦ 1 19(1.11 to 1.28)
LangVi
Shorter v longer questionnaire 40 (40 668) 1 86 (1.5510 2.24)
A ppunnct 
Brawn envelope vwhrte 
Coloured ink v standard
2 (5311) 
1 (3540)
.......- 1 52 (0.67 to 3.44) 
1 30 (1.16 to 1.67)
Folder or bocMet v stapled pages 2 (1845) 1 17 (0.94 to 1.45)
Mora personalised vless personahsed 38 (36 210) ♦ 1 16 (1.06 to 1.28)
Identifying teatore on return vnone 7 (4014) 1 06 (0 78 to 1 51)
Coloured questionnaire v while 8 (14 797) 1.06 (0.99 to 1.14)
Delivery
Recorded debvery v standard
Stamped returned envelope vbusmess reply or tranked
6 (2127) 
14 (38256)
.... . 221 (1.51 to 3.25) 
126 (1.13to 1.41)
Questionnaire sent to work address v home address 2 (1140) 1 16 (0.89 to 1 52)
first dess outward maikng v otter dass 1 (7370) ♦ 1 12 (1.02 to 1.23)
Pre-pant return envelope v not pre-p»d 
Stamped outward envelope v franked
4 (4064)
6 (13664) 4
« _ 1.09 (0.71 to 1.68) 
0.95 (0.88 to 1.03)
Commamoratve stamp v ordnary stamp 4 (5238) 0.92 (0.78 to 1.09)
Contact
Pracontacl vnopreconlact 28 (28 793) 1 54 (1 24 to 1 92)
Follow cp v no Mow up 12 (16 740) * ♦ - 1 44 (1.22 to 1.70)
Postal Mow ip  ndudng quesborrare vpoetal Mow up 
exdudng questionnaire 
Manbon of Mow up contact v none
6 (6310) 
6 (6553)
4 .... 1 41 (1.02 to 1.94) 
1 04 (0.91 to 1.18)
Preconlact by telephone v po6t 2 (1375) 0.90 (0.70 to 1.16)
Content
More nteresbng viess interesting questonnaire 2 (2151) .. 2 44 (1.99 to 3.01)
User fnendly questionnaie v standard 1 (3540) -4"* 1.46 (1.21 to 1.75)
Factual questions only v factual and antudnal 1 (1280) ♦ 1 34 (1.01 to1 77)
More relevanl questions irst v otter items Irst 1 (5817) ♦ 123 (1.10 to 1.37)
Demognphrc items irst v other items first 2 (1040) 1.04 (0.81 to 1.34)
"Don't know* boxes mduded vnol nduded 1 (1360) 1 03 (0.82 to 1.29)
Sensitive quesbon included v no sensitve quesbon 6 (19851) 4 0.92 (0 87 to 0.98)
Most general question first v Iasi 1 (2000) 0 80 (0.67 to 0.96)
Origin
University sponsorship or as source v other or gams ab on 13 (20 428) - 4- 1 31 (111 to1.54)
Sent by more sentor or wel known person v less senor 4 (2584) 1.13(0.9510 1 35)
or less web known 
E Sneaky umdenbiablerwhite name v other name 2 (1800) 1 11 (0 91 to 1 36)
Communication
Explanabon lor not pariopabng requested vnct requested 1 (1240) ■ "♦.. 1 32 (1.05 to 1 66)
Appeal stresses benefit to respondent v other 6 (9332) 4 - 1 06 (0.92 to 1.22)
Appeal stresses benefit to sponsor v otoer 7 (9708) 101 (0.86 to 1.19)
Appeal stresses benefit to sooely v other 8 (10 088) 1 00 (0.84 to 1.20)
Response deadline given vno deadhne 4 (4340) 1 00 (0.84 to 1.20)
instiuctions given vnot given 1 (2000) 0.89 (0.74 to 1.06)
Choice to opt out from study given vnone 3 (3045) 0 76 (0 65 to 0 89)
01 02  05 1 2 3 4 5
Response lower Response higher
with (Irst category with first category
P vatu* tor 
heterogenety
<0.00001 
<0.00001 
<0 00001
<0.00001
<0 00001
<0 00001 
<0 001
<0.01 
<0 00001
<0 00001
<0 00001 
<0 0001 
<0.00001
<0 00001
<0 05 
<001 
<0 05
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Appendix 5: Template of Monthly surveillance forms from BPSU-like scheme
NLSTEPSS - No r t h  Lo n d o n  c o n v u l s iv e  s t a t u s  T F il e p t ic u s  in  
c h il d h o o d  Su r v e il l a n c e  S tudy
Surveillance Report Card Month-year
Code [«Source»«Number»]
Dear «Title» «FirstName» «LastName»:
Thank you for assisting in this important study. Please complete this form and return it in the 
enclosed self addressed envelope.
Indicate below, in the appropriate box, the number of cases of convulsive status epilepticus 
(SE) aged between 29 days to 15 years you have seen or been informed of this month of 
February.
If no cases have been seen or have presented to your department, then please
tick NO CASES. If there have been cases, please also provide the patient details below.
The working definition of convulsive status epilepticus being used is “A seizure with focal or 
generalised motor manifestations, or series of such seizures between which consciousness is 
not regained, which last for 30 minutes or more.”
NO CASES □ Cases of status epilepticus □
Patient’s Initials DOB Registration Number Date of SE
Yours sincerely,
Richard Chin
Clinical Research Fellow in Paediatric 
Neurosciences
Rod Scott
Wellcome Advanced Fellow and Lecturer in 
Paediatric Neurology
Brian Neville
Professor of Paediatric Neurology
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Appendix 6: Templates of reminders to non-responders to the Monthly surveillance
forms from BPSU-like scheme.
NLSTEPSS - No r t h  Lo n d o n  CONVULSIVE STATUS EPILEPTICUS IN 
c h il d h o o d  S u r v e il l a n c e  S tudy
Surveillance Report Card January - 2003
Code [«Source»«Number»]
Dear «Title» «FirstName» «LastName»:
Thank you for assisting in this important study. Unfortunately, we did not receive a reply for 
January. Please complete this form and return it in the enclosed self addressed envelope.
Indicate below, in the appropriate box, the number of cases of convulsive status epilepticus 
aged between 29 days to 15 years you have seen or been informed of, for the month of 
January.
If no cases have been seen or have presented to your department, then please
tick NO CASES. If there have been cases, please also provide the patient details below.
The working definition of convulsive status epilepticus being used is “A seizure with focal or 
generalised motor manifestations, or series of such seizures between which consciousness is 
not regained, which last for 30 minutes or more.”
NO CASES □ Cases of status epilepticus □
Patient’s Initials DOB Registration Number Date of SE
' * ‘  i  C ' Y *  \ '
• '  '  ' 1 -  
-v 'y .  y
- 0
1
* 1 
'  \
'  %
1 '  \  u  -
> '  s  *  /  '  "
Yours sincerely,
Richard Chin
Clinical Research Fellow in Paediatric 
Neurosciences
Brian Neville
Professor of Paediatric Neurology
Rod Scott
Wellcome Advanced Fellow and Lecturer in 
Paediatric Neurology
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Appendix 7: Information sheets on NLSTEPSS sent to all paediatricians in North 
London
NLSTEPSS (North London convulsive STatus EPilepticus in childhood Surveillance Study)
INFORMATION SHEET for HEALTH PROFESSIONALS
Objective:
Principal
Investigators:
Duration: 
Coverage:
To determine the incidence, seizure types, treatment strategies, and short term 
mortality of convulsive status epilepticus in a population of children aged between 
29 days to 15 years in North London.
Dr. Rodney Scott 
Wellcome Advanced Fellow and 
Lecturer in Paediatric Neurology 
The Wolfson Centre 
Dr. Richard Chin 
Clinical Research Fellow 
Neurosciences Unit 
The Wolfson Centre 
Mecklenburgh Square 
Professor Brian Neville 
Professor of Paediatric Neurology 
Neurosciences Unit 
The Wolfson Centre 
Mecklenburgh Square 
May 2002 for 24 months; extension subject to review
London Boroughs of Barnet,, Brent, Camden, City of London, Enfield, Hackney, 
Hammersmith & Fulham, Haringey, Harrow, Islington, Kensington & Chelsea, 
Newham, Tower Hamlets, City of Westminster, Waltham Forest.
Case Definition: Report any child aged 29 days to 15 years with convulsive status epilepticus (CSE).
1) include :Febrile children with a seizure with focal or generalised motor 
manifestations, or series of such seizures between which consciousness 
is not regained, which last for 30 minutes or more.
2) include: Afebrile children with a seizure with focal or generalised 
motor manifestations, or series of such seizures between which 
consciousness is not regained, which last for 30 minutes or more
3) exclude:
i) children with non-convulsive status epilepticus
ii) children younger than 29 days
iii) children 16 years or older
iv) children whose seizure is less than 30 minutes
If in doubt please discuss with the Co-ordinating Centre ( )
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Reporting instructions:
1. As soon as possible after presentation to your service, please notify by 
telephone to the NLSTEPSS  Co-ordinating Centre (  
), any child with CSE (febrile or afebrile) according to 
the case definition above. Please leave your name, telephone number, 
patient date of birth, patient sex, patient hospital registration number, 
and the patient’s full home postal code.
2. In addition, on the monthly surveillance cards please report all cases of 
CSE (febrile or afebrile) according to the case definition above which 
you have seen or made aware of in the last month.
Both methods of reporting are needed for maximum ascertainment. The aim is to be over- 
inclusive so if in doubt, please discuss with the NLSTEPSS  Co-ordinating Centre (  
).
Study Design: All children aged 29 days to 15 years with convulsive status epilepticus
within the North London region are being notified to the NLSTEPSS  Co­
ordinating centre. The patient’s postal code will be checked on a database 
held by the Co-ordinating centre to determine eligibility for the study based 
on residence in North London. If the patient is eligible you will be 
contacted by telephone as soon as possible to confirm eligibility. If the 
patient is not eligible, then no further information will be sought. If the 
patient is eligible for the study, the patient will be anonymised and a coded 
study identification number generated by the Co-ordinating centre and 
provided to the local researcher at your centre. Within five days of 
notification, a telephone questionnaire will be conducted with a member of 
the local paediatric team. All the information sought from the reporting 
local paediatric team will be available from medical records.
The study aims to obtain patient data from medical records and it is not the 
intention of the Co-ordinating centre to take over the clinical management 
and investigation of patients by participating centres. Neither is it intended to 
change the referral system as it currently exists.
Paediatric Intensive Care Consultants will be approached together with all 
Paediatricians. All Neurophysiology and Accident and Emergency 
Consultants who help to manage patients from North London will be 
independently approached regularly for any cases presenting or known to 
them. Patient officer databases, paediatric admission databases, A&E 
databases in each participating hospital will also be reviewed.
Ethical Approval: London MREC
Further information available on request or access our web-page under the Neurosciences unit, 
Institute of Child Health http://www.ich.ud.ac.uk/nlstepss
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Appendix 8: Template of letter publicising and requesting assistance in NLSTEPSS. 
Letters were sent to all paediatricians in North London.
[Date]
[Name of Doctor]
[Address of Doctor]
Dear [Name of Doctor]
NLSTEPSS (North London convulsive STatus EPilepticus in childhood Surveillance Study)
We would like to ask for your assistance in a prospective surveillance study on the 
epidemiology of status epilepticus in childhood. The study design is similar to that of 
the British Paediatric Surveillance Unit but will be regional rather than national and 
will involve 22 centres that provide treatment for children who live in North London.
A Research Collaborative Group has been formed and is made up of Consultants from 
each of the participating centres. The research will be co-ordinated through the 
NLSTEPSS Co-ordinating Centre.
We understand how busy you are and we have kept the information required down to 
a minimum but are very grateful for your help.
You can help us by :
1) Completing the yellow surveillance card that will be sent to you monthly and
2) To telephone report to the NLSTEPSS Co-ordinating Centre (  
), all cases of convulsive status epilepticus as soon as possible after 
presentation.
Should you have any questions then you could contact either your local collaborator, 
or Dr. Richard Chin or Dr. Rodney Scott or Professor Brian Neville. For full contact 
details please see enclosed NLSTEPSS Information Sheet.
We have also enclosed a flyer.
The study commencement date is May 1, 2002.
Yours sincerely,
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Appendix 9: Questionnaire (Admission Proforma) used in NLSTEPSS
CLERKING PROFORMA
for
Status Epilepticus in Childhood
Date of completion of Proforma:
Time of completion of Proforma:
Attach label here
Name: Address
HosDital Number
Date of Birth Post Code
Sex
Consultant:
GP Name:
GP Address: 
GP Telephone:
PROBLEM LIST:
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History taken from:
Were there any difficulties in obtaining the history? Yes □ Non
If YES, please specify:
1. History of Presenting Complaint
a) Date of status epilepticus (if different):
b) Time of onset of status epilepticus: __
(From witness)
:__ am / pm
c) What time was the ambulance called ? __ :___
(see ambulance notes)
am / pm N/An
d) What time did the ambulance arrive to the child?
(see ambulance notes)
—  • — am / pm N/A n
a) What time did the ambulance arrive to A&E?
(see ambulance notes)
—  • — am / pm N/A n
f) Time of termination of status epilepticus: am / pm
g) Total duration of status epilepticus
h) Did the parents think the child was febrile? Yes □ Non Unsure n
If yes, did they measure the temperature? 
What was the temperature recorded?
Yes □ Non
i) Was the seizure onset Focal □ or Generalised □
j) Vital Observations oh admission
GCS
(See below)
Temp Pulse CRT BP RR 0 2 Sats
Eyes Opening
Score >1 year < 1 year
Spontaneously Spontaneously
To verbal command To shout
To pain To pain
No response No response
Best Motor Response
Score year < 1 year
Obeys Spontaneous
Localises pain Localises pain
Flexion - withdrawal Flexion -  withdrawal
Flexion - abnormal 
(Decorticate rigidity)
Flexion -  abnormal 
(Decorticate rigidity)
Extension Extension
No response No response
Best Verbal response
Score >5 yrs 2-5 yrs 0-23 months
Orientated and converses Appropriate words and 
phrases____________
Smiles, coos
Disorientated and converses Inappropriate words Cries, unconsolable
Inappropriate words Persistent screams or cries Persistent inappropriate 
crying/screaming
Incomprehensible
Grunts
Grunts_____
No response
Grunts or restless 
No response
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1. History of P resen ting  Com plaint (Continued)______
k) In the space below, please give further details of HPC:
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2. TREATMENT OF STATUS EPILEPTICUS
Treatment given for status epilepticus including at home, by the paramedics, and 
on arrival to hospital: (Please continue on separate sheet if necessary)
Home/paramedics/
hospital
Drug Dose Route Time 
given 
(h r: min)
Complications 
of treatment
For example:
How-e P R 0 0 : 1 5 N il
3. PERINATAL HISTORY__________________________________________
a) Is this child a: Singleton □ Twin I □ Twin II □ OtherD
b) Place of Birth
c) Gestation ( in weeks)
d) Type of Delivery Spontaneous Vaginal Delivery □
Other □
If other, please give details
e) Birth Weight
f) Were there any problems during Pregnancy, Labour, Delivery, or the Neonatal 
period? YesD NoD DKn
If yes, please specify :
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4. DEVELOPMENT______________________________________________________
a)
Were there any parental concerns about any aspect of their child’s development 
prior to this episode of status epilepticus? Yesn Non DK □
If yes, please specify :
b) To the best of the parent’s recollection, when were these Milestones achieved:
Social smile at____weeks Walked unaided at____ months
First words a t____ months Putting words together a t  months
c) If the child is of school age:
- Does the child need special help in school? YesD Non
- Is the child statemented? Yesn Non
5. PAST MEDICAL HISTORY
a) Has the  patien t previously  been  d iag n o sed  with ep ilepsy  o r h as  had 
previous seizure(s), o r h a s  had  a “funny tu rn ”? Yes n No n DKn
If No or Don’t Know then please go to Q5 (b)
If the answer is Yes, please continue and specify the following :
i) Age of patient at first seizure/”funny turn”:
ii) Cause (if known):
b) D oes the  child have any  o th er m edical illn e sse s?  Yes n N on
If Yes, then please specify:
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5. PAST MEDICAL HISTORY (Continued)
c) Has the  patien t previously  been adm itted  to  hospital for s ta tu s  ep ilep ticus 
o r any o ther illn e sse s?  YesD Nod DK D
If Yes, please complete the table below :
Date Age Hospital Duration of 
admission
Cause 
(if known)
d) H as the patien t previously  been  investigated  for se iz u re s?  Yes □ No □
EEG Yes □ No □ Date: NormalD Abnormal □
CT of Brain Yes □ No □ Date: NormalD
Abnormal □
MRI of Brain Yes □ No □ Date: NormalD Abnormal □
If any abnorm al, specify  hospital w here  te s t perform ed and  result:
e) Is the  patien t currently  on any anti-epileptic m edication(s) o r any o th er 
m edication? YesD Nod DK d
If the answer is No or Don’t Know then please go to Q 5 (f)
If the answer is Yes, please complete the table below:_______________________
Medication Dose and frequency Dose (mg/kg)
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5. PAST MEDICAL HISTORY (Continued)_________________________________
f)
i) P rev ious anti-epileptic m edications 
ii) P lease  outline any  change  in m edication type/ d o sa g e  in the  last 2/52
g) Most recen t anti-epileptic m edication levels and  date:
Date Medication Level Normal range
h) Any Drug a llerg ies?
If yes, please specify
YesD Non
i) Is the  patien t fully im m unised for a g e?
If NO, please specify reason:
YesD Non
j) P lease  outline any  o th er sign ifican t m edical h istory
6. TRAVEL HISTORY
Any recent travel overseas 
If yes, please specify
Yesn Non
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7. FAMILY HISTORY
a) Please draw family tree
b) Is there any consanguinuity? YesD NoD
If YES, please specify
c) Is there a family history of seizures or developmental problems?
Yes □ No □ 
DK □
If YES, please specify:
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8. Social History____________________________
a) P lease  outline any  significant social history:
b) W hat ethn ic  g roup  d o e s  the  patien t belong to?
(Can check nursing notes)________________________
Mixed Asian/Asian British
White and Black Caribbean □ Indian □
White and Black African □ Pakistani □
White and Asian □ Bangladeshi □
Other - please state □ Other - please state □
White Biack/Black British
British □ Caribbean □
Irish □ African □
Other - please state □ Other - please state □
C hinese o r o th er Ethnic Group
Chinese □
Other - please state □
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EXAMINATION
9. EXAMINATION WITHIN 30 MINUTES POST TERMINATION OF STATUS
GCS Tem p Pu lse  CRT BP RR 0 2 S a ts
Any dysm orphic  fea tu res? : YesD NoD 
If yes, please specify:
Don’t Know D
Any birthm arks o r congenita l abnorm alities of the  skin o r hair?
YesD NoD Don’t Know D 
If yes, please specify:
Head Circum ference: Percentile:
W eight: Percentile:
Height: Percentile:
Is the  head  sh a p e  norm al? Normal D 
If abnormal, please specify
AbnormalD Don’t KnowD
ENT Normal D 
If abnormal, please specify
AbnormalD Don’t KnowD
C ardiovascu lar system  Normal D 
abnormal, please specify
AbnormalD Don’t KnowD
R espiratory  sy stem  Normal D 
If abnormal, please specify
AbnormalD Don’t KnowD
A bdom en Normal D 
If abnormal, please specify
AbnormalD Don’t KnowD
Genitalia Normal D 
If abnormal, please specify
AbnormalD Don’t KnowD
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9. EXAMINATION WITHIN 30 MINUTES POST TERMINATION OF STATUS
(CONT’D)______________________________________________________________
W ere you ab le  to  s e e  the  optic fundi? YesD NoD
If yes, please specify findings:
Neurological exam ination : Normal D AbnormalD 
If abnormal, please specify abnormality:
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10. INVESTIGATIONS & RESULTS
TESTS Y/N DATE RESULTS
11. OUTCOME
a) Patient survived? YesD NoD
b) Patient transferred to PICU?
If yes, please specify which PICU:
YesD Nod
Provisional diagnosis:
Signature of person completing Proforma: 
Name of person completing Proforma: 
Position of person completing Proforma 
Bleep of person completing Proforma
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12. DISCHARGE NEUROLOGICAL EXAMINATION FINDINGS
Did you find any p rob lem s with the cranial n e rv es?  YesD 
If yes, please give details below
Nod
Did you find any  prob lem s with tone, power, coordination , se n sa tio n  or 
reflexes in the  lim bs? YesD NoD 
If yes, please give details below
W ere you able to  s e e  the  optic fundi? YesD 
If yes, please specify findings:
Nod
Any o ther abnorm alities of the  nervous sy s te m ?  YesD 
If yes, please specify findings
Nod
Signature of person doing discharge examination: 
Name of person doing discharge examination: 
Position of person doing discharge examination: 
Bleep of person doing discharge examination
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Appendix 10: Data collection form for retrospective group in PICU study described 
in Chapter 7
GOSH PICU Status Epilepticus
Attach label here
2. Name: 3. Post Code
4. Date of Birth
6.GOSH Rea Number
7.Consultant:
8.Referrina HosDital
5.Sex: M F
9.GP Name:
10.GP Address:
11.GP TeleDhone:
12.Patient Details - Ethnic Origin of patien t 
Mixed
1) White and Black Caribbean □
2) White and Black African □
3) White and Asian □
4) Other - please state □
White
9) British □
10) Irish □
11) Other - please state □
C hinese or o ther Ethnic Group
15) Chinese □
16) Other - please state □
Asian/A sian British
5) Indian □
6) Pakistani □
7) Bangladeshi □
8) Other - please state □
Black/Black British
12) Caribbean □
13) African □
14) Other -p leasesta te  □
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STATUS EPILEPTICUS EVENT DETAILS_________________________________
13. Date of status epilepticus:_____________________________________________
14. Time of onset of status epilepticus:  :____ am / pm
(From witness)_______________________________________________________________________________
15. What time was the ambulance called ? __ :  am / pm N/A □
(see ambulance notes)_________________________________________________________________________
16. What time did the ambulance arrive to the ch ild ?  :  am / pm N/A □
(see ambulance notes)_________________________________________________________________________
17. What time did the ambulance arrive to A&E? ___:  am / pm N/A □
(see ambulance notes)_________________________________________________________________________
18.Time of clinical termination of status e p ile p t ic u s :__ : ____ am / pm
19. Did the parents think the child w as febrile? 1) Y 2) N 3) Unsure/DK
20. If yes, did they m easure the temperature? 1) Y 2) N
21. What w as the temperature recorded? 0 C
22. Was the seizure onset 1) Focal □ or 2) Generalised □
23.Description of SZ:
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STATUS EPILEPTICUS EVENT DETAILS - Treatment of SE
24.Treatment given for status epilepticus including at home, by the paramedics, and on 
arrival to hospital: (Please continue on separate sheet if necessary)
Home/paramedics/
hospital
Drug Dose Route Time 
given 
(h r: min)
Complications of 
treatment
For example:
H om e b la z e p a m 3 m g PRL 0 6 : 1 5 N il
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25. Ventilated Y/N
26. Time of Entubation __ :___ am / pm
27. R eason  for Ventilation 1. Safety of tran sfe r
2. R espiratory  insufficiency
a) compromised airway
b) decreased resp drive
c) sats<95 and/or cap pC02> 6.5kPa
3. GCS<8
4. C ause  not specified
28. Child paralysed  for T ransfer Y/N
29. EEG m onitoring for SZ 
control
Y/N
30. If yes, tim e of Sz
term ination (based  on EEG)
__ :___ am / pm
Patien t Details - PERINATAL HISTORY
Q31.
1) Singleton 2) Twin 1 3) Twin 2 4) Other
32. . G estation  (/40):
33. Induced: 1)Y es
34. Type of Delivery :
1) Vaginal 2) Elec C/S
2) No 3) Don't Know
3) Emer C/S 4) Forceps 5) Ventouse
6)Forceps and 7) Ventouse 
C/S and C/S
8)Forceps and 9) Other 
Ventouse
35. Birth W eight (in kgs):
36. APGARS: @1 @5
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@10
37. Perinat. P ro b 's 1) Yes 2) No 3) Don't Know
38. If yes to  perinatal problem s:
a) Maternal DM 1) Yes 2) No 3) Don't Know
b) G estational DM 1) Yes 2) No 3) Don't Know
c) HPT pre-pregnan 1) Yes 2) No 3) Don't Know
d) HPT in p regnancy 1) Yes 2) No 3) Don’t Know
e) P re-eclam psia 1) Yes 2) No 3) Don't Know
f) Infection 1) Yes 2) No 3) Don't Know
g) Social Drugs 1) Yes 2) No 3) Don't Know
h) Prem  ROM 1) Yes 2) No 3) Don't Know
i) Prolong ROM 1) Yes 2) No 3) Don't Know
j) A dvanced re su s 1) Yes 2) No 3) Don't Know
k) SCBU 1) Yes 2) No 3) Don't Know
1) Ventilated 1) Yes 2) No 3) Don't Know
m) Seizures 1) Yes 2) No 3) Don't Know
n) HIE 1) Yes 2) No 3) Don't Know
o) ICB/IVH 1) Yes 2) No 3) Don't Know
p) H ydrocephalus 1) Yes 2) No 3) Don't Know
- 2 4 9 -
Patient Details - D evelopm ent
39. Any developmental abnormalities?
40. If yes, please specify :
1) Yes 2) No 3) DK
If the child was of school age:
41. Did the child need special help in school?
42. Was the child statemented?
1) YesD 2) Nod
1) YesD 2) NoD
Patien t Details - Family &Social H istory
43. Was there any consanguinuity? 1) YesD 2) NoD
44. If YES, please specify
45. Was there a F/HX of seizures or developmental problems?
46. If YES, please specify:
1)Y 2) N 3)DK
Patient Details - PMH- Previous Sz___________________________________________
47. Had the  patien t previously  been  d iag n o sed  with e p ile p s y , h a s  had previous 
seizure(s), o r had a “funny tu rn”?  1 )Y 2) N 3)DK
If the answer is No or Don’t Know then please go to Q62
If the answer is Yes, please continue and specify the following :
48. Age of patient at first seizure/”funny turn”:
49. Cause /diagnosis (if known):
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Patient Details - PMH -P ast Hospital adm iss ions
50. W as the patien t previously been adm itted  to  hospital for s ta tu s  ep ilep ticus or 
prolonged febrile convulsion or any  o ther illn e sse s?  1 )Y 2) N 3)DK
51. If yes, please complete the table below :
Date Age Hospital Duration of 
admission
Cause (if 
known)
Patien t Details - PMH -P ast Hospital ad m iss io n s___________________________
52. Prior to SE, had the patient previously been investigated for seizures? Y N
53. EEG Yes □ No d Date: NormalD Abnormal D
54. CT of Brain Yes □ No d Date: NormalD Abnormal D
55. MRI of Brain Yes □ No d Date: NormalD Abnormal D
56. If any abnormal, specify hospital where test performed and result:
Patient Details - PMH -M aintenance AED's_____________________________________
57. W as the  patien t on any anti-epileptic m edication(s) o r any o ther m edication?
1)Y 2) N 3)DK
If the answer is No or Don’t Know then please go to Q61
58. If the answer is Yes, please complete the table below:__________________________
Medication Dose and frequency Dose (mg/kg)
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Patient Details - PMH -Previous AED's
Q59. - P revious m edications 
Q60 - P lease  outline any change  in m edication type o r d o sa g e  in the  las t 2/52
Patien t Details - PMH -M aintenance AED levels
61. Most recen t anti-epileptic m edication levels and  date:
Date Medication Level Normal range
Patient Details - PMH -Other significant PMH
62. Any o ther relevant p a s t m edical h isto ry? YesD NoD 
63.If yes, please specify :
Don’t Know D
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EXAMINATION
EVENT EXAMINATION - VITALS ON ADMISSION (Q64-Q70)
GCS Temp Pulse CRT BP RR O2 S ats
EVENT EXAMINATION - < 30 MINS POST TERMINATION OF SE (Q70-Q76)
GCS T em pPulse CRT BP RR 0 2 S a ts
77.Any dysm orphic fea tu res? :
78.If yes, please specify:
1 )YesD 2) NoD 3) Don’t Know □
79.Any birthm arks o r congenital abnorm alities of skin / hair?  1) Y 2) N 3) DK
80.lf yes, please specify:
81 .Head Circum ference: 
83.W eight:
85.Height:
82. Percentile: 
84. Percentile: 
86. Percentile:
87. Lymph nodes
88. if abnormal, please specify
1) Normal □ 2) AbnormalD 3) Don’t KnowD
89. Is the  head sh a p e  norm al? 1) Normal □
90. If abnormal, please specify
2) AbnormalD 3) Don’t KnowD
91. C ardiovascular system
92. If abnormal, please specify
1) Normal □ 2) AbnormalD 3) Don’t KnowD
93. R espiratory  sy stem
94. If abnormal, please specify
1) Normal □ 2) AbnormalD 3) Don’t KnowD
95. Abdom en
96. If abnormal, please specify
1) Normal □ 2) AbnormalD 3) Don’t KnowD
97. Genitalia
98. If abnormal, please specify
1) Normal □ 2) AbnormalD 3) Don’t KnowD
99. Neurological exam ination : 1) Normal □
100. If abnormal, please specify abnormality:
2) AbnormalD
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PICU C O U R S E
CVS
101. Lowest Systolic BP
102. Lowest HR
103. Highest HR
104. Cardiac Arrest
105. Lowest pH (with normal PaC02)
106. Inotropic support needed Y/N
Respiratory Syste m (G 107-127)
Time PARAMETERS
Min
VR
Max
VR
Max
spont
RR
Max
MAP
Min
Pa02
Min
Pa02/
Fi02
Max
PaC02
Max
Ol
Ventilation
Duration
Throughout Admission
At lowest Vent Rate (VR) N/A N/A N/A
At highest VR N/A N/A N/A
Nervous System
128. Lowest GCS
129. Fixed dilated pupils Y/N
Haematological
130. Lowest Hb See Inv Results
131. Lowest WBC See Inv Results
132. Lowest Platelets S ee Inv Results
Renal System
133. Highest Urea See Inv Results
134. Highest Creatinine See Inv Results
135. Dialysis Y/N
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EVENT DETAILS - DISCHARGE EXAMINATION FINDINGS
135. Did you find any  problem s with the  cranial ne rv es?  1) YesD 
136.If yes, please give details below
2) Nod
137.Any problem s with tone/ power/ coord ination /sensation / reflexes in the  lim bs?
1) YesD 2) NoD Q138.If yes, please give details below
139.W ere you able to  se e  the  optic fundi? 1) YesD
140.If yes, please specify findings:
2) Nod
141 .Any o ther abnorm alities of the  nervous sy stem  ?  1) YesD
142.If yes, please specify findings
2) Nod
EVENT DETAILS ■ OUTCOME___________________________
143.Patient survived? 1)YesD 2) NoD
144.Provisional diagnosis:
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EVENT DETAILS - INVESTIGATIONS
A) BLOOD Y/N Date Results
145. Full Blood Count Hb WBC Pit
146. Lowest Hb
147. Lowest WBC
148. Lowest Platelets
149. Differential WBC Neut Lymp
150. ESR
151. CRP
152. Glucose
153. Urea and Electrolytes Na K C 02  
Urea Creatinine
154. Highest Urea
155. Highest Creatinine
156. Calcium
157. Magnesium
158. Antiepileptic drug level 
LMT
Carbamazepine 
Phenytoin 
Phenobarbitone 
Propofol Thiopentone 
Valproate
(Others - List names)
159. Lowest pH (with 
normal PaC02)
160. Lactate
161. Ammonia
162. Serum Amino Acids
163. Blood Virology
164. Blood Culture
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165. Other Blood tests
B) CSF (If applicable)
166. Cell Count RBC WBC 
Org
167. Protein, Glucose, 
lactate
Protein Glucose Lac
168. Culture &S
169. Virology including 
HSV, echo, entero, adeno, 
coxsackie, HHV 6,
HHV7
170. Saved CSF
171. Other CSF
EVENT DETAILS - INVESTIGATIONS
Urine
172. Organic Acids
173. Amino Acids
174. Culture
175. Dipstix
176. Other
Genetics/lmaging/EEG
177. Chromosomes
178.Other Genetics
179.MRI
180.CT
181.Cranial U/S
182.EEG
-2 5 7 -
m other
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